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A voi, 
che rendete la mia vita speciale… 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Una storia come la mia non andrebbe mai raccontata, perché il 
mio mondo è tanto proibito quanto fragile, senza i suoi misteri 
non può sopravvivere. 
Di certo non ero nata per una vita da geisha, come molte cose 
nella mia strana vita, ci fui trasportata dalla corrente. 
La prima volta che seppi che mia madre stava male, fu quando 
mio padre ributtò in mare i pesci, quella sera soffrimmo la fame, 
"per capire il vuoto", lui ci disse. 
Mia madre diceva sempre che mia sorella Satsu era come il 
legno, radicata al terreno come un albero sakura. 
Ma a me diceva che ero come l'acqua, l'acqua si scava la strada 
attraverso la pietra, e quando è intrappolata, l'acqua si crea un 
nuovo varco. 
 
“Memorie di una Geisha” 
Arthur Golden  
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Preface 
 
n the last decade, Nanotechnology and its applications have been among the 
research topics of great interest in the scientific community. In particular, 
nanomedicine has perhaps been the most popular application due to its potential 
as a tool directed towards life quality improvement and welfare. 
As part of a multidisciplinary approach including different scientific disciplines (chemistry, 
physics, biology and medicine), this research project is only a “brick” in a much larger 
building-project which aims to the synthesis of new nanosystems as both novel diagnostic 
and therapeutic agents. The work of a chemist is therefore fundamental for the construction 
of these new nanoscopic "objects" that have to be characterized in terms of their chemical 
and  physical properties, as well as for their biological activities. Medical applications are an 
ambitious, but possible goal for the future. 
Being an organic chemist, the approach I used was to consider the nanoparticles used in this 
project as molecules, and consequently to study their surface reactivity from a chemical 
perspective. 
This made possible to discover (also thanks to the careful observation and explanation of one 
of the many early failures) a novel synthetic method for the functionalization of 
Superparamagnetic Iron Oxide Nanoparticles (SPIONs). Such method has been successfully 
employed for the support of biomolecules onto the magnetic metallic core. The “usual” 
experimental failures  observed early in the project were, in reality, the gateway leading to 
significant, tangible results obtained in the second half of the three years of doctoral 
research. 
These results are instrumental for the preparation of several scientific papers which we plan 
to publish as soon as possible. Meanwhile, we got positive feedbacks from the presentation 
of some of our results at various conferences. We believe there is, thus, the possibility to start 
new fruitful collaborations with chemical and biomedical research groups working in the 
field. 
To this regard, in the last months, we have begun a collaboration with Prof. Seneci’s research 
group of the University of Milan. Our goal is to study and synthesize novel nanosystems 
composed by SPIONs “decorated” with bioactive molecules able to modulate the apoptotic 
process. The first nanoconjugates of this new family of molecules have been synthesized in 
I 
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the last few weeks. Their characterization will be reported elsewhere, but will be dependent 
from the efforts described in this thesis. 
Our research group is also part of a wider research project that will start in 2013, through the 
granted funding of a Cariplo grant. The project will be aimed to the study of the interaction 
of new nanosystems within the central nervous system,  and therefore to the possible 
modulation of neurodegenerative diseases. 
egarding the structure of this thesis, I divided it into two main parts. The first 
includes a comprehensive introduction to the world of Nanotechnology, then 
goes more into the specifics of magnetic metal nanoparticles, and finally 
focuses on the SPIONs. Reading the first 3 chapters can be quite demanding, but it is 
essential for those who (like me at first), are not aware of the characteristics and properties 
of these nanomaterials. 
The second part of the thesis is its real foundation, as it contains all the novel experimental 
data obtained in these years. 
Chapter 4 is perhaps the true heart of the thesis, in which I discuss the experimental data to 
demonstrate the discovery of a new method of surface functionalization for SPIONs. Earlier in 
this chapter some fundamental theoretical concepts are remarked, so to enable the reader to 
understand all the information given in the following paragraphs, even without having read 
the first three introductory chapters. 
Chapter 5 presents some early results in the SPIONs applications as magnetic supports for 
biomolecules, in particular for a class of mimics of natural oligonucleotides, the Peptide 
Nucleic Acids (PNAs). It was therefore necessary to begin the chapter with an exhaustive 
introduction on PNAs - what they are, their characteristics, synthesis and properties, as well 
as their possible biomedical applications. Subsequently, I focused the discussion on new 
magnetic PNAs, and in particular on four new nanoconjugates that have been synthesized 
and have demonstrated their unique ability to recognize complementary nucleic acids with 
high affinity binding. 
 
 
Good reading, 
Claudio Carrara 
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Abstract 
 
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) have demonstrated great promise for 
diagnostic and therapeutic applications. Thanks to their magnetic properties and to their 
size, comparable to that of biologically objects, they are very useful for biomedical 
applications, such as, for example, automated DNA extraction, targeted gene delivery, 
magnetic resonance imaging (MRI), and magnetic field induced hyperthermia for cancer 
therapy. For these applications, SPIONs must be coupled with targeting agents, therapeutic 
drugs, and other functional probes. Hence, the need to develop efficient synthetic strategies 
for the conjugation of molecules to SPIONs is an important and appealing target. 
The strategies used can involve passive noncovalent adsorption on the outer particle surface 
(for instance, by a carboxylate moiety) or the formation of a more stable covalent bond by 
using appropriate heterobifunctional linkers, in which one functional group specifically binds 
the nanoparticle, while the other reacts with the biomolecule in order to form the new 
nanoconjugate (Figure 1). 
 
Figure 1 - The heterobifunctional linker bears two orthogonal functional groups (FG’ and 
FG’’) able to selectively react with the SPION surface or with the organic molecule that we 
want to support on nanoparticle. 
During this Ph.D. research work, both non-covalent and covalent surface interactions were 
investigated in order to obtain new bionanoconjugates. Specifically, we were interested in 
the search for new heterobifunctional linkers able to covalently bind the SPIONs surface, as 
an alternative to the most used methodology which involves the use of the 3-
(aminopropyl)triethoxysilane (APTES) 1. 
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In this work, commercially available γ-Fe2O3 maghemite SPIONs (Alfa Aesar) with an average 
diameter of 10±2 nm were used. Generally, APTES functionalized nanoparticles can be easily 
synthesized as reported in Scheme 1. 
APTES 1 is added to a suspension of naked maghemite SPIONs under sonication; after 4 
hours at 60 °C it is possible to isolate the corresponding NP-APTES 2. The free amino-groups 
can be used to bind proper biomolecules as itself or after a functional group interconversion.  
Using the same strategy, we decided to use the 3-(triethoxysylil)propyl isocyanate (TESPI) 3, 
instead of APTES 1, in order to obtain a new nanoconjugates bearing free NCO-groups on the 
surface (Scheme 2). 
                                  Scheme 1 
                                                    
                                                                                           Scheme 2 
Unexpectedly, we didn’t obtain the desired product in which the alkoxysilane reacted with 
the SPION surface. From FTIR spectroscopy and elemental analysis (E.A.) we have deduced 
that the isocyanate group of TESPI 3 had interacted with the SPION surface leading to a new 
species of nanoconjugate. Our hypothesis was that the NCO moiety reacted with the surface 
OH-groups of the nanoparticle, forming carbamate-like bond, affording the new 
nanoconjugate NP-TESPI 4 (Scheme 2). This unexpected result led us to further investigate 
the reactivity of the isocyanate group towards the SPION surface. 
To the best of our knowledge, only two examples of the use of an isocyanate moiety as the 
anchoring group onto nanoparticle materials (silica and titania) are reported in literature. 
Since in these papers no exhaustive studies are made to demonstrate the formation of a 
carbamate bond between the isocyanate group and the nanoparticles surface, and nothing is 
reported in literature about iron oxide nanoparticle grafting with isocyanates, we decided to 
deep investigate this new anchoring methodology. 
In fact, the generality of the grafting of isocyanate molecules onto SPIONs surface, could be 
exploited as a new anchoring system and a new class of heterobifunctional linkers for 
SPIONs could be proposed. 
The scope of this new possible anchoring strategy was evaluated preparing a small library of 
new nanoconjugates starting from commercially available (5-9) or easily synthesizable (10) 
differently substituted isocyanates, reported in Figure 2. 
Abstract 
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Figure 2 
Isocyanates 8-10 were endowed with a second functional group which, in principle, could be 
used to support organic molecules to the SPIONs surface through the linker. 
The general procedure used to anchor isocyanates 5-10 onto the naked SPIONs is shown in 
Scheme 3. 
 
Scheme 3 - Standard procedure for the synthesis of new carbamate-based nanoconjugates. 
The proper isocyanate (0.2, 0.4 or 0.8 millimoles) was added to a suspension of 100 mg of 
naked SPIONs in dry toluene, under sonication at 60 °C for 4 hours. The resulting suspension 
was then centrifugated at 5000 round per minute for 10 minutes; the supernatant was 
eliminated and the solid residue was washed with fresh toluene (3x5 ml) and diethyl ether 
(3x5 ml) affording the desired nanoconjugates 15-20 (Figure 3). 
 
Figure 3 
All nanoconjugates were characterized by elemental analysis (E.A.) and infrared 
spectroscopy (FTIR), while only some of them have been further characterized by High 
Resolution Magic Angle Spinning NMR technique (HR-MAS NMR). The results obtained 
confirmed us the formation of a stable carbamate-like bond between the isocyanate group 
of the organic molecules and the surface hydroxyl groups of the nanoparticles. 
The synthetic protocol used to synthesize nanoconjugates 15-20, was set up in order to 
verify the reproducibility of the methodology and the possibility to tune the quantity of 
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organic molecule grafted onto the SPIONs surface. For these reasons the final loading of 
each nanoconjugate was determined by E.A. and the results obtained in the three series of 
test reactions with 0.2, 0.4 and 0.8 millimoles of isocyanates per 100 milligrams of naked 
nanoparticles have been compared. An average loading was calculated (as the arithmetic 
mean of those obtained for each nanoconjugates) and as shown in Figure 4, the loadings can 
be easily tuned just increasing the amount of starting isocyanate, confirming the efficacy of 
this new grafting methodology. 
 
Figure 4 - Linear regressions on average loading values. 
FTIR spectroscopy helps to point out the interaction between the isocyanate group and the 
SPIONs surface, confirming the formation of a carbamate bond for all products as reported 
in Table 1, in which the stretching of the obtained carbamate bond are reported. 
Furthermore, FTIR spectroscopy has proved to be the choice technique for the analysis of 
these kind of nanoconjugates. 
In Table 2, the HR-MAS experiments performed on nanoconjugates 15-17 and 20 are 
summarized proving the versatility of this technique, while nanoconjugates 18 and 19 were 
not characterized with NMR spectroscopy due to the lability of the additional -SO2Cl and -
COCl moieties. Concerning the general use of the HR-MAS technique, we can state that the 
results obtained demonstrate the grafting of isocyanate molecules onto the SPIONs surface, 
leading to the formation of a carbamate bond. The MAS tool has proved to be versatile and 
furthermore, can be used to overcome all the problems related to the presence of a 
superparamagnetic core. Very nice spectra were obtained and preliminary DOSY 
experiments were performed. 
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R-NCO Nanoconjugate 
Stretching [cm-1] 
-N=C=O C=O carbamate 
5 15 2258 1626 
6 16 2259 1647 
7 17 2265 1632 
8 18 2265 1699 
9 19 2265 1682 
10 20 2306 1693 
Table 1 - C=O Stretching values of starting isocyanate and corresponding nanoconjugates. 
Nanoconjugate HR-MAS experiments 
15 1H, 13C, COSY, HSQC 
16 1H, 13C 
17 1H, 13C 
20 1H, DOSY 
Table 2 - HR-MAS experiments performed on some nanoconjugates. 
Having established the easy anchoring of isocyanates onto the SPIONs surface by the 
formation of a carbamate bond, we decided to compare the efficiency of this new grafting 
methodology with the already known non-covalent adsorption of carboxylic acid and with 
the most used linker based on siloxane interaction. 
For this purpose we started comparing the loadings of nanoconjugates 16 and 20 (obtained 
by anchoring the phenyl isocyanate 6 and the (p-maleimido)phenyl isocyanate 10, 
respectively) versus the loadings of the nanoconjugates 23 and 24 that have been 
synthesized starting from the corresponding carboxylic compounds, the benzoic acid 22 and 
the (p-maleimido)benzoic acid 12 (Figure 5). Functionalized nanoparticles 23 and 24 bear the 
same organic residue of the analogous nanoconjugates 16 and 20, but differ from the 
anchoring group. 
 
Figure 5 - Synthesis of comparable nanoconjugates 16, 20, 23 and 24. In a) and c) 16 and 20 
are formed by covalent interaction between the starting isocyanates 6 and 10 with SPIONs, 
while in b) and d) a non-covalent adsorption were used to obtain nanoconjugate 23 and 24 
from the corresponding carboxylic acids 22 and 12. 
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In order to obtain comparable loading values for the nanoconjugates 23 and 24, the same 
synthetic protocol used for the grafting of isocyanates onto SPIONs, previously shown in 
Scheme 3, was applied. Thus, 0.2, 0.4 and 0.8 millimoles of carboxylic acids 22 e 12 were 
added to a suspension of 100 milligrams of naked SPIONs in toluene. After 4 hours at 60 °C 
under sonication, the desired functionalized nanoparticles 23 and 24 were isolated. The 
loadings were determined by E.A. and FTIR spectra were acquired demonstrating the 
anchoring of the organic carboxylic acid by a non-covalent adsorption with formation of a 
carboxylate species. From the loading values obtained, we can state that the covalent 
grafting of isocyanates leads to higher loading compared with the non-covalent interaction 
of carboxylic acids and in Figure 6 these values are summarized. Furthermore, only a slight 
increase in final loading was observed increasing the amount of the starting carboxylic 
ligand. 
 
Figure 6 - Loading comparison of nanoconjugates 16 and 20 (covalent interaction) versus 23 
and 24 (non-covalent adsorption), express as total percentage in weight of organic part 
loaded onto SPIONs [mmol/gNPs]. 
The same approach was used to compare the amount of isocyanate loaded onto SPIONs 
against the covalent silylation of APTES 1 (Figure 7). 
 
 
 
Abstract 
 
XIX 
 
 
Figure 7 – Synthetic approach for the synthesis of a)  nanoconjugates  2, from the 
corresponding alkoxysylane APTES 1 and b) nanoconjugates 15-20, from starting isocyanates 
5-10. The loading values obtained for the silyloxy-derivative will be compared with the 
average loading calculate for the new grafting methodology. 
Nanoconjugate 2 was therefore synthesized accordingly to Schemes 1 and 3, using 0.2, 0.4 
and 0.8 millimoles of 1 per 100 milligrams of naked nanoparticles. The functionalized SPIONs 
were analyzed by E.A. and the loadings obtained were compared with the average loading 
found for the isocyanate covalent interaction. The results are summarized in Figure 8. 
 
Figure 8 - Loading comparison of nanoconjugate 2 (Si-O covalent interaction) versus the 
average loading calculated on nanoconjugate 15-20 (carbamate covalent interaction). 
We may conclude by stating that the new methodology developed in this research leads to 
significantly higher loading values if compared to the classical non-covalent adsorption of 
carboxylic acids and also with respect to the main used covalent silylation of nanoparticles. 
The outstanding functionalization of SPIONs with isocyanates, with formation of a covalent 
carbamate bond, led us to further investigate the possibility of using these organic molecules 
as heterobifunctional linkers. From the beginning of this research work, we decided to study 
this new functionalization methodology with the final aim of conjugating bioactive molecules 
onto the SPIONs surface thanks to the use of specifically designed linkers. For this reason, 
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isocyanates 8-10 were chosen in order to obtain the corresponding nanoconjugates 18-20, 
that bear an additional reactive functional group. 
The chlorosulfonyl and the chloroacyl moieties are highly reactive towards amines and 
alcohols, affording the corresponding amides and esters, while the maleimido group is a 
classical Michael acceptor able to react with strong nucleophiles, as thiols and amines. 
The first step was to demonstrate that the -SO2Cl and -COCl groups are not reactive towards 
the nanoparticles surface. Indeed, the functionalization reaction consists in the direct 
addition of the isocyanates 8 and 9 in a suspension of naked SPIONs in dry toluene so, in 
principle, a possible competitive reaction can occur with formation of the corresponding 
esters with the surface hydroxyl groups. 
To verify this possibility, blank reactions were performed with tosyl chloride 25 and benzoyl 
chloride 26 (Scheme 4 and Scheme 5, respectively). 
 
                        Scheme 4                                                                               Scheme 5 
The recovered nanoparticles were analyzed by E.A. and FTIR spectroscopy, but no significant 
interaction with the SPIONs surface was detected. Having established that the chlorosulfonyl 
and the chloroacyl moieties are not able to directly bind the SPIONs surface, we decided to 
use the (p-chlorosulfonyl)phenyl isocyanate 8 and the (p-isocyanate)benzoyl chloride 9 as 
heterobifunctional linkers. 
The reactivity of nanoconjugates 18 and 19 was then tested reacting them with n-
butylamine, in order to form the corresponding sulfonamide and amide derivatives 27 and 
28 respectively, as shown in Scheme 6 and Scheme 7. 
 
Scheme 6 
 
Scheme 7 
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E.A. and FTIR spectroscopy confirm the formation of the desired product, proving the 
possibility of use these systems as heterobifunctional linkers for the covalent binding of 
biomolecules onto SPIONs. 
Concerning the nanoconjugate 20, the maleimido group cannot interact itself with the 
nanoparticle surface, so it can be present as unreactive functional group during the grafting 
of the corresponding isocyanate 10. 
To check the reactivity of the maleimido group once anchored onto SPIONs, nanoconjugate 
20 was first reacted with the commercially available 1-dodecanthiol (Scheme 8) and then 
with N-acetyl-cysteine (N-Ac-Cys-OH) as Michael donor (Scheme 9). 
 
Scheme 8 
 
Scheme 9 
Functionalized nanoparticles were isolated and characterized, confirming the formation of 
the desired nanoconjugate 34 and 35. 
Given the results obtained, we can conclude that isocyanate-based heterobifunctional 
linkers can be easily used for the supporting of organic molecules onto SPIONs. 
Nanoconjugates 18-20 have so proved to be good candidates for this purpose. 
 
In our laboratories, one research field is the synthesis of Peptide Nucleic Acids (PNAs), that 
are mimics of natural oligonucleotides, in which each ribose phosphate unit is replaced by an 
aminoethylglycine ones (aegPNA) (Figure 9). PNAs bind complementary DNA and RNA 
strands with excellent affinity. However, the first generation of PNAs suffers from some 
drawbacks, which hamper their full exploitation in gene therapy, including low cell uptake 
and some low solubility in physiological media. To overcome these problems, and to 
improve their physical-chemical properties, many modified PNAs have been synthesized in 
the last years following different strategies, one of which is to create new 
bionanoconjugates between SPIONs and PNAs for potential applications in diagnostic and 
therapy. In our laboratories several PNA-SPION conjugates have already been synthesized, 
using both passive noncovalent adsorption onto the outer particles surface by carboxylate 
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moiety and covalent binding exploiting the reactivity of siloxanes towards the nanoparticles 
(Figure 10). 
 
Figure 9 - PNA oligomer (B: adenine, cytosine, guanine, thymine). 
 
Figure 10 - Library of SPION-PNA nanoconjugates that have been already synthesized in our 
laboratories ([T]10: homothymine PNA 10-mer, [STD]: standard sequence PNA 10-mer). 
In this Ph.D. Thesis we decided to synthesize new fluorescent PNA nanoconjugates that 
combine the presence of a magnetic metallic core, PNA strands and a fluorescent probe. 
For this purpose we synthesized the two new nanoconjugates 36 and 37, reported in Figure 
11, in which a homothymine and a standard sequence decamers were modified with a 
succinic linker at the N-terminus and with a lysine at the C-terminus. The free carboxylic 
moiety can be exploited to bind in a non-covalent interaction the SPION surface, while the ε-
free amino group of the lysine residue can be used to bind the fluorescent probe, in this case 
the fluorescein isothiocyanate (FITC), leading to the formation of the corresponding thiourea 
(FITU). 
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Figure 11 - New fluorescent PNA nanoconjugates 36 and 37. 
Nanoconjugates 36 and 37 were isolated and characterized by E.A., FTIR and UV-Vis 
spectroscopy confirming the grafting of the fluorescent PNAs onto the nanoparticles surface. 
Furthermore, the ability of 36 and 37 to recognize and bind complementary DNA by the 
determination of the melting temperature Tm of the hybrids formed, were tested (Figure 12 
and 13). 
                                 Figure 12                                                                       Figure 13 
The Tm values obtained are very encouraging, if we consider that strong binding affinity 
were obtained regardless of the presence of a strong hydrophobic fluorescent probe and 
despite the anchoring onto SPIONs. (Reference homothymine PNA2:DNA hybrid Tm: 72 °C, 
reference standard sequence PNA:DNA hybrid Tm: 53 °C). Similarly, the N-terminus cysteine 
modified homothymine and standard sequence PNA oligomers were supported onto 
functionalized nanoparticles 20, in order to obtained the two new NCO-based SPION-PNA 
nanoconjugates 45 and 46 (Figure 14). 
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Figure 14 - New NCO-based SPION-PNA nanoconjugates 45 and 46. Are also shown the 
structures of the starting functionalized nanoparticles 20 and of the N(α)-Boc-S-
tbutylmercapto cysteine. 
The two new nanoconjugates 45 and 46 were isolated and characterized by E.A., FTIR and 
UV-Vis spectroscopy confirming, also in these cases,  the grafting of the oligomers onto the 
nanoparticles surface. Furthermore, to check the ability of 45 and 46 to recognize and bind 
complementary DNAs, the melting temperature Tm of the hybrids formed were determined 
(Figure 15 and 16). 
 
                              Figure 15                                                                        Figure 16 
Also for these two new SPION-PNA nanoconjugates the hybridation experiments have 
confirmed the formation of the corresponding PNA2:DNA and PNA:DNA hybrids, 
respectively. The Tm values obtained confirm the strong affinity binding capacity of these 
nanoconjugates towards the complementary DNAs, regardless of the presence of 
nanoparticles. 
 
In conclusion, in this Ph.D. research work a systematic study concerning the surface 
modification of superparamagnetic iron oxide nanoparticles, is reported. 
In particular, the discovery of a new covalent grafting methodology based on the reactivity 
of isocyanate group towards the surface hydroxyl groups of the nanoparticles, is reported. 
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In order to demonstrate this innovative anchoring system, a small library of isocyanate-base 
nanoconjugates has been synthesized (15-20). Analytical and spectroscopical 
characterizations helped us to point out the effective formation of a covalent carbamate-like 
bond between a generic isocyanate molecule and the SPIONs surface. 
Some of the nanoconjugates bear different additional functional groups (18-20), that 
resulted to be stable in the grafting reaction conditions, while remains still reactive for the 
binding of other organic molecules (27, 28, 34, 35). 
Thus, properly functionalized isocyanates could be used as heterobifunctional linkers for the 
supporting of biomolecules onto SPIONs, opening new strategies for the synthesis of a new 
class of bionanoconjugates. 
Furthermore, in this research work, four new SPION-PNA nanoconjugates have been 
designed and synthesized (36, 37, 45, 46). 
36 and 37 are characterized by the presence of a fluorescent probe and have been loaded 
onto the nanoparticle surface by a carboxylate-base non-covalent interaction, while 45 and 
46 were obtained by a covalent C-S bond formation between the properly modified PNAs 
and the NCO-based functionalize SPIONs 20. All these SPIONS-PNA nanoconjugates have 
shown a strong affinity binding towards the complementary DNA strands, regardless of the 
presence of the magnetic nanoparticles, thus opening the possibility to use these systems in 
theranostic fields. 
 
We have also recently started a profitable collaboration with Prof. Seneci’s research group of 
the Dept. of Chemistry, University of Milan, with the aim to support apoptosis inhibitors 
mimics onto SPIONs and to study their bioactivity. Biological studies will be performed in 
collaboration with the National Institute of Tumors (INT) in Milan. Only preliminary results 
were obtained and for this reason are not here reported. 
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Chapter 1: 
Something about Nanotechnology 
 
1 Nanotechnology 
1.1 Some General Definition 
Nanotechnology (sometimes shortened to "nanotech") is the manipulation of matter on an 
atomic and molecular scale. Generally, nanotechnology works with materials, devices, and 
other structures with at least one dimension sized from 1 to 100 nanometers. Quantum 
mechanical effects are important at this quantum-realm scale. With a variety of potential 
applications, nanotechnology is a key technology for the future and governments have 
invested billions of dollars in its research. 
Nanotechnology is very diverse, ranging from extensions of conventional device physics to 
completely new approaches based upon molecular self-assembly, from developing new 
materials with dimensions on the nanoscale to direct control of matter on the atomic scale. 
Nanotechnology entails the application of fields of science as diverse as surface science, 
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organic chemistry, molecular biology, semiconductor physics, microfabrication, and many 
others. 
Scientists debate the future implications of nanotechnology. Nanotechnology may be able to 
create many new materials and devices with a vast range of applications, such as in 
medicine, electronics, biomaterials and energy production. On the other hand, 
nanotechnology raises many of the same issues as any new technology, including concerns 
about the toxicity and environmental impact of nanomaterials,1 and their potential effects 
on global economics, as well as speculation about various doomsday scenarios. These 
concerns have led to a debate among advocacy groups and governments on whether special 
regulation of nanotechnology is warranted. 
1.1.1 Origins 
Although nanotechnology is a relatively recent development in scientific research, the 
development of its central concepts happened over a longer period of time. The emergence 
of nanotechnology in the 1980s was caused by the convergence of experimental advances 
such as the invention of the scanning tunneling microscope in 1981 and the discovery of 
fullerenes in 1985, with the elucidation and popularization of a conceptual framework for 
the goals of nanotechnology beginning with the 1986 publication of the book “Engines of 
Creation”. 
The scanning tunneling microscope, an instrument for imaging surfaces at the atomic level, 
was developed in 1981 by Gerd Binnig and Heinrich Rohrer at IBM Zurich Research 
Laboratory, for which they received the Nobel Prize in Physics in 1986.2,3 Fullerenes were 
discovered in 1985 by Harry Kroto, Richard Smalley, and Robert Curl, who together won the 
1996 Nobel Prize in Chemistry.4,5 
Around the same time, K. Eric Drexler developed and popularized the concept of 
nanotechnology and founded the field of molecular nanotechnology. In 1979, Drexler 
encountered Richard Feynman's 1959 talk "There's Plenty of Room at the Bottom". The term 
"nanotechnology", originally coined by Norio Taniguchi in 1974, was unknowingly 
appropriated by Drexler in his 1986 book “Engines of Creation: The Coming Era of 
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Nanotechnology”, which proposed the idea of a nanoscale "assembler" which would be able 
to build a copy of itself and of other items of arbitrary complexity. He also first published the 
term "grey goo" to describe what might happen if a hypothetical self-replicating molecular 
nanotechnology went out of control. 
In the early 2000s, the field was subject to growing public awareness and controversy, with 
prominent debates about both its potential implications, exemplified by the Royal Society's 
report on nanotechnology,6 as well as the feasibility of the applications envisioned by 
advocates of molecular nanotechnology, which culminated in the public debate between 
Eric Drexler and Richard Smalley in 2001 and 2003.7 Governments moved to promote and 
fund research into nanotechnology with programs such as the National Nanotechnology 
Initiative. 
The early 2000s also saw the beginnings of commercial applications of nanotechnology, 
although these were limited to bulk applications of nanomaterials, such as the Silver 
Nanoplatform for using silver nanoparticles as an antibacterial agent, nanoparticle-based 
transparent sunscreens, and carbon nanotubes for stain-resistant textiles.8,9 
1.1.2 Fundamental Concepts 
Nanotechnology is the engineering of functional systems at 
the molecular scale. This covers both current work and 
concepts that are more advanced. In its original sense, 
nanotechnology refers to the projected ability to construct 
items from the bottom up, using techniques and tools 
being developed today to make complete, high 
performance products. 
One nanometer (nm) is one billionth, or 10−9, of a meter. 
By comparison, typical carbon-carbon bond lengths, or the 
spacing between these atoms in a molecule, are in the 
range 0.12 – 0.15 nm, and a DNA double-helix has a 
Figure 1 
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diameter around 2 nm (Figure 1). 
On the other hand, the smallest cellular life-forms, the bacteria of the genus Mycoplasma, 
are around 200 nm in length. By convention, nanotechnology is taken as the scale range 1 to 
100 nm following the definition used by the National Nanotechnology Initiative in the US. 
The lower limit is set by the size of atoms (hydrogen has the smallest atoms, which are 
approximately a quarter of a nm diameter) since nanotechnology must build its devices from 
atoms and molecules. The upper limit is more or less arbitrary but is around the size that 
phenomena not observed in larger structures start to become apparent and can be made 
use of in the nano device.10 These new phenomena make nanotechnology distinct from 
devices which are merely miniaturised versions of an equivalent macroscopic device; such 
devices are on a larger scale and come under the description of microtechnology.11 
To put that scale in another context, the comparative size of a nanometer to a meter is the 
same as that of a marble to the size of the earth.12 Or another way of putting it: a nanometer 
is the amount an average man's beard grows in the time it takes him to raise the razor to his 
face.12 
Two main approaches are used in nanotechnology. In the "bottom-up" approach, materials 
and devices are built from molecular components which assemble themselves chemically by 
principles of molecular recognition. In the "top-down" approach, nano-objects are 
constructed from larger entities without atomic-level control.13 
Areas of physics such as nanoelectronics, nanomechanics, nanophotonics and nanoionics 
have evolved during the last few decades to provide a basic scientific foundation of 
nanotechnology. 
1.1.3 From Larger to Smaller: a Materials Perspective 
Several phenomena become pronounced as the size of the system decreases. These include 
statistical mechanical effects, as well as quantum mechanical effects, for example the 
“quantum size effect” where the electronic properties of solids are altered with great 
reductions in particle size. This effect does not come into play by going from macro to micro 
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dimensions. However, quantum effects become dominant when the nanometer size range is 
reached, typically at distances of 100 nanometers or less, the so called quantum realm. 
Additionally, a number of physical (mechanical, electrical, optical, etc.) properties change 
when compared to macroscopic systems. One example is the increase in surface area to 
volume ratio altering mechanical, thermal and catalytic properties of materials. Diffusion 
and reactions at nanoscale, nanostructures materials and nanodevices with fast ion 
transport are generally referred to nanoionics. Mechanical properties of nanosystems are of 
interest in the nanomechanics research. The catalytic activity of nanomaterials also opens 
potential risks in their interaction with biomaterials. 
Materials reduced to the nanoscale can show different properties compared to what they 
exhibit on a macroscale, enabling unique applications. For instance, opaque substances 
become transparent (copper); stable materials turn combustible (aluminum); insoluble 
materials become soluble (gold). A material such as gold, which is chemically inert at normal 
scales, can serve as a potent chemical catalyst at nanoscales. Much of the fascination with 
nanotechnology stems from these quantum and surface phenomena that matter exhibits at 
the nanoscale.14 
1.1.4 From Simple to Complex: a Molecular Perspective 
Modern synthetic chemistry has reached the point where it is possible to prepare small 
molecules to almost any structure. These methods are used today to manufacture a wide 
variety of useful chemicals such as pharmaceuticals or commercial polymers. This ability 
raises the question of extending this kind of control to the next-larger level, seeking methods 
to assemble these single molecules into supramolecular assemblies consisting of many 
molecules arranged in a well defined manner. 
These approaches utilize the concepts of molecular self-assembly and/or supramolecular 
chemistry to automatically arrange themselves into some useful conformation through a 
bottom-up  approach. The concept of molecular recognition is especially important: 
molecules can be designed so that a specific configuration or arrangement is favored due to 
non-covalent intermolecular forces. The Watson–Crick basepairing rules are a direct result of 
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this, as is the specificity of an enzyme being targeted to a single substrate, or the specific 
folding of the protein itself. Thus, two or more components can be designed to be 
complementary and mutually attractive so that they make a more complex and useful 
whole. 
Such bottom-up approaches should be capable of producing devices in parallel and be much 
cheaper than top-down methods, but could potentially be overwhelmed as the size and 
complexity of the desired assembly increases. Most useful structures require complex and 
thermodynamically unlikely arrangements of atoms. Nevertheless, there are many examples 
of self-assembly based on molecular recognition in biology, most notably Watson–Crick 
basepairing and enzyme-substrate interactions. The challenge for nanotechnology is 
whether these principles can be used to engineer new constructs in addition to natural ones. 
1.2 Social Implications 
The Center for Responsible Nanotechnology warns of the broad societal implications of 
untraceable weapons of mass destruction, networked cameras for use by the government, 
and weapons developments fast enough to destabilize arms races.15 
Another area of concern is the effect that industrial-scale manufacturing and use of 
nanomaterials would have on human health and the environment, as suggested by 
nanotoxicology research. For these reasons, groups such as the Center for Responsible 
Nanotechnology advocate that nanotechnology be regulated by governments. Others 
counter that overregulation would stifle scientific research and the development of 
beneficial innovations. Public health research agencies, such as the National Institute for 
Occupational Safety and Health are actively conducting research on potential health effects 
stemming from exposures to nanoparticles.16 
Some nanoparticle products may have unintended consequences. Researchers have 
discovered that bacteriostatic silver nanoparticles used in socks to reduce foot odor are 
being released in the wash.17 These particles are then flushed into the waste water stream 
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and may destroy bacteria which are critical components of natural ecosystems, farms, and 
waste treatment processes.18 
Public deliberations on risk perception in the US and UK carried out by the Center for 
Nanotechnology in Society found that participants were more positive about 
nanotechnologies for energy applications than for health applications, with health 
applications raising moral and ethical dilemmas such as cost and availability.19 
Experts, including director of the Woodrow Wilson Center's Project on Emerging 
Nanotechnologies David Rejeski, have testified20 that successful commercialization depends 
on adequate oversight, risk research strategy, and public engagement. Berkeley (California) 
is currently the only city in the United States to regulate nanotechnology;21 Cambridge 
(Massachusetts) in 2008 considered enacting a similar law,22 but ultimately rejected it.23 
Relevant for both research on and application of nanotechnologies, the insurability of 
nanotechnology is contested.24 Without state regulation of nanotechnology, the availability 
of private insurance for potential damages is seen as necessary to ensure that burdens are 
not socialized implicitly. 
1.2.1 Regulation 
Calls for tighter regulation of nanotechnology have occurred alongside a growing debate 
related to the human health and safety risks of nanotechnology.25 There is significant debate 
about who is responsible for the regulation of nanotechnology. Some regulatory agencies 
currently cover some nanotechnology products and processes (to varying degrees) – by 
“bolting on” nanotechnology to existing regulations – there are clear gaps in these regimes.26 
Davies (2008) has proposed a regulatory road map describing steps to deal with these 
shortcomings.27 
Stakeholders concerned by the lack of a regulatory framework to assess and control risks 
associated with the release of nanoparticles and nanotubes have drawn parallels with 
bovine spongiform encephalopathy ("mad cow" disease), thalidomide, genetically modified 
food,28 nuclear energy, reproductive technologies, biotechnology, and asbestosis. Dr. 
Andrew Maynard, chief science advisor to the Woodrow Wilson Center’s Project on 
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Emerging Nanotechnologies, concludes that there is insufficient funding for human health 
and safety research, and as a result there is currently limited understanding of the human 
health and safety risks associated with nanotechnology.29 As a result, some academics have 
called for stricter application of the precautionary principle, with delayed marketing 
approval, enhanced labelling and additional safety data development requirements in 
relation to certain forms of nanotechnology.30 
The Royal Society report6 identified a risk of nanoparticles or nanotubes being released 
during disposal, destruction and recycling, and recommended that “manufacturers of 
products that fall under extended producer responsibility regimes such as end-of-life 
regulations publish procedures outlining how these materials will be managed to minimize 
possible human and environmental exposure”. Reflecting the challenges for ensuring 
responsible life cycle regulation, the Institute for Food and Agricultural Standards has 
proposed that standards for nanotechnology research and development should be 
integrated across consumer, worker and environmental standards. They also propose that 
NGOs and other citizen groups play a meaningful role in the development of these 
standards. 
The Center for Nanotechnology in Society has found that people respond differently to 
nanotechnologies based upon application – with participants in public deliberations more 
positive about nanotechnologies for energy than health applications – suggesting that any 
public calls for nano regulations may differ by technology sector.19 
1.3 General fields of Nanotechnology Applications 
With nanotechnology, a large set of materials and improved products rely on a change in the 
physical properties when the feature sizes are shrunk. Nanoparticles, for example, take 
advantage of their dramatically increased surface area to volume ratio. Their optical 
properties, e.g. fluorescence, become a function of the particle diameter. When brought into 
a bulk material, nanoparticles can strongly influence the mechanical properties of the 
material, like stiffness or elasticity. For example, traditional polymers can be reinforced by 
nanoparticles resulting in novel materials which can be used as lightweight replacements for 
Chapter 1: Something about Nanotechnology 
 
11 
 
metals. Therefore, an increasing societal benefit of such nanoparticles can be expected. Such 
nanotechnologically enhanced materials will enable a weight reduction accompanied by an 
increase in stability and improved functionality. Practical nanotechnology is essentially the 
increasing ability to manipulate (with precision) matter on previously impossible scales, 
presenting possibilities which many could never have imagined - it therefore seems 
unsurprising that few areas of human technology are exempt from the benefits which 
nanotechnology could potentially bring. Some examples are now reported. 
1.3.1 Medicine 
The biological and medical research communities have exploited the unique properties of 
nanomaterials for various applications (e.g. contrast agents for cell imaging and therapeutics 
for treating cancer). Terms such as biomedical nanotechnology, nanobiotechnology, and 
nanomedicine are used to describe this hybrid field. Functionalities can be added to 
nanomaterials by interfacing them with biological molecules or structures. The size of 
nanomaterials is similar to that of most biological molecules and structures; therefore, 
nanomaterials can be useful for both in vivo and in vitro biomedical research and 
applications. Thus far, the integration of nanomaterials with biology has led to the 
development of diagnostic devices, contrast agents, analytical tools, physical therapy 
applications, and drug delivery vehicles. 
1.3.1.1 Diagnostics 
Nanotechnology-on-a-chip is one more dimension of lab-on-a-chip technology. Magnetic 
nanoparticles, bound to a suitable antibody, are used to label specific molecules, structures 
or microorganisms. Gold nanoparticles tagged with short segments of DNA can be used for 
detection of genetic sequence in a sample. Multicolor optical coding for biological assays has 
been achieved by embedding different-sized quantum dots into polymeric microbeads. 
Nanopore technology for analysis of nucleic acids converts strings of nucleotides directly into 
electronic signatures. 
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1.3.1.2 Drug Delivery 
Nanotechnology has been a boon for the medical field by delivering drugs to specific cells 
using nanoparticles. The overall drug consumption and side-effects can be lowered 
significantly by depositing the active agent in the morbid region only and in no higher dose 
than needed. This highly selective approach reduces costs and human suffering. An example 
can be found in dendrimers and nanoporous materials. Another example is to use block co-
polymers, which form micelles for drug encapsulation.31 They could hold small drug 
molecules transporting them to the desired location. Another vision is based on small 
electromechanical systems; nanoelectromechanical systems are being investigated for the 
active release of drugs. Some potentially important applications include cancer treatment 
with iron nanoparticles or gold shells. A targeted or personalized medicine reduces the drug 
consumption and treatment expenses resulting in an overall societal benefit by reducing the 
costs to the public health system. Nanotechnology is also opening up new opportunities in 
implantable delivery systems, which are often preferable to the use of injectable drugs, 
because the latter frequently display first-order kinetics (the blood concentration goes up 
rapidly, but drops exponentially over time). This rapid rise may cause difficulties with 
toxicity, and drug efficacy can diminish as the drug concentration falls below the targeted 
range. 
Buckyballs can "interrupt" the allergy/immune response by preventing mast cells (which 
cause allergic response) from releasing histamine into the blood and tissues, by binding to 
free radicals "dramatically better than any anti-oxidant currently available, such as vitamin 
E".32 
1.3.1.3 Tissue Engineering 
Nanotechnology can help reproduce or repair damaged tissue. “Tissue engineering” makes 
use of artificially stimulated cell proliferation by using suitable nanomaterial-based scaffolds 
and growth factors. For example, bones can be regrown on carbon nanotube scaffolds. 
Tissue engineering might replace today's conventional treatments like organ transplants or 
artificial implants. Advanced forms of tissue engineering may lead to life extension. 
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1.3.2 Energy 
The most advanced nanotechnology projects related to energy are: storage, conversion, 
manufacturing improvements by reducing materials and process rates, energy saving (by 
better thermal insulation for example), and enhanced renewable energy sources. 
1.3.2.1 Reduction of Energy Consumption 
A reduction of energy consumption can be reached by better insulation systems, by the use 
of more efficient lighting or combustion systems, and by use of lighter and stronger 
materials in the transportation sector. Currently used light bulbs only convert approximately 
5% of the electrical energy into light. Nanotechnological approaches like light-emitting 
diodes (LEDs) or quantum caged atoms (QCAs) could lead to a strong reduction of energy 
consumption for illumination. 
1.3.2.2 Increasing of Efficiency of Energy Production 
Today's best solar cells have layers of several different semiconductors stacked together to 
absorb light at different energies but they still only manage to use 40 percent of the Sun's 
energy. Commercially available solar cells have much lower efficiencies (15-20%). 
Nanotechnology could help increase the efficiency of light conversion by using 
nanostructures with a continuum of bandgaps. 
The degree of efficiency of the internal combustion engine is about 30-40% at present. 
Nanotechnology could improve combustion by designing specific catalysts with maximized 
surface area. In 2005, scientists at the University of Toronto developed a spray-on 
nanoparticle substance that, when applied to a surface, instantly transforms it into a solar 
collector. 
1.3.2.3 Nuclear Accident Cleanup and Waste Storage 
Nanomaterials deployed by swarm robotics may be helpful for decontaminating a site of a 
nuclear accident which poses hazards to humans because of high levels of radiation and 
radioactive particles. Hot nuclear compounds such as corium (is a lava-like molten mixture of 
Claudio Carrara, Ph.D. Thesis 2012  
 
14 
 
portions of nuclear reactor core, formed during a nuclear meltdown, the most severe class 
of a nuclear reactor accident) or melting fuel rods may be contained in "bubbles" made from 
nanomaterials that are designed to isolate the harmful effects of nuclear activity occurring 
inside of them from the outside environment that organisms inhabit. 
1.3.3 Information and Communication 
Current high-technology production processes are based on traditional top down strategies, 
where nanotechnology has already been introduced silently. The critical length scale of 
integrated circuits is already at the nanoscale (50 nm and below) regarding the gate length 
of transistors in CPUs or DRAM devices. 
1.3.3.1 Memory Storage 
Electronic memory designs in the past have largely relied on the formation of transistors. 
However, research into crossbar switch based electronics have offered an alternative using 
reconfigurable interconnections between vertical and horizontal wiring arrays to create ultra 
high density memories. Two leaders in this area are Nantero which has developed a carbon 
nanotube based crossbar memory called Nano-RAM and Hewlett-Packard which has 
proposed the use of memristor material as a future replacement of Flash memory. 
1.3.3.2 Novel Semiconductor Devices 
An example of such novel devices is based on spintronics. The dependence of the resistance 
of a material (due to the spin of the electrons) on an external field is called 
magnetoresistance. This effect can be significantly amplified (GMR - Giant Magneto-
Resistance) for nanosized objects, for example when two ferromagnetic layers are separated 
by a nonmagnetic layer, which is several nanometers thick (e.g. Co-Cu-Co). The GMR effect 
has led to a strong increase in the data storage density of hard disks and made the gigabyte 
range possible. The so called tunneling magnetoresistance (TMR) is very similar to GMR and 
based on the spin dependent tunneling of electrons through adjacent ferromagnetic layers. 
Both GMR and TMR effects can be used to create a non-volatile main memory for 
computers, such as the so called magnetic random access memory or MRAM. 
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In 1999, the ultimate CMOS transistor developed at the Laboratory for Electronics and 
Information Technology in Grenoble, France, tested the limits of the principles of the 
MOSFET transistor with a diameter of 18 nm (approximately 70 atoms placed side by side). 
This was almost one tenth the size of the smallest industrial transistor in 2003 (130 nm in 
2003, 90 nm in 2004, 65 nm in 2005 and 45 nm in 2007). It enabled the theoretical 
integration of seven billion junctions on a €1 coin. However, the CMOS transistor, which was 
created in 1999, was not a simple research experiment to study how CMOS technology 
functions, but rather a demonstration of how this technology functions now that we 
ourselves are getting ever closer to working on a molecular scale. Today it would be 
impossible to master the coordinated assembly of a large number of these transistors on a 
circuit and it would also be impossible to create this on an industrial level.33 
1.3.3.3 Novel Optoelectronic Devices 
In the modern communication technology traditional analog electrical devices are 
increasingly replaced by optical or optoelectronic devices due to their enormous bandwidth 
and capacity, respectively. Two promising examples are photonic crystals and quantum dots. 
Photonic crystals are materials with a periodic variation in the refractive index with a lattice 
constant that is half the wavelength of the light used. They offer a selectable band gap for 
the propagation of a certain wavelength, thus they resemble a semiconductor, but for light 
or photons instead of electrons. Quantum dots are nanoscaled objects, which can be used, 
among many other things, for the construction of lasers. The advantage of a quantum dot 
laser over the traditional semiconductor laser is that their emitted wavelength depends on 
the diameter of the dot. Quantum dot lasers are cheaper and offer a higher beam quality 
than conventional laser diodes. 
1.3.4 Heavy Industry 
Nanotechnology has numerous potential applications in heavy industry. 
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1.3.4.1 Aerospace 
Lighter and stronger materials will be of immense use to aircraft manufacturers, leading to 
increased performance. Spacecraft will also benefit, where weight is a major factor. 
Nanotechnology would help to reduce the size of equipment and thereby decrease fuel-
consumption required to get it airborne. 
Hang gliders may be able to halve their weight while increasing their strength and toughness 
through the use of nanotech materials. Nanotech is lowering the mass of supercapacitors 
that will increasingly be used to give power to assistive electrical motors for launching hang 
gliders off flatland to thermal-chasing altitudes. 
Space operations can also benefit from the use of nanorobots, presented as single devices or 
forming swarms of larger sets. For the last option, nano-sized technology may be useful for 
polishing telescopes with a better accuracy than with existing methods, even in space, or for 
the exploration of extraterrestrial bodies, such as the Moon or Mars. 
Space exploration can take leverage of nanorobotic swarms to study Earth’s and outer 
bodies’ atmosphere (when existing) or surface, providing more accurate information about 
their composition and distribution. For example, it may enhance our knowledge of the water 
distribution on the Moon’s Poles, providing a better accuracy than the obtained with current 
methods, and thus enabling us a further exploration of the Moon, with the aim to place a 
future permanent base. 
1.3.4.2 Catalysis 
Chemical catalysis benefits especially from nanoparticles, due to the extremely large surface 
to volume ratio. The application potential of nanoparticles in catalysis ranges from fuel cell 
to catalytic converters and photocatalytic devices. Catalysis is also important for the 
production of chemicals. 
The synthesis provides novel materials with tailored features and chemical properties: for 
example, nanoparticles with a distinct chemical surrounding (ligands), or specific optical 
properties. In this sense, chemistry is indeed a basic nanoscience. In a short-term 
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perspective, chemistry will provide novel “nanomaterials” and in the long run, superior 
processes such as “self-assembly” will enable energy and time preserving strategies. In a 
sense, all chemical synthesis can be understood in terms of nanotechnology, because of its 
ability to manufacture certain molecules. Thus, chemistry forms a base for nanotechnology 
providing tailor-made molecules, polymers, as well as clusters and nanoparticles. 
Platinum nanoparticles are now being considered in the next generation of automotive 
catalytic converters because the very high surface area of nanoparticles could reduce the 
amount of platinum required.34 However, some concerns have been raised due to 
experiments demonstrating that they will spontaneously combust if methane is mixed with 
the ambient air.35 Ongoing research at the Centre National de la Recherche Scientifique 
(CNRS) in France may resolve their true usefulness for catalytic applications.36 Nanofiltration 
may come to be an important application, although future research must be careful to 
investigate possible toxicity.37 
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Chapter 2: 
Magnetic Nanoparticles, an Overview 
 
2 Magnetic Nanoparticles 
2.1 Nanoparticles 
First of all, it is necessary to consider the generaI concepts related to the nanosized objects. 
A nanoobject is a physical object differing appreciably in properties from the corresponding 
bulk material and having at least 1 nm dimension (not more than 100 nm). When dealing 
with nanoparticles, magnetic properties (and other physical ones) are size dependent to a 
large extent. Therefore, particles whose sizes are comparable with (or lesser than) the sizes 
of magnetic domains in the corresponding bulk materials are the most interesting from a 
magnetism scientist viewpoint. 
As introduced in the Chapter 1, nanotechnology is the technology dealing with both single 
nanoobjects and materials, and devices based on them, and with processes that take place 
in the nanometer range. Nanomaterials are those materials whose key physical 
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characteristics are dictated by the nanoobjects they contain. Nanomaterials are classified 
into compact materials and nanodispersions. The first type includes so-called 
nanostructured materials,38 i.e., materials isotropic in the macroscopic composition and 
consisting of contacting nanometer-sized units as repeating structural elements.39 Unlike 
nanostructured materials, nanodispersions include a homogeneous dispersion medium 
(vacuum, gas, liquid, or solid) and nanosized inclusions dispersed in this medium and isolated 
from each other. The distance between the nanoobjects in these dispersions can vary over 
broad limits from tens of nanometers to fractions of a nanometer. In the latter case, we are 
dealing with nanopowders whose grains are separated by thin (often monoatomic) layers of 
light atoms, which prevent them from agglomeration. Materials containing magnetic 
nanoparticles, isolated in nonmagnetic matrices at the distances longer than their diameters, 
are most interesting for magnetic investigations. 
A nanoparticle (NP) is a quasi-zero-dimensional (OD) nanoobject in which all characteristic 
linear dimensions are of the same order of magnitude (not more than 100 nm).40 
Nanoparticles can basically differ in their properties from larger particles, for example, from 
long- and well-known ultradispersed powders with a grain size above 0.5 μm. As a rule, 
nanoparticles are shaped like spheroids. 
Nanoparticles with a clearly ordered arrangement of atoms (or ions) are called 
nanocrystallites. Nanoparticles with a clear-cut discrete electronic energy levels are often 
referred to as "quantum dots" or "artificial atoms"; most often, they have compositions of 
typical semiconductor materials, but not always. Many magnetic nanoparticles have the 
same set of electronic levels. 
Nanoparticles are of great scientific interest because they represent a bridge between bulk 
materials, molecules and structures at an atomic level. The term "cluster," which has been 
widely used in the chemical literature in previous years, is currently used to designate small 
nanoparticles with sizes less than 1 nm. Magnetic polynuclear coordination compounds 
(magnetic molecular clusters) belong to the special type of magnetic materials often with 
unique magnetic characteristics. Unlike nanoparticles, which always have the distributions in 
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sizes, molecular magnetic clusters are the fully identical small magnetic nanoparticles. Their 
magnetism is usually described in terms of exchange-modified paramagnetism. 
Nanorods and nanowires, as shown in Figure 2, are quasi-one-dimensional (1D) nanoobjects. 
In these systems, one dimension exceeds by an order of magnitude the other two 
dimensions, which are in the nanorange. 
 
Figure 2 - Molecular models of different types of sp2-like hybridized carbon nanostructures exhibiting 
different dimensionalities, 0D, 1D, 2D and 3D: (a) C60: Buckminsterfullerene; (b) nested giant 
fullerenes or graphitic onions; (c) carbon nanotube; (d) nanocones or nanohorns; (e) nanotoroids; (f) 
graphene surface; (g) 3D graphite crystal; (h) Haeckelite surface; (i) graphene nanoribbons; (j) 
graphene clusters; (k) helicoidal carbon nanotube; (l) short carbon chains; (m) 3D Schwarzite crystals; 
(n) carbon nanofoams (interconnected graphene surfaces with channels); (o) 3D nanotube networks, 
and (p) nanoribbons 2D networks. 
 
The group of two-dimensional objects (2D) includes planar structures nanodisks, thin-film 
magnetic structures, magnetic nanoparticle layers, etc., in which two dimensions are an 
order of magnitude greater than the third one, which is in the nanometer range. 
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The nanoparticles are considered by many authors as giant pseudomolecules having a core 
and a shell and often also external functional groups. The unique magnetic properties are 
usually inherent in the particles with a core size of 2-30 nm. For magnetic nanoparticles, this 
value coincides (or less) with the size of a magnetic domain in most bulk magnetic materials. 
Methods of synthesis and properties of nanoparticles were considered in this section and 
reports.41 
2.2 Scope 
Among many of known nanomaterials, the special position belong to those, in which isolated 
magnetic nanoparticles (magnetic molecular clusters) are divided by dielectric nonmagnetic 
medium. These nanoparticles present giant magnetic pseudoatoms with the huge overall 
magnetic moment and "collective spin." In this regard nanoparticles fundamentally differ 
from the classic magnetic materials with their domain structure. As a result of recent 
investigations, the new physics of magnetic phenomena - nanomagnetism - was developed. 
Nanomagnetism advances include superparamagnetism, ultrahigh magnetic anisotropy and 
coercive force, and giant magnetic resistance. The fundamental achievement of the last time 
became the development of the solution preparation of the objects with advanced magnetic 
parameters. 
Currently, unique physical properties of nanoparticles are under intensive research.42 A 
special place beIongs to the magnetic properties in which the difference between a massive 
(bulk) material and a nanomaterial is especially pronounced. In particular, it was shown that 
magnetization (per atom) and the magnetic anisotropy of nanoparticles could be much 
greater than those of a bulk specimen, while differences in the Curie or Néel temperatures 
between nanoparticle and the corresponding microscopic phases reach hundreds of 
degrees. The magnetic properties of nanoparticles are determined by many factors, the key 
of these including the chemical composition, the type and the degree of defectiveness of the 
crystal lattice, the particle size and shape, the morphology (for structurally inhomogeneous 
particles), the interaction of the particle with the surrounding matrix and the neighboring 
particles. By changing the nanoparticle size, shape, composition, and structure, one can 
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control to an extent the magnetic characteristics of the material based on them. However, 
these factors cannot always be controlled during the synthesis of nanoparticles nearly equal 
in size and chemical composition; therefore, the properties of nanomaterials of the same 
type can be markedly different.  
In addition, magnetic nanomaterials were found to possess a number of unusual properties, 
as giant magnetoresistance, abnormally high magnetocaloric effect, and so on. 
Nanomagnetism usually considers so-called single-domain particles; typical values for the 
singIe-domain size range from 15 to 150 nm. However, recently the researchers focused 
their attention on the particles, whose sizes are smaller than the domain size range; a single 
particle of size comparable to the minimum domain size would not break up into domains; 
there is a reason to call these particles domain free magnetic nanoparticles (DFMN). Each 
such particle behaves like a giant paramagnetic atom and shows superparamagnetic 
behavior when the temperature is above the so-called blocking temperature. The 
experiment shows that the last one can vary in wide diapasons, from few kelvins till higher 
than room temperature.  
It is important to mention that the intensity of interparticle interactions can dramatically 
affect the magnetic behavior of their macroscopic ensemble.  
Nowadays it became possible to prepare individual nanometer metal or oxide particles not 
only as ferromagnetic fluids (whose preparation was developed back in the 1960s)43 but also 
as single particles covered by ligands or as particles included into "rigid" matrices (polymers, 
zeolites, etc.).  
The purpose of this section is to briefly survey the state-of-the-art views on physics, 
chemistry and methods of preparation and stabilization of magnetic nanoparticles used in 
nanotechnology for the design of new instruments and devices. 
Some examples of the most important applications of magnetic nanoparticles are: 
ferrofluids for seals, bearings and dampers in cars and other machines, magnetic recording 
industry, magnetooptic recording devices and giant magnetoresistive devices. In recent 
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years, there has been an increasing interest to use magnetic nanoparticles in biomedical 
applications. Examples of the exciting and broad field of magnetic nanoparticles applications 
include drug delivery, contrast agents, magnetic hyperthermia, therapeutic in vivo 
applications of magnetic carriers, and in vitro magnetic separation and purification, 
molecular biology investigations, immunomagnetic methods in cell biology and cell 
separation and in pure medical applications. 
2.3 Special Features of Magnetic Nanoparticles 
Two key issues dominate the magnetic properties of nanoparticles: finite-size effects and 
surface effects which give rise to various special features, as summarized in Figure 3.44 
 
Figure 3 - The different magnetic effects occurring in magnetic nanoparticles. The spin arrangement 
in a) a ferromagnet (FM) and b) an antiferromagnet (AFM); D=diameter, Dc=critical diameter. c) A 
combination of two different ferromagnetic phases (magenta arrows and black arrows in (a)) may be 
used for the creation of novel functional nanomaterials, for example, permanent magnets, which are 
materials with high remanence magnetization (Mr) and high coercivity (HC), as shown schematically in 
the magnetization curve (c), d) An illustration of the magnetic moments in a superparamagnet (SPM). 
A superparamagnet is defined as an assembly of giant magnetic moments which are not interacting, 
and which can fluctuate when the thermal energy, kBT, is larger than the anisotropy energy. 
Superparamagnetic particles exhibit no remanence or coercivity, that is, there is no hysteresis in the 
magnetization curve (d). e) The interaction (exchange coupling; linked red dots) at the interface 
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between a ferromagnet and an antiferromagnet produces the exchange bias effect. In an exchange 
biased system, the hysteresis is shifted along the field axis (exchange bias field (Heb))and the coercivity 
increases substantially. f) Pure antiferromagnetic nanoparticles could exhibit superparamagnetic 
relaxation as well as a net magnetization arising from uncompensated surface spins (blue arrows in 
(b)). This Figure, is a rather simplistic view of some phenomena present in small magnetic particles. In 
reality, a competition between the various effects will establish the overall magnetic behavior. 
Finite-size effects result, for example, from the quantum confinement of the electrons, 
whereas typical surface effects are related to the symmetry breaking of the crystal structure 
at the boundary of each particle. Without attempting to be exhaustive, these two issues will 
be addressed in the next sections. More complete reviews on magnetism in nanoscale 
systems can be found elsewhere.45 
2.3.1 Finite-Size Effect 
The two most studied finite-size effects in nanoparticles are the singledomain limit and the 
superparamagnetic limit. In large magnetic particles, it is well known that there is a 
multidomain structure, where regions of uniform magnetization are separated by domain 
walls. The formation of the domain walls is a process driven by the balance between the 
magnetostatic energy (ΔEMS), which increases proportionally to the volume of the materials 
and the domain-wall energy (Edw), which increases proportionally to the interfacial area 
between domains. If the sample size is reduced, there is a critical volume below which it 
costs more energy to create a domain wall than to support the external magnetostatic 
energy (stray field) of the single-domain state. This critical diameter typically lies in the range 
of a few tens of nanometers and depends on the material. It is influenced by the 
contribution from various anisotropy energy terms. The critical diameter of a spherical 
particle, Dc, below which it exists in a single-domain state is reached when ΔEMS = Edw, which 
implies that       
      
    
, where A is the exchange constant, Keff is anisotropy constant, 
μ0 is the vacuum permeability, and M is the saturation magnetization. 
A single-domain particle is uniformly magnetized with all the spins aligned in the same 
direction. The magnetization will be reversed by spin rotation since there are no domain 
walls to move. This is the reason for the very high coercivity observed in small 
nanoparticles.46 Another source for the high coercivity in a system of small particles is the 
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shape anisotropy. The departure from sphericity for single-domain particles is significant and 
has an influence on the coercivity.45b 
The second important phenomenon which takes place in nanoscale magnetic particles is the 
superparamagnetic limit. The superparamagnetism can be understood by considering the 
behavior of a well-isolated single-domain particle. The magnetic anisotropy energy per 
particle which is responsible for holding the magnetic moments along a certain direction can 
be expressed as follows:                
  , where V is the particle volume, Keff 
anisotropy constant and Θ is the angle between the magnetization and the easy axis. The 
energy barrier Keff V separates the two energetically equivalent easy directions of 
magnetization. With decreasing particle size, the thermal energy, kB T, exceeds the energy 
barrier Keff V and the magnetization is easily flipped. For kB T > Keff V, the system behaves like 
a paramagnet, instead of atomic magnetic moments, there is now a giant (super)moment 
inside each particle (Figure 3d). This system is named a superparamagnet. Such a system has 
no hysteresis and the data of different temperatures superimpose onto a universal curve of 
M versus H/T. The relaxation time of the moment of a particle, τ, is given by the Néel-Brown 
expression reported below,45b where kB is the Boltzmann’s constant, and τ0 ≈ 10
-9 s. 
        
     
   
  
If the particle magnetic moment reverses at times shorter than the experimental time scales, 
the system is in a superparamagnetic state, if not, it is in the so-called blocked state. The 
temperature, which separates these two regimes, the so called blocking temperature, TB, 
can be calculated by considering the time window of the measurement. The blocking 
temperature depends on the effective anisotropy constant, the size of the particles, the 
applied magnetic field, and the experimental measuring time. For example, if the blocking 
temperature is determined using a technique with a shorter time window, such as 
ferromagnetic resonance which has a τ ≈ 10-9 s, a larger value of TB is obtained than the 
value obtained from dc magnetization measurements. Moreover, a factor of two in particle 
diameter can change the reversal time from 100 years to 100 nanoseconds. While in the first 
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case the magnetism of the particles is stable, in the latter case the assembly of the particles 
has no remanence and is superparamagnetic. 
Many techniques are available to measure the magnetic properties of an assembly of 
magnetic nanoparticles, as reported in the related references.47 
2.3.1.1 Determination of the Blocking Temperature, TB 
A simple and rapid way to estimate the blocking temperature is provided by dc 
magnetometry measurements, in which a zero-field-cooled/field-cooled procedure is 
employed. Briefly, the sample is cooled from room temperature in zero magnetic field (ZFC) 
and in a magnetic field (FC). Then a small magnetic field is applied (about 100 Oe) and the 
magnetization is recorded on warming. As temperature increases, the thermal energy 
disturbs the system and more moments acquire the energy to be aligned with the external 
field direction. The number of unblocked, aligned moments reaches a maximum at TB. Above 
the blocking temperature the thermal energy is strong enough to randomize the magnetic 
moments leading to a decrease in magnetization. A distribution of the particle sizes results in 
a distribution of the blocking temperatures. As pointed out already, the above discussion 
about the time evolution of the magnetization only holds for particles with one single 
domain. Taking into account the magnetic interactions between nanoparticles which have a 
strong influence on the superparamagnetic relaxation, the behavior of the system becomes 
more complicated. The main types of magnetic interactions which can be present in a 
system of small particles are: a) dipole– dipole interactions, b) direct exchange interactions 
for touching particles, c) superexchange interactions for metal particles in an insulating 
matrix, d) RKKY (Ruderman-Kittel-Kasuya-Yosdida) interactions for metallic particles 
embedded in a metallic matrix.45a Dipolar interactions are almost always present in a 
magnetic particle system and are typically the most relevant interactions. They are of long-
range character and are anisotropic. From an experimental point of view, the problem of 
interparticle interactions is very complex. First, it is very complicated to separate the effects 
of interactions from the effects caused by the random distributions of sizes, shapes, and 
anisotropy axes. Second, several interactions can be present simultaneously in one sample. 
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This situation makes it even more complicated to assign the observed properties to specific 
interactions. 
2.3.2 Surface Effect 
As the particles size decreases, a large percentage of all the atoms in a nanoparticle are 
surface atoms, which implies that surface and interface effects become more important. For 
example, for face-centered cubic (fcc) cobalt with a diameter of around 1.6 nm, about 60% 
of the total number of spins are surface spins.45a Owing to this large surface atoms/bulk 
atoms ratio, the surface spins make an important contribution to the magnetization. This 
local breaking of the symmetry might lead to changes in the band structure, lattice constant 
or/and atom coordination. Under these conditions, some surface and/or interface related 
effects occur, such as surface anisotropy and, under certain conditions, core–surface 
exchange anisotropy can occur. 
2.3.2.1 No or Magnetically Inert Surface Coatings 
Surface effects can lead to a decrease of the magnetization of small particles, for instance 
oxide nanoparticles, with respect to the bulk value. This reduction has been associated with 
different mechanisms, such as the existence of a magnetically dead layer on the particle’s 
surface, the existence of canted spins, or the existence of a spin-glass-like behavior of the 
surface spins.48 On the other hand, for small metallic nanoparticles, for example cobalt, an 
enhancement of the magnetic moment with decreasing size was reported as well.49 Respaud 
et al. associated this result with a high surface-to-volume ratio, however, without more 
detailed explanation. Another surface-driven effect is the enhancement of the magnetic 
anisotropy, Keff with decreasing particle size.
49,50 This anisotropy value can exceed the value 
obtained from the crystalline and shape anisotropy and is assumed to originate from the 
surface anisotropy. In a very simple approximation, the anisotropy energy of a spherical 
particle with diameter D, surface area S, and volume V, may be described by one 
contribution from the bulk and another from the surface:         
 
 
   , where KV e KS 
are the bulk and surface anisotropy energy constants, respectively. Bøder et al.50 have 
shown that Keff changes when the surfaces are modified or adsorb different molecules, 
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which explains very well the contribution of the surface anisotropy to Keff. For uncoated 
antiferromagnetic nanoparticles, weak ferromagnetism can occur at low temperatures 
(Figure 3f), which has been attributed to the existence of uncompensated surface spins of 
the antiferromagnet.51 Since this situation effectively corresponds to the presence of a 
ferromagnet in close proximity to an antiferromagnet, additional effects, such as exchange 
bias, can result. However, only in some cases can a clear correlation between the surface 
coating and the magnetic properties be established. For example, a silica coating is used to 
tune the magnetic properties of nanoparticles, since the extent of dipolar coupling is related 
to the distance between particles and this in turn depends on the thickness of the inert silica 
shell.52 A thin silica layer will separate the particles, thereby preventing a cooperative 
switching which is desirable in magnetic storage data. In other cases, the effect of the 
coating is less clear. A precious-metal layer around the magnetic nanoparticles will have an 
influence on the magnetic properties. For example, it was shown that gold-coated cobalt 
nanoparticles have a lower magnetic anisotropy than uncoated particles, whereas gold 
coating of iron particles enhances the anisotropy, an effect which was attributed to alloy 
formation with the gold.53 Hormes et al. also discussed the influence of various coatings 
(e.g., Cu, Au) on the magnetic properties of cobalt nanoparticles, and came to the conclusion 
that a complex interplay between particle core and coating determines the properties, and 
tuning may therefore be difficult.54 
Organic ligands, used to stabilize the magnetic nanoparticles, also have an influence on their 
magnetic properties, that is, ligands can modify the anisotropy and magnetic moment of the 
metal atoms located at the surface of the particles.53 As Paulus and co-workers reported, 
cobalt colloidal particles stabilized with organic ligands show a reduction of the magnetic 
moment and a large anisotropy.53 Leeuwen et al. proposed that surface-bonded ligands lead 
to the quenching of the surface magnetic moments, resulting in the reduction of 
magnetization.55 In the case of nickel nanoparticles, Cordente et al. have demonstrated that 
donor ligands, such as amines, do not alter the surface magnetism but promote the 
formation of rods, whereas the use of trioctylphosphine oxide leads to a reduction in the 
magnetization of the particles.56 Overall, it must be concluded that the magnetic response of 
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a system to an inert coating is rather complex and system specific, so that no firm 
correlations can be established at present. 
2.3.2.2 Magnetic Coatings for Magnetic Nanoparticles 
A magnetic coating on a magnetic nanoparticle usually has a dramatic influence on the 
magnetic properties. The combination of two different magnetic phases will lead to new 
magnetic nanocomposites, with many possible applications. The most striking feature which 
takes place when two magnetic phases are in close contact is the exchange bias effect. A 
recent review of exchange bias in nanostructured systems is given by Nogués et al.57 
The exchange coupling across the interface between a ferromagnetic core and an 
antiferromagnetic shell or vice versa, causes this effect. Exchange bias is the shift of the 
hysteresis loop along the field axis in systems with ferromagnetic (FM)–antiferromagnetic 
(AFM) interfaces (Figure 3e). This shift is induced by a unidirectional exchange anisotropy 
created when the system is cooled below the Néel temperature of the antiferromagnet. This 
exchange coupling can provide an extra source of anisotropy leading to magnetization 
stabilization. The exchange bias effect was measured for the first time in cobalt 
nanoparticles surrounded by an antiferromagnetic CoO layer. There are numerous systems 
where the exchange bias has been observed, and some of the most investigated systems 
are: ferromagnetic nanoparticles coated with their antiferromagnetic oxides (e. g., Co/CoO, 
Ni/NiO), nitrides (Fe–Fe2N), and sulfides (Fe–FeS), ferrimagnetic–antiferromagnetic (Fe3O4–
CoO), or ferrimagnetic–ferromagnetic (TbCo–Fe20Ni80) nanoparticles. 
Recently, single-domain pure antiferromagnetic nanoparticles have shown an exchange-bias 
effect arising from uncompensated spins on the surface. This reveals a complicated surface 
spin structure which is responsible for the occurrence of a weak ferromagnetism (Figure 3f), 
the exchange bias effect, and the so-called training effect.58 The training effect represents a 
reduction of the exchange bias field upon subsequent field cycling. Metallic particles 
embedded in a matrix are interesting systems of magnetic-coated particles. Skumryev et al. 
have demonstrated the role of the matrix in establishing the magnetic response of small 
particles.59 The magnetic behavior of the isolated 4 nm Co particles with a CoO shell changes 
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dramatically when, instead of being embedded in a paramagnetic matrix, they are 
embedded in an antiferromagnetic matrix. The blocking temperature of Co particles 
embedded in an Al2O3 or C matrix was around 10 K, but by putting them in a CoO matrix, 
they remain ferromagnetic up to 290 K. Thus, the coupling of the ferromagnetic particles 
with an antiferromagnetic matrix is a source of a large additional anisotropy. 
Exchange biased nanostructures have found applications in many fields, such as permanent 
magnets (Figure 3c), recording media, and spintronics. A new approach to produce high-
performance permanent magnets is the combination of a soft magnetic phase (easily 
magnetized), such as Fe3Pt, and a hard magnetic phase (difficult to magnetize and thus 
having high coercivity), such as Fe3O4 which interact through magnetic exchange coupling.
60 
The right choice of ferromagnetic and antiferromagnetic components can provide a 
structure suitable for use as a recording medium. The exchange coupling can supply the 
extra anisotropy which is needed for magnetization stabilization, thus generating 
magnetically stable particles. Another interesting aspect related to a magnetic coating is 
given by the bimagnetic core–shell structure, where both the core and the shell, are strongly 
magnetic (e. g., FePt/CoFe2O4).
61 These bimagnetic core–shell nanoparticles will allow a 
precise tailoring of the magnetic properties through tuning the dimensions of the core and 
shell, which selectively controls the anisotropy and the magnetization. 
Some important aspects should be emphasized. The magnetic behavior of an assembly of 
nanoparticles is a result of both the intrinsic properties of the particles and the interactions 
among them. The distribution of the sizes, shapes, surface defects, and phase purity are only 
a few of the parameters influencing the magnetic properties, which makes the investigation 
of the magnetism in small particles very complicated. One of the great challenges remains 
the manufacturing of an assembly of monodisperse particles, with well-defined shape, a 
controlled composition, ideal chemical stability, tunable interparticle separations, and a 
functionalizable surface. Such particles will tremendously facilitate the discrimination 
between finite-size effects, interparticle interactions, and surface effects. Thus, the synthesis 
of magnetic nanoparticles with well-controlled characteristics is a very important task 
sections. 
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2.4 The Most Extensively Studied Magnetic Nanoparticles 
and Their Preparation 
A series of generaI methods for the nanoparticle synthesis have now been developed.44,62 
Most of them can also be used for the preparation of magnetic particles. An essential 
feature of their synthesis is the preparation of particles of a specified size and shape; at 
least, the dispersity should be small and controllable, since the blocking temperature (and 
other magnetic characteristics) depends on the particle size. The shape control and the 
possibility of synthesis of anisotropic magnetic structures are especially important. In order 
to eliminate (or substantially decrease) the interparticle interactions, magnetic nanoparticles 
often need to be isolated from one another by immobilization on a substrate surface or in 
the bulk of a stabilizing matrix or by surfacing with long chain ligands. It is important that the 
distance between the particles in the matrix should be controllable. Finally, the synthetic  
procedure should be relatively simple, inexpensive and reproducible. 
The physical characteristics of nanoparticles are known to be substantially dependent on 
their dimensions. Unfortunately, most of the currently known methods of synthesis afford 
nanoparticles with rather broad size distributions (dispersion > 10%). The thorough control 
of reaction parameters (time, temperature, stirring velocity, and concentrations of reactants 
and stabilizing ligands) does not always allow one to narrow down this distribution to the 
required range. Therefore, together with the development of methods for synthesis of 
nanoparticles with a narrow size distribution, the techniques of separation of nanoparticles 
into rather monodisperse fractions are perfected. This is done using controlled precipitation 
of particles from surfactant-stabilized solutions followed by centrifugation. The process is 
repeated until nanoparticle fractions with specified sizes and dispersion degrees are 
obtained. 
The methods of nanoparticle preparation cannot be detached from stabilization methods. 
For 1-10 nm particles with a high surface energy, it is difficult to select a really inert 
medium,63 because the surface of each nanoparticle bears the products of its chemical 
modification, which affect appreciably the nanomaterial properties. This is especially 
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important for magnetic nanoparticles in which the modified surface layer may possess 
magnetic characteristics markedly differing from those of the particle core. Nevertheless, 
the generaI methods for nanoparticle synthesis are not related directly to the stabilization 
and the special methods exist where the nanoparticle formation is accompanied by 
stabilization (in matrices, by encapsulation, etc.). 
Among a wide range of the magnetic nanomaterials, nanoparticles of magnetic metals, 
simple and complex magnetic oxides, and alloys may be separated for detailed analysis. 
2.4.1 Metals 
The metallic nanoparticles have larger magnetization compared to metal oxides, which is 
interesting for many applications. But metallic magnetic nanoparticles are not air stable, and 
are easily oxidized, resulting in the change or loss (fully or partially) of their magnetization. 
2.4.1.1 Iron (Fe) 
Iron is a ferromagnetic material with high magnetic moment density (about 220 emu/g) and 
is magnetically soft. Iron nanoparticles in the size range below 20 nm are 
superparamagnetic. 
Procedures leading to monodisperse Fe nanoparticles have been well documented.64 
Nevertheless, the preparation of nanoparticles consisting of pure iron is a complicated task, 
because they often contain oxides, carbides and other impurities. A sample containing pure 
iron as nanoparticles (10.5 nm) can be obtained by evaporation of the metal in an argon 
atmosphere followed by deposition on a substrate.65 When evaporation took place in a 
helium atmosphere, the particle size varied in the range of 10-20 nm.66 Relatively small (100-
500 atoms) Fe nanoparticles are formed in the gas phase on laser vaporization of pure iron.67 
The common chemical methods used for the preparations include thermal decomposition of 
Fe(CO)5 (the particles so prepared are extremely reactive), reductive decomposition of some 
iron(II) salts, or reduction of iron(III) acetylacetonate; there is a chemical reduction with  
TOPO capping (TOPO: trioctylphosphine oxide).68 
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The method of reducing metal salts by NaBH4 has been widely used to synthesize iron-
containing nanoparticles in organic solvents.69 Normally, reductive synthesis of Fe 
nanoparticles in an aqueous solution with NaBH4 yields a mixture including FeB.
70 Well-
dispersed colloidal iron is required for applications in biological systems such as MRI contrast 
enhancement and biomaterials separation. Nevertheless, the syntheses have as yet a 
difficulty in producing stable Fe nanoparticle dispersions, especially aqueous dispersions, for 
potential biomedical applications. 
To prevent the iron nanoparticles from agglomerating, dispersing agents were added during 
synthesis, as a rule poly(vinylpyrolidone) (PVP). The size dispersion of the nanoparticles 
produced using physical methods is broader than that in nanoparticles synthesized by 
chemical methods like reverse micelle, coprecipitation, etc. However, chemical methods 
yield as a rule only limited quantities of materials. 
2.4.1.2 Cobalt (Co) 
Co nanoparticles depending upon the synthetic route are observed in at least three 
crystallographic phases: typical for bulk Co hcp, 8-CO cubic,71 or multiply twinned fcc-based 
icosahedral.72 Conditions of synthesis reactions is influence on the final product structure; in 
rare cases of the determined phase nanoparticles can be obtained. Often a size and phase 
selection was required to obtain Co nanocrystals with a specific size and even shape. 
Methods for the synthesis and magnetic properties of cobalt nanoparticles' different 
structures have been described in detail in a review.8c  
A popular approach is to synthesize colloidal particles by inversed micelle synthesis; the 
inverse micelles are defined as a microreactor.73 In order to obtain stable cobalt 
nanoparticles with a narrow size distribution, Co(AOT)2 reverse micelles are used (AOT: 
Aerosol OT, better known as dioctyl sodium sulfosuccinate); their reduction is obtained by 
using NaBH4 as a reducing agent. Such particles are stabilized by surfactants and are often 
monodispersed in size, but are also unstable unless kept in a solution. Nevertheless, the 
chemical surface treatment by lauric acid highly improves the stability and cobalt 
nanoparticles could be stored without aggregation or oxidation for at least one week.74 In 
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many instances it is possible to obtain Co nanoparticles coated by other ligands, which can 
be either dispersed in a solvent or deposited on a substrate; in the latter case, self-organized 
monolayers having a hexagonal structure can be obtained. 
In some instances of reduction with NaBH4 it is possible to obtain Co- B nanoparticles. The 
size, composition, and structure of this kind of nanoparticles strongly depend on the 
concentration of the solution, pH, and the mixing procedure.75 It is well known that the 
presence of oxides in magnetic materials, which form spontaneously when the metallic 
surface is in contact with oxygen, drastically changes the magnetic behavior of the particles. 
An enhanced magnetoresistance, arising from the uniform Co core size and CoO shell 
thickness, has been reported.76 This effect is caused by the strong exchange coupling 
between the ferromagnetic Co core and the antiferromagnetic CoO layer. However, up to 
now the understanding of this effect has not been well understood. 
2.4.1.3 Nickel (Ni) 
In contrast to cobalt and iron, relatively few reports have been dealing with the physical 
properties and synthesis of nickel particles. However, the nanosized ferromagnetic Ni is also 
being widely studied as it presents both an interest for fundamental sciences and an interest 
for applications such as magnetic storage, ferrofluids, medical diagnosis, multilayer 
capacitors and especially catalysis. Because these properties and applications can be  
tuned by manipulating the size and structure of the particles, the development of flexible 
and precise synthetic routes has been an active area of research. A wide variety of 
techniques have been used to produce nickel nanoparticles: thermal decomposition,77 sol-
gel,78 spray pyrolysis,79 sputtering,80 and high-energy ball milling81. The organometallic 
precursors such as Ni(CO)4, Ni(COD)2, and Ni(Cp)2 have also been used for the synthesis and 
spectroscopic studies of nickel nanoparticles.82,83 At present, Ni nanoparticles are generally 
prepared by microemulsion techniques, using cetyltrimethylammonium bromide (CTAB)84 or 
by reduction of Ni ions in the presence of alkyl amines or TOPO.85 Some authors showed that 
the surface of Ni-nanoparticles was readily oxidized to NiO. On the basis of this discovery, 
they envisioned that the synthesis of large-sized Ni nanoparticles and their subsequent 
oxidation would provide an NiO shell having high affinity for biomolecules. 
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2.4.2 Nanoparticles of Rare Earth Metals 
Six of the nine rare earth elements (REE) are ferromagnetic. The magnetic nanomaterials 
based on these REE occupy a special place, as they can be used in magnetic cooling 
systems.86 However, REE nanoparticles (of both metals and oxides) are still represented by 
only a few examples, most of all, due to the high chemical activity of highly dispersed REE. A 
synthesis of coarse (95 x 280 nm) spindle-shaped ferromagnetic EuO nanocrystals suitable 
for the design of optomagnetic materials has been reported.87 The EuS nanocrystals were 
prepared by passing H2S through a solution of europium in liquid ammonia.
88 The size of the 
EuS magnetic nanoparticles formed can be controlled (to within 20-36 nm) by varying the 
amount of pyridine added to the reaction medium.88 
Gadolinium nanoparticles (12 nm) were prepared by reduction of gadolinium chloride by Na 
metal in THF. They proved to be extremely reactive and pyrophoric, which, however, did not 
prevent characterization of these particles and measuring their magnetic parameters.89 The 
Gd, Dy, and Tb nanoparticles with an average size of 1.5-2.1 nm and an about 20 degree of 
dispersion were obtained in a titanium matrix by ion beam sputtering.90 
2.4.3 Magnetic Alloys 
2.4.3.1 Fe-Co Alloy 
It is known that Co and Fe form a body-centered-cubic solid solution (COxFe100-x) over an 
extensive range. The ordered Co-Fe alloys are excellent soft magnetic materials with 
negligible magnetocrystalline anisotropy.91 The saturation magnetization of Fe-Co alloys 
reaches a maximum at a Co content of 35 at%; other magnetic characteristics of these 
metals also increase when they are mixed. Therefore, FeCo nanoparticles attract 
considerable attention. Thus Fe, Co, and Fe-Co (20 at%, 40 at%, 60 at%, 80 at%) 
nanoparticles (40-51 nm) with a structure similar to the corresponding bulk phases have 
been prepared in a stream of hydrogen plasma.92 The Fe-Co particles reach a maximum 
saturation magnetization at 40 at%  of Co, and a maximum coercive force is attained at 80 
at% of Co. Chemical reduction by NaBH4 is also used for the preparation of FeCo 
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nanoparticles.93 X-ray data show that the ratio of Co to Fe is around 30: 70 in the prepared 
nanoparticles. 
2.4.3.2 Fe-Ni Alloy 
The bulk samples of the iron-nickel alloys are either nonmagnetic or magnetically soft 
ferromagnets (for example, permalloys containing >30 of Ni and various doping additives). 
The Fe-Ni nanoparticles have a much lower saturation magnetization than the corresponding 
bulk samples over the whole concentration range.94 An alloy containing 37 of Ni has a low 
Curie point and an fcc structure. It consists of nanoparticles (12-80 nm) superparamagnetic 
over a broad temperature range.95 Theoretical calculations predict a complex magnetic 
structure for these Fe-Ni particles.96 
2.4.3.3 Fe-Pt Alloy 
Nanoparticles of this composition have received much attention in recent years due to the 
prospects for a substantial increase in the information recording density for materials based 
on them.97 The face-centered tetragonal (fct) (also known as L10 phase) Fe-Pt alloy 
possesses a very high uniaxial magnetocrystalline anisotropy of ca. 6 x 106 J/m3, which is 
more than 10 times as high as that of the currently utilized CoCr-based alloys and, thus, 
exhibit large coercivity at room temperature, even when their size is as small as several  
nanometers.98 These unique properties make them possible candidates for the next 
generation of magnetic storage media and high-performance permanent magnets.99 To 
realize these potentials it is important to develop synthetic methods that yield magnetic 
nanoparticles of tunable size, shape, dispersity and composition. For these syntheses the 
most commonly used is the thermal decomposition of organometallic precursors or 
reduction of metal salts in the presence of long-chain acid or amine and phosphine or 
phosphine oxide ligands.100 The as-synthesized FePt nanoparticles possess an fcc structure 
and are superparamagnetic at room temperature. 
The FePt nanoparticles (6 nm) with a narrow size distribution were prepared by joint 
thermolysis of Fe(CO)5 and Pt(acac)2 in the presence of oleic acid and oleylamine. Further 
heating resulted in the formation of a protective film from the products of thermal 
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decomposition of the surfactant on the nanoparticle surface, which does not change 
significantly the particle size. These particles can be arranged to form regular films and so-
called colloid crystals. For many practical applications, magnetic nanoparticles larger than 6 
nm are preferred because coercivity and the saturation magnetization of the nanoparticles 
are closely related to the size of magnetic nanoparticles.101 Later it has been however found 
that most FePt nanoparticles have the broad composition distribution: approximately 40 and 
30 of the nanoparticles were Pt-rich and Fe-rich, respectively. 
2.4.4 Magnetic Oxides 
2.4.4.1 Iron Oxides 
Iron oxides have received increasing attention due to their extensive applications, such as 
magnetic recording media, catalysts, pigments, gas sensors, optical devices, and 
electromagnetic devices.102 They exist in a rich variety of structures (polymorphs) and 
hydration states; therefore until recently, knowledge of the structural details, 
thermodynamics and reactivity of iron oxides has been lacking. Furthermore, physical 
(magnetic) and chemical properties commonly change with particle size and degree of 
hydration. By definition, superparamagnetic iron oxide particles are generally classified with 
regard to their size into superparamagnetic iron oxide particles (SPIO), displaying 
hydrodynamic diameters larger than 30 nm, and ultrasmall superparamagnetic iron oxide 
particles (USPIO), with hydrodynamic diameters smaller than 30 nm. USPIO particles are now 
efficient contrast agents used to enhance relaxation differences between healthy and 
pathological tissues, due to their high saturation magnetization, high magnetic susceptibility, 
and low toxicity. More in general SPIO and USPIO are commonly named SPIONs 
(Superparamagnetic Iron Oxide Nanoparticles). 
The biodistribution and resulting contrast of these particles are highly dependent on their 
synthetic route, shape, and size.103 There has been much interest in the development of 
synthetic methods to produce high-quality iron oxide systems. The synthesis of controlled 
size magnetic nanoparticles is described in multiple publications. High-quality iron oxide 
nanomaterials have been generated using high-temperature solution phase methods similar 
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to those used for semiconductor quantum dots. Other synthesis methods such as polyol-
mediated, sol-gel104 and sonochemical105 were also proposed.  
For the variety of magnetic nanomaterials properties the different morphologies including 
spheres, rods, tubes, wires, belts, cubes, starlike, flowerlike, and other hierarchical 
architectures were fabricated by various approaches. Finally, some bacteria couple the 
reduction of Fe(III) with the metabolism of organic materials, which can include 
anthropogenic contaminants, or simply use iron oxides as electron sinks during 
respiration.106 
2.4.4.1.1 Fe2O3 
Among several crystalline modifications of anhydrous ferric oxides there are two magnetic 
phases, namely, rhombohedral hematite (α-Fe2O3) and cubic maghemite (γ-Fe2O3), and the 
less common ε-Fe2O3 phases. In the α-structure, all Fe
3+ ions have an octahedral 
coordination, whereas in γ-Fe2O3 having the structure of a cation-deficient AB2O4 spinel, the 
metal atoms A and B occur in tetrahedral and octahedral environments, respectively. The 
oxide α-Fe2O3 is antiferromagnetic at temperatures below 950 K, while above the Morin 
point (260 K) it exhibits so-called weak ferromagnetism. Hematite, the thermodynamically 
stable crystallographic phase of iron oxide with a band gap of 2.2 eV, is a very attractive 
material because of its wide applications, except magnetic recording materials, also in 
catalysis, as a gas sensors, pigments, and paints. Its nontoxicity is, attractive features for 
these applications. 
The α-Fe2O3 and FeOOH (goethite) nanoparticles are obtained by controlled hydrolysis of 
Fe3+ salts.107 In order to avoid the formation of other phases, a solution of ammonia is added 
to a boiling aqueous solution of Fe(NO3)3 with intensive stirring. After boiling for 2.5 h and 
treating with ammonium oxalate (to remove the impurities of other oxides), the precipitate 
forms a red powder containing α-Fe2O3 nanoparticles (20 nm).
108 These nanoparticles are 
also formed on treatment of solutions of iron salts (Fe2+ : Fe3+ = 1 : 2) with an aqueous 
solution of ammonium hydroxide in air.109 The synthesis of regularly arranged α-Fe2O3 
nanowires with a diameter of 2-5 nm and a length of 20-40 nm has been described.110 
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A bulk γ-Fe2O3 sample is a ferrimagnet below 620 °C. The γ-Fe2O3 nanoparticles (4-16 nm) 
with a relatively narrow size distribution have been obtained by mild oxidation (Me3NO) of 
preformed metallic nanoparticles.111 The same result can be attained by direct introduction 
of Fe(CO)5 into a heated solution of Me3NO. The oxidation with air is also used to prepare γ-
Fe2O3 nanoparticles. For this purpose, the Fe3O4 nanoparticles (9 nm) are boiled in water at 
pH 12-13.112  
The most popular route to γ-Fe2O3 nanoparticles is thermal decomposition of Fe
3+ salts in 
various media. Rather exotic groups are used in some cases as anions. For example, good 
results have been obtained by using iron complexes with cupferron.113 A mechanochemical 
synthesis of γ-Fe2O3 has been described.
114 An iron powder was milled in a planetary mill 
with water; this is a convenient one-stage synthesis of maghemite nanoparticles (15 nm). 
Additionally, nonspherical Fe2O3 nanoparticles, such as nanorods, nanowires, nanobelts, and 
nanotubes, have also been synthesized and used for investigating their peculiar magnetic 
properties.115 
2.4.4.1.2 Fe3O4 (Magnetite) 
Among all iron oxides, magnetite Fe3O4 possess the most interesting properties because of 
the presence of iron cations in two valence states, Fe2+ and Fe3+, in the inverse spinel 
structure. The cubic spinel Fe3O4 is ferrimagnetic at temperatures below 858 K. The route to 
these particles used most often involves treatment of a solution of a mixture of iron salts 
(Fe2+ and Fe3+) with a base under an inert atmosphere. For example, the addition of an  
aqueous solution of ammonia to a solution of FeCl2 and FeCl3 (1:2) yields nanoparticles, 
which are transferred into a hexane solution by treatment with oleic acid.116 The repeated 
selective precipitation gives Fe3O4 nanoparticles with a rather narrow size distribution. The 
synthesis can be performed starting only from FeCl2, but in this case, a specified amount of 
an oxidant (NaNO2) should be added to the aqueous solution apart from alkali. This method 
alIows one to vary both the particle size (6.5-38 nm) and (to a certain extent) the particle 
shape.117 
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In some cases, thermal decomposition of compounds containing Fe3+ ions under oxygen-
deficient conditions is accompanied by partial reduction of Fe3+ to Fe2+. Thus thermolysis of 
Fe(acac)3, in diphenyl ether in the presence of small amounts of hexadecane-1,2-diol 
(probable reducer of a part of Fe3+ ions to Fe2+) gives very fine Fe3O4 nanoparticles (about 1 
nm), which can be enlarged by adding excess Fe(acac)3, into the reaction mixture.
118 Fe3O4 
nanoparticles can be also prepared in uniform sizes of about 9 nm by autoclave heating the 
mixture, consisting of FeCl3, ethylene glycol, sodium acetate, and polyethylene glycol.
119 For 
partial reduction of Fe3+ ions, hydrazine has also been recommended.120 The reaction of 
Fe(acac)3, with hydrazine is carried out in the presence of a surfactant. This procedure 
resulted in superparamagnetic magnetite nanoparticles with controlled sizes, 8 and 11 nm. 
Thus, Fe3O4 nanoparticles with an average size of 3.5 nm have been prepared by thermal 
decomposition of Fe2(C2O4)3∙5H20 at T > 400 °C.
121 Furthermore, the controlled reduction of 
ultradispersed α-Fe2O3 in a hydrogen stream at 723 K (15 min) is a more reliable method of 
synthesis of Fe3O4 nanoparticles. Particles with ca. 13 nm size were prepared in this way.
122  
The stabilization in the water media is interesting for bioapplications, but at the same time a 
problem also. For solving it cyclodextrin was used to transfer obtained organic ligand 
stabilized iron oxide nanoparticles to aqueous phase via forming an inclusion complex 
between surface-bound surfactants and cyclodextrin.123 In contrast, higher nanoparticles (20 
nm < d < 100 nm) are of great interest, mainly for hyperthermia because of their 
ferrimagnetic behavior at room temperature. 
2.4.4.1.3 FeO (Wustite) 
Cubic Fe2+ oxide is antiferromagnetic (Tc = 185 K) in the bulk state. Joint milling of Fe and 
Fe2O3 powders taken in a definite ratio give nanoparticles (5-10 nm) consisting of FeO and 
Fe.124 On heating these particles at temperatures of 250-400 °C, the metastable FeO phase 
disproportionates to Fe3O4 and Fe, while above 550 °C it is again converted into 
nanocrystalline FeO.125 
 
Claudio Carrara, Ph.D. Thesis 2012  
 
44 
 
2.4.4.1.4 FeOOH 
The oxyhydroxides, nominally FeOOH, include goethite, lepidocrocite, akaganeite, and 
several other polyrnorphs. They often contain excess water. Ferrihydrite Fe5HO8∙4(H20) is 
typically considered a metastable iron oxide that can act as a precursor to the more stable 
iron oxides such as goethite and hematite.126 Oxyhydroxides are normally obtained by 
precipitation from an aqueous solution. The particle size is controlled by initial iron 
concentration, organic additives, pH, and temperature. 
Among the known oxide hydroxides Fe2O3·H2O, the orthorhombic α-FeOOH (goethite) is 
antiferromagnetic in the bulk state and has Tc = 393 K.
127 Synthetic goethite nanoparticles 
are typically acicular and are often aggregated into bundles or rafts of oriented crystallites.  
β-FeOOH (akagenite) is paramagnetic at 300 K.128 Akaganeite always has a significant surface 
area and some amount of excess water, which increases tremendously with the decreasing 
particle size. Recent studies of nanoakaganite show that at very high surface areas, where 
the particle size becomes comparable to a few unit cells, akaganeite may contain goethite-
like structural features possibly related to the collapse of exposed tunnels.  
γ-FeOOH (lipidocrokite) is paramagnetic at 300 K and δ-FeOOH (ferroxyhite) is 
ferromagnetic.129 Although the bulk α-FeOOH is antiferromagnetic, in the form of 
nanoparticles it has a nonzero magnetic moment due to the incomplete compensation of 
the magnetic moments of the sublattices. Goethite nanoparticles have been studied by 
Mössbauer spectroscopy.130 As a rule, α-FeOOH is present in iron nanoparticles as an 
admixture phase. Ferrihydrite is widespread but the nature of its extensive disorder is still 
controversial. Because of chemical and structural variability in FeOOH containing 
nanoparticles, it is also critical to determine their chemical composition, including  
water content, surface area, and particle size. 
2.4.4.2 Cobalt Oxides 
Cubic cobalt oxide is antiferromagnetic and has TN = 291 K. Cobalt monoxide has played an 
important role in the discovery of the "exchange shift" of the hysteresis curve, first found for 
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samples consisting of oxidized Co nanoparticles.131 Data on the dependence of TN on the 
particle size were obtained in a study of CoO nanoparticles dispersed in a LiF matrix.132 The 
particles obtained by vacuum deposition contained a small metal core, according to powder 
X-ray diffraction. As the particle size decreased from 3 to 2 nm, TN decreased from 170 to 55 
K. Apparently, the presence of an oxide layer on cobalt nanoparticles can markedly increase 
the coercive force. For example, the coercive forces (at 5 K) of monodisperse 6 and 13 nm 
oxidized Co particles obtained by plasma gas condensation in an installation for the 
investigation of molecular beams were ca. 5 and 2.4 kG, respectively.133 Unfortunately, the 
blocking temperature for 6 nm nanoparticles was lower than room temperature (about 200 
K); therefore, under normal conditions, their coercive force was equal to zero. 
2.4.4.2.1 Co3O4 
The Co3O4 nanoparticles (cubic spinel) with sizes of 15-19 nm dispersed in an amorphous 
silicon matrix exhibited ferrimagnetic properties at temperatures below 33 K (for bulk 
samples, TN = 30 K).
134 A method for controlled synthesis of Co3O4 cubic nanocrystallites (10-
100 nm) has been developed.135 
2.4.4.3 Nickel Oxide 
Bulk crystals of NiO are antiferromagnetic, the Néel temperature being 523 K, but when the 
nanoparticles sizes are of the order of a few nanometers, they become superparamagnetic 
or superantiferromagnetic.136 NiO possess not only magnetic but also electrical properties. 
The conductivity increases by 6-8 orders of magnitude in nanosized NiO as compared to that 
of bulk crystals, something that is attributed to the high density of defects.137 It has been 
pointed out that electrodes composed of NiO nanoparticles exhibit a higher capacity and 
better cyclability than the ordinary ceramic material.138 
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2.5 Protection/Stabilization of Magnetic Nanoparticles 
Although there have been many significant developments in the synthesis of magnetic 
nanoparticles, maintaining the stability of these particles for a long time without 
agglomeration or precipitation is an important issue. Stability is a crucial requirement for 
almost any application of magnetic nanoparticles. Especially pure metals, such as Fe, Co, and 
Ni and their metal alloys, are very sensitive to air. Thus, the main difficulty for the use of 
pure metals or alloys arises from their instability towards oxidation in air, and the 
susceptibility towards oxidation becomes higher the smaller the particles are. Therefore, it is 
necessary to develop efficient strategies to improve the chemical stability of magnetic 
nanoparticles. The most straightforward method seems to be protection by a layer which is 
impenetrable, so that oxygen cannot reach the surface of the magnetic particles. Often, 
stabilization and protection of the particles are closely linked with each other. 
All the protection strategies result in magnetic nanoparticles with a core–shell structure, 
that is, the naked magnetic nanoparticle as a core is coated by a shell, isolating the core 
against the environment. 
The applied coating strategies can roughly be divided into two major groups: coating with 
organic shells, including surfactant and polymers,139 or coating with inorganic components, 
including silica,140 carbon,141 precious metals (such as Ag,142 Au143) or oxides, which can be 
created by gentle oxidation of the outer shell of the nanoparticles, or additionally deposited, 
such as Y2O3.
144 As an alternative, magnetic nanoparticles can also be dispersed/embedded 
into a dense matrix, typically in polymer, silica, or carbon, to form composites, which also 
prevents or at least minimizes the agglomeration and oxidation. However, the nanoparticles 
are then fixed in space relative to each other, which is often not desired. In contrast, 
individually protected nanocrystals are freely dispersible and stable in a variety of media 
owing to the protecting shell around them.145 
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2.5.1 Surface Passivation by Mild Oxidation 
A very simple approach to protect the magnetic particles is to induce a controlled oxidation 
of a pure metal core, a technique long known for the passivation of air-sensitive supported 
catalysts. This oxidation can be achieved by various methods. For example, Peng et al. 
developed a method for oxidizing gas-phase nanoparticles by using a plasma-gas-
condensation-type cluster deposition apparatus.146 Boyen et al. demonstrated that very 
good control over the chemical state of the cobalt nanoparticles was achieved by their 
exposure to an oxygen plasma.147 The control of the oxide layer has a tremendous impact on 
exchange-biased systems, where a well-defined thickness of the ferromagnetic core and the 
antiferromagnetic shell are desirable. Moreover, a direct correlation of the structure and 
magnetism in the small particles can be determined. Bönnemann et al. developed a mild 
oxidation method, using synthetic air to smoothly oxidize the as-synthesized cobalt 
nanoparticles to form a stable CoO outer layer which can stabilize the cobalt nanoparticles 
against further oxidation.148 
2.5.2 Surfactant and Polymer Coating 
Surfactants or polymers are often employed to passivate the surface of the nanoparticles 
during or after the synthesis to avoid agglomeration. In general, electrostatic repulsion or 
steric repulsion can be used to disperse nanoparticles and keep them in a stable colloidal 
state. The best known example for such systems are the ferrofluids which were invented by 
Papell in 1965.149 In the case of ferrofluids, the surface properties of the magnetic particles 
are the main factors determining colloidal stability. The major measures used to enhance the 
stability of ferrofluids are the control of surface charge150 and the use of specific 
surfactants.151 For instance, magnetite nanoparticles synthesized through the co-
precipitation of Fe2+ and Fe3+ in ammonia or NaOH solution are usually negatively charged, 
resulting in agglomeration. To achieve stable colloids, the magnetite nanoparticle precipitate 
can be peptized (to disperse a precipitate to form a colloid by adding of surfactant) with 
aqueous tetramethylammonium hydroxide or with aqueous perchloric acid.150 The 
magnetite nanoparticles can be acidified with a solution of nitric acid and then further 
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oxidized to maghemite by iron nitrate. After centrifugation and redispersion in water, a 
ferrofluid based on positively charged γ-Fe2O3 nanoparticles was obtained, since the surface 
hydroxy groups are protonated in the acidic medium.152 Commercially, water- or oil-based 
ferrofluids are available. They are usually stable when the pH value is below 5 (acidic 
ferrofluid) or over 8 (alkaline ferrofluid). 
In general, surfactants or polymers can be chemically anchored or physically adsorbed on 
magnetic nanoparticles to form a single or double layer,153 which creates repulsive (mainly 
as steric repulsion) forces to balance the magnetic and the van der Waals attractive forces 
acting on the nanoparticles. Thus, by steric repulsion, the magnetic particles are stabilized in 
suspension. Polymers containing functional groups, such as carboxylic acids, phosphates, 
and sulfates, can bind to the surface of magnetite154 or maghemite. Suitable polymers for 
coating include poly(pyrrole), poly(aniline), poly(alkylcyanoacrylates), poly(methylidene 
malonate), and polyesters, such as poly(lactic acid), poly (glycolic acid), poly(ε-caprolactone), 
and their copolymers.155 Surface-modified magnetic nanoparticles with certain 
biocompatible polymers are intensively studied for magnetic-field-directed drug targeting, 
and as contrast agents for magnetic resonance imaging.156 
Chu et al. reported a synthesis of polymer-coated magnetite nanoparticles by a single 
inverse microemulsion.157 The magnetite particles were first synthesized in an inverse 
microemulsion, consisting of water/sodium bis(2-ethylhexylsulfosuccinate)/toluene. 
Subsequently, water, monomers (methacrylic acid and hydroxyethyl methacrylate), 
crosslinker (N,N’-methylenebis(acrylamide)), and an initiator (2,2’-azobis(isobutyronitrile)) 
were added to the reaction mixture under nitrogen, and the polymerization reaction was 
conducted at 55 °C. After polymerization, the particles were recovered by precipitation in an 
excess of an acetone/ methanol mixture (9:1 ratio). The polymer-coated nanoparticles have 
superparamagnetic properties and a narrow size distribution at a size of about 80 nm. 
However, the long term stability of these polymer-coated nanoparticles was not addressed. 
Polyaniline can also be used to coat nanosized ferromagnetic Fe3O4 by oxidative 
polymerization in the presence of the oxidant ammonium peroxodisulfate.158 The 
nanoparticles obtained are polydisperse (20–30 nm averaged diameter) and have the 
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expected core–shell morphology. Asher et al. reported that single iron oxide particles (ca. 10 
nm) can be embedded in polystyrene spheres through emulsion polymerization to give 
stable superparamagnetic photonic crystals.159 Polystyrene coating of iron oxide 
nanoparticles was also achieved by atom transfer radical polymerization.160 
Metallic magnetic nanoparticles, stabilized by single or double layers of surfactant or 
polymer are not air stable, and are easily leached by acidic solution,161 resulting in the loss of 
their magnetization. A thin polymer coating is not a good enough barrier to prevent 
oxidation of the highly reactive metal particles. Polymer coating is thus not very suitable to 
protect very reactive magnetic nanoparticles. 
Another drawback of polymer-coated magnetic nanoparticles is the relatively low intrinsic 
stability of the coating at higher temperature, a problem which is even enhanced by a 
possible catalytic action of the metallic cores. Therefore, the development of other methods 
for protecting magnetic nanoparticles against deterioration is of great importance. 
2.5.3 Precious-Metal Coating 
Precious metals can be deposited on magnetic nanoparticles through reactions in 
microemulsion,162 redox transmetalation,163 iterative hydroxylamine seeding,164 or other 
methods, to protect the cores against oxidation. 
Cheon et al. reported a synthesis of platinum-coated cobalt by refluxing cobalt nanoparticle 
colloids (ca. 6 nm) and [Pt-(hfac)2] (hfac = hexafluoroacetylacetonate) in a nonane solution 
containing C12H25NC as a stabilizer.
163a After 8 h reflux and addition of ethanol and 
centrifugation, the colloids are isolated from the dark red-black solution in powder form. 
These particles are air stable and can be redispersed in typical organic solvents. The reaction 
byproduct was separated and analyzed as [Co(hfac)2], indicating that the formation of the 
core–shell structure was driven by redox transmetalation reactions between Co0 and Pt2+. 
Gold seems to be an ideal coating owing to its low reactivity. However, it was found that the 
direct coating of magnetic particles with gold is very difficult, because of the dissimilar 
nature of the two surfaces.165 Progress has been made, though, recently. O’Connor and co-
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workers have synthesized gold-coated iron nanoparticles with about 11 nm core size and a 
gold shell of about 2.5 nm thickness.163b These gold coated iron particles are stable under 
neutral and acidic aqueous conditions. The coating was achieved by a partial replacement 
reaction in a polar aprotic solvent. Briefly, a yellow solution of FeCl3, dissolved in N-
methylpyrrolydone (NMP), was added to a dark green NMP solution containing sodium and 
naphthalene under intensive stirring at room temperature. Thus, the Fe3+ ions were reduced 
by sodium to form the metallic cores. After removal of sodium chloride by centrifugation, 
and the addition of 4-benzylpyridine as capping agent at elevated temperature, the iron 
nanoparticles were coated with gold by the addition of dehydrated HAuCl4 dissolved in NMP. 
Gold-coated iron nanoparticles could also be prepared by a reverse microemulsion method. 
The inverse micelles were formed with cetyltrimethylammonium bromide (CTAB) as 
surfactant, 1-butanol as a co-surfactant, and octane as the continuous oil phase. FeSO4 was 
reduced by NaBH4, then addition of HAuCl4 coated gold on the iron nanoparticles.
143a 
Zhang et al. reported a new method for the preparation of gold coated iron magnetic core–
shell nanoparticles by the combination of wet chemistry and laser irradiation. The 
synthesized iron nanoparticles and gold powder were irradiated by a laser in a liquid 
medium to deposit the gold shell.166 The 18 nm body centered cubic (bcc) iron single domain 
magnetic cores are covered by a gold shell of partially fused approximately 3 nm-diameter 
fcc gold nanoparticles. The core–shell particles are superparamagnetic at room temperature 
with a blocking temperature, TB, of approximately 170 K. After four months of shelf storage 
in normal laboratory conditions, their magnetization normalized to iron content was 
measured to be 210 emu/g, roughly 96% of the bulk iron value, which indicates the high 
stability. 
Guo et al. have reported a synthesis of gold coated cobalt nanoparticles based on a chemical 
reduction reaction.167 The cobalt particles were fabricated using 3-(N,N-
dimethyldodecylammonio) propanesulfonate as the surfactant to prevent agglomeration, 
and lithium triethylhydridoborate as the reducing agent. The cobalt nanoparticles produced 
were added to KAuCl4 in tetrahydrofuran (THF) solution under ultrasonication and inert 
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atmosphere. The gold shell was deposited on the cobalt nanoparticle through reduction of 
the Au3+ by cobalt surface atoms. 
Gold coating of magnetic nanoparticles is especially interesting, since the gold surface can be 
further functionalized with thiol groups. This treatment allows the linkage of functional 
ligands which may make the materials suitable for catalytic and optical applications.168 
2.5.4 Silica Coating 
A silica shell does not only protect the magnetic cores, but can also prevent the direct 
contact of the magnetic core with additional agents linked to the silica surface thus avoiding 
unwanted interactions. For instance, the direct attachment of dye molecules to magnetic 
nanoparticles often results in luminescence quenching. To avoid this problem, a silica shell 
was first coated on the magnetic core, and then dye molecules were grafted on the silica 
shell.169 Silica coatings have several advantages arising from their stability under aqueous 
conditions (at least if the pH value is sufficiently low), easy surface modification, and easy 
control of interparticle interactions, both in solution and within structures, through variation 
of the shell thickness. 
The Stöber method and sol–gel processes are the prevailing choices for coating magnetic 
nanoparticles with silica.170 The coating thickness can be tuned by varying the concentration 
of ammonium and the ratio of tetraethoxysilane (TEOS) to H2O. The surfaces of silica-coated 
magnetic nanoparticles are hydrophilic, and are readily modified with other functional 
groups.171 The functionalization could introduce additional functionality, so that the 
magnetic particles are potentially of use in biolabeling, drug targeting, drug delivery. 
Previous studies involved the coating of hematite (Fe2O3) spindles and much smaller 
magnetite clusters with silica;172 the oxide cores could subsequently be reduced in the dry 
state to metallic iron.173 The advantage of this method is that silica coating was performed 
on an oxide surface, which easily binds to silica through OH surface groups. 
Xia and co-workers have shown that commercially available ferrofluids can be directly 
coated with silica shells by the hydrolysis of TEOS.170c A water-based ferrofluid (EMG 340) 
was diluted with deionized water and 2-propanol. Ammonia solution and various amounts of 
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TEOS were added stepwise to the reaction mixture under stirring. The coating step was 
allowed to proceed at room temperature for about 3 h under continuous stirring. The 
coating thickness could be varied by changing the amount of TEOS. Since the iron oxide 
surface has a strong affinity towards silica, no primer was required to promote the 
deposition and adhesion of silica. Owing to the negative charges on the silica shells, these 
coated magnetic nanoparticles are redispersible in water without the need of adding other 
surfactants. 
Kobayashi et al. described a method for the synthesis of monodisperse, amorphous cobalt 
nanoparticles coated with silica in aqueous ethanolic solution by using 3-
aminopropyltrimethoxysilane and TEOS as the silica precursor.174 Shi and co-workers have 
prepared uniform magnetic nanospheres (ca. 270 nm) with a magnetic core and a 
mesoporous-silica shell.175 The synthesis involved forming a thin and dense silica coating on 
hematite nanoparticles by the Stöber process, a second coating, the mesoporous silica shell, 
was added by a simultaneous sol–gel polymerization of TEOS and n-
octadecyltrimethoxysilane. The hematite core can be reduced to the metallic state by H2. 
Though great progress in the field of silica-coated nanoparticles has been made, the 
synthesis of uniform silica shells with controlled thickness on the nanometer scale still 
remains challenging. As an alternative, the microemulsion method was also tried.176 
Homogeneous silica-coated Fe2O3 nanoparticles with a silica shell of controlled thickness 
(1.8–30 nm) were synthesized in a reverse microemulsion.177 
Tartaj et al. reported a synthesis of monodisperse air-stable superparamagnetic α-Fe 
nanocrystals encapsulated in nanospherical silica particles of 50 nm in diameter. The iron 
oxide nanoparticles are embedded in silica by the reverse microemulsion technique, the α-
Fe is obtained by reduction with hydrogen at 450 °C.178 Similarly, a reverse micelle 
microemulsion approach was also reported to coat a layer of silica around spinel ferrite 
nanoparticles of CoFe2O4 and MnFe2O4.
179 
Although metals protected by silica can be synthesized by reduction after synthesis, silica 
deposition directly on pure metal particles is more complicated because of the lack of OH 
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groups on the metal surface. An additional difficulty for coating metallic nanoparticles, such 
as iron and cobalt with silica, which has to be overcome, is that iron and cobalt are readily 
oxidized in the presence of dissolved oxygen. Therefore, it is necessary to use a primer to 
make the surface “vitreophilic” (glasslike).180 This chemistry has been used to coat precious 
metals.181 Another possibility would be using stable cobalt nanoparticles, passivated by the 
gentle oxidation method developed by Bönnemann et al.,148 as starting materials for such 
silica coating. However, no corresponding report has appeared to date. 
From the mentioned examples above, it can be seen that silica coating of magnetic oxide 
nanoparticles is a fairly controllable process. However, silica is unstable under basic 
condition, in addition, silica may contain pores through which oxygen or other species could 
diffuse. Coating with other oxides is much less developed, and therefore alternative 
methods, especially those which would allow stabilization under alkaline conditions, are 
needed. 
2.5.5 Carbon Coating 
Although to date most studies have focused on the development of polymer or silica 
protective coatings, recently carbon-protected magnetic nanoparticles are receiving more 
attention, because carbon-based materials have many advantages over polymer or silica, 
such as much higher chemical and thermal stability as well as biocompatibility. 
Right after the discovery of fullerenes, it was found that carbon-encapsulated metal or metal 
carbide nanocrystallites can be generated by the Krätschmer arc-discharge process.182 Since 
then, many studies have shown that in the presence of metal nanoparticles (Co, Fe, Ni, Cr, 
Au, etc), graphitized carbon structures, such as carbon nanotubes and carbon onions, are 
formed under arc-discharge, laser ablation, and electron irradiation.183 The well-developed 
graphitic carbon layers provide an effective barrier against oxidation and acid erosion. These 
facts indicate that it is possible to synthesize carbon-coated magnetic nanoparticles, which 
are thermally stabile and have high stability against oxidation and acid leaching, which is 
crucial for some applications.184 Moreover, carbon-coated nanoparticles are usually in the 
metallic state, and thus have a higher magnetic moment than the corresponding oxides. 
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Though carbon-coated magnetic nanoparticles have many advantageous properties, such 
particles are often obtained as agglomerated clusters, owing to the lack of effective 
synthetic methods, and a low degree of understanding of the formation mechanism. The 
synthesis of dispersible, carbon-coated nanoparticles in isolated form is currently one of the 
challenges in this field. 
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3 Superparamagnetic Iron Oxide Nanoparticles: 
Some General Remarks 
Among all the class of magnetic nanoparticle, Superparamagnetic Iron Oxide Nanoparticles 
(SPIONs) have recently attracted the attention of the scientific community thanks to their 
peculiar characteristics.  
As previously largely discuss, bulk magnetic materials are composed of regions, called 
magnetic domains, within which there is an alignment of the magnetic moments. If the 
volume of the material is reduced, as in the case of SPIONs, a situation in which just one 
domain is reached occurs and the magnetic properties are no longer similar to bulk 
materials. 
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Due to their small volume, SPIONs present superparamagnetic behavior, meaning that the 
thermal energy may be enough to change spontaneously the magnetization within each 
nanoparticles. In other words, the magnetic moment of each SPION will be able to rotate 
randomly just because of the temperature influence. For this reason, in the absence of an 
electromagnetic field (Figure 4) the net magnetic moment of a system containing SPIONs will 
be zero at high enough temperatures. However, in the presence of a field, there will be a net 
statistical alignment of magnetic moments, analogous to what happens to paramagnetic 
materials, except that now the magnetic moment is not that of a single atom but of the 
SPIONs containing various atoms which can be up to 104 times larger than for a 
paramagnetic material. This property, marked by the lack of remanent magnetization after 
removal of external fields, enables the SPIONs to maintain their colloidal stability and avoid 
agglomeration, which is important for biomedical applications.185 
 
Figure 4 - Schematic representation of a superparamagnetic particle. Note that although the 
moments within each particle are ordered (red arrows), the net magnetic moment of a system 
containing SPIONs will be zero in the zero field and at high enough temperatures. In the presence of a 
field, there will be a net statistical alignment of magnetic moments. 
For these reasons, the application of an external alternating magnetic field (AMF) to SPIONs 
leads to the production of energy, in the form of heat, if the magnetic field is able to reorient 
the magnetic moments of the SPIONs.186 Such an effect can be exploited to use SPIONs as 
mediators in magnetic hyperthermia. 
In bigger multidomain magnetic nanoparticles, this reorientation is produced through the 
movement of domain walls, while in small monodomain SPIONs, the reorientation of the 
magnetic moments can occur due to (i) the rotation of the moment within the SPIONs, 
overcoming their anisotropy energy barrier (Néel loss), or (ii) the mechanical rotation of the 
SPIONs that will create frictional losses with the environment (Brown loss) (Figure 5). For 
maghemite γ-Fe2O3 SPIONs, below 15 nm, theoretically, Néel relaxation prevails over Brown 
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relaxation while for larger sizes and low viscosity media, Brown relaxation is the rotation 
mechanism.187 
 
Figure 5 - (Left) Rotation of the moment within the SPION, overcoming their anisotropy energy barrier 
that leads to Néel Loss, (centre) mechanical rotation of the SPIONs, that will create frictional losses 
with the environment and lead to Brown losses and (right) movement of domain walls in multidomain 
SPIONs that leads to hysteresis loss. 
SPIONs are also able to create small local magnetic fields, which cause a shortening of the 
relaxation times (T1 and T2) of the surrounding protons. This effect is named proton 
relaxation enhancement and leads to a change of the Nuclear Magnetic Resonance (NMR) 
signal intensity in its surroundings. 
MRI contrast is improved due to the presence of SPIONs acting as contrast enhancing agents. 
MRI contrast enhancement relies on the different engulfment of magnetic nanoparticles by 
different cells.188 It has been shown that the use of SPIONs improves lesion detection and 
diagnostic accuracy of MRI.189 T1 and T2 are called the longitudinal and transverse proton 
relaxation times, respectively. The longitudinal relaxation involves redistributing the 
populations of the nuclear spin states in order to reach the thermal equilibrium distribution. 
It reflects an exchange of energy, as heat, from the system to its surrounding. T1 measures 
the dipolar coupling of the proton moments to their surrounding; thereby isolated protons 
would show negligible rates of T1 relaxation. The transverse relaxation is related to the 
decoherence of the magnetization of the precessing protons due to magnetic interactions 
with each other and with other fluctuating moments in their surroundings. SPIONs are 
magnetically saturated at common field strengths used for MRI and their presence produces 
a marked shortening of T2 along with a less marked reduction of T1. Therefore, most of the 
published examples of the use of SPIONs as contrast agents are based in T2 weighted 
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imaging even though the impact on T1 is significant and often higher compared to 
paramagnetic chelates.190 
From a chemical point of view, SPIONs are small synthetic γ-Fe2O3 (maghemite) or Fe3O4 
(magnetite) particles with a core size normally under 15 nm. For more details, refer to 
section 2.4.4.1 and references therein. 
3.1 Biomedical Application of SPIONs 
In order to use SPIONs in biomedical field, a proper surface functionalization is required. 
Organic molecules that exhibit specific bioactivity must be loaded onto SPION surface and in 
this thesis the mainly used strategies will be shown [see Chapter 4]. 
The surface modification by organic molecules has different tasks to fulfill:191 (i) stabilize the 
nanoparticles in a biological suspension with a pH around 7.4 and a high salt concentration, 
(ii) provide functional groups at the surface for further derivatization, and finally (iii) avoid 
immediate uptake by the reticulendothelial system (RES).192 
Drug targeting has emerged as one of the modern technologies for drug delivery.193 
Drug targeting involves passive, active or physical targeting. In passive targeting the 
distribution of the drugs within the body occurs through drug and carrier properties that are 
unchanged (“Prodrugs’”). Active targeting is achieved with mechanisms that allow direct 
targeting of drugs and/or carriers to specific cells, tissues or organ systems through specific 
recognition mechanisms. Physical targeting allows distribution of drugs and carrier systems 
through external influences, such as magnets in the case of SPIONs or heat. 
SPIONs in combination with an external magnetic field allow delivering particles to the 
desired target area and fixing them at the local site while the medication is released and acts 
locally (Magnetic Drug Targeting, MDT).193,194 [see section 3.4.2] Therefore, the dosage of the 
medication can be reduced and the systemic effect of the drugs kept to a minimum.193,195 
The possibilities of SPIONs applications have drastically increased in recent years.194c,195,196 In 
the clinical area of human medicine, these particles are being used as delivery systems for 
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drugs,197 genes198 and radionuclides.196b Furthermore, ferrofluids, as contrast agents in 
magnetic resonance imaging (MRI) [see section 3.4.1], are routinely applied in the field of 
diagnostic imaging.199 SPIONs are also attractive for in vitro applications in medical 
diagnostics, such as research in genetics198b and technologies based on immune magnetic 
separation (IMS) of cells, proteins, DNA/RNA, bacteria, virus and other biomolecules.200 
Furthermore, in recent years, advances were made using SPIONs in clinical studies of cancer 
therapy in veterinary201 and human medicine194a,202 by attacking solid tumors with 
magnetically targeted 4-epidoxorubicin, or enhancing intraarterial chemotherapy through 
targeted retention of particles. 
Magnetic Fluid Hyperthermia (MFH) is another field where SPIONs are applied to create an 
increase in temperature by applying an oscillating magnetic field to kill the tumor cells.203 
This type of therapy is already used in human patients in the field of oncology [see section 
3.4.3]. 
One of the promising applications of SPIONs in the future could be focused on the 
musculoskeletal system in humans and animals.204 Many of the diseases in the 
musculoskeletal system are characterized by local inflammatory processes and currently are 
treated with systemic non-steroidal antiinflammatory drugs (NSAID’s)205 or 
corticosteroids.206 Apart from systemic side effects from these drugs, such as gastric ulcers 
or bleeding tendencies, local access or maintaining of therapeutic drug concentrations may 
be a problem. SPIONs could serve a major purpose through drug delivery to inflammatory 
sites to maintain appropriate concentrations while at the same time reducing cost, overall 
dosage and unwanted side effects. The magnets used in conjunction with SPIONs as drug 
carriers would allow switching on and off the magnetic field, thus targeting the particles at 
the local site for time, dosage and elimination. 
One of the reasons why the use of SPIONs was limited in the last 2 decades was their 
insufficient characterization, the inhomogenous morphology and fast elimination through 
the RES.195 However, new technologies in synthesis and methods of particle analysis 
together with more sophisticated coatings optimized properties of SPIONs and thus, their 
use has become highly attractive for medical applications in diagnostics and therapy. 
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3.2 Properties and Characteristics of SPIONs for 
Biomedical Applications 
3.2.1 Size of Particles 
The size of particles usually refers to the total diameter of the particles including the iron 
core and the coating. Since the smallest diameter of capillaries in the body is 4 μm,207 larger 
particles will be mainly captured and withheld in the lungs.208 Particles with larger sizes 
and/or aggregations of small particles thus may be trapped, causing emboli within the 
capillary bed of the lungs.209 Depending on their magnetic energy, most nanoparticles have a 
tendency to aggregate, thus reducing their surface charge. This may lead to precipitation 
that could prove dangerous if these particles are injected intravenously. Therefore, it is 
important to know the surface charge and aggregation behavior of the particles in blood.210 
Most intravenously applied nanoparticles are recognized as ‘‘foreign’’ from the body system 
and are eliminated immediately through macrophages of the mononuclear phagocytosis 
system (MPS).211 Particles smaller than 4 μm are taken up through cells of the 
reticuloendothelial system, mainly in the liver (60–90%) and spleen (3–10%).209,211 While it is 
more likely that small particles up to 100 nm will be phagocytosed through liver cells 
(openings in the endothelium of liver sinusoids are between 100 and 150 nm), there is a 
tendency for particles larger than 200 nm to be filtered by the venous sinuses of the 
spleen.212 If particles between 30 and 100 nm are intravenously applied, the liver eliminates 
the larger particles faster from the bloodstream compared to the smaller sizes. Thus, the 
larger the particles are, the shorter is their plasma half-life-period.213 
Depending on particle size, uptake may be subdivided in phagocytosis (all sizes) or 
pinocytosis (particles < 150 nm).211,214 Large particles will be only removed by cells capable of 
phagocytosis, whereas smaller particles can be removed by all types of cells through 
pinocytosis (all cells are capable of pinocytosis). Phagocytotic activity increases with size of 
particles.214 
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Under physiologic conditions, particles larger than 10 nm cannot penetrate the 
endothelium.195 However, this permeability barrier may be increased under pathologic 
conditions, such as inflammation or tumor infiltration. There, the penetration threshold can 
be increased to allow 700 nm particles.212 This can also be temporarily achieved through the 
help of medication, immune modulators, heat or radiation.195 
In conclusion, the uptake of nanoparticles is strongly dependent on particle size as it was 
proven in vitro215 and in vivo.214,216 
3.2.2 Toxicity of Particles 
All pharmaceutical substances intended for use in humans and animals require extensive 
testing for toxic side effects. This is also true for SPIONs. Apart from acute toxicity, the 
toxicity of degradation products, stimulation of cells with subsequent release of 
inflammatory mediators,214 and toxic effects through the particulate system have to be 
seriously considered. 
A first indication about the toxicity can be obtained by studying tissues from cell cultures 
histologically after incubation with nanoparticles.204,217 However, the cytotoxicity is usually 
much higher in vitro compared to in vivo. This may be explained by the fact that degradation 
products responsible for the toxicity are eliminated continuously from the application site in 
vivo. Therefore, toxicity tests conducted in vitro may have limited application.214 
If suspensions containing nanoparticles are used in vivo, they should be hydrophilic and their 
pH should be close to 7.4.195 In addition, they should be degraded and eliminated by the 
body system without residues, otherwise they may accumulate in certain cell compartments, 
such as liposomes, or tissues from the phagocytosis system (MPS).214 
One of the feasible toxicity tests in vivo is the intraperitoneal application of nanoparticles in 
mice218 that allows studying the LD50 dosage, the mitotic index (mutagenicity), and the effect 
of particles on macrophages and other cells (liver, spleen, kidney, peritoneal cells) by means 
of histology. 
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The toxicity (acute and subacute toxicity, mutagenicity), and pharmacokinetics (body 
distribution, metabolism, bioavailability, elimination) of nanoparticles with a median 
diameter of 80 nm (measured by laser light scattering) was investigated earlier in a large 
experimental study in dogs as well as mice.219 The particles tested were planned for later 
studies centered on MRI diagnostics of liver problems. Before intravenous application, the 
particles were functionalized with radioactive iron and several parameters were studied: (i) 
the distribution of radioactivity within different tissues using a special indicator for Fe 
isotopes, (ii) the relaxation time of liver and spleen in MRI, (iii) the capability to treat a 
previously induced iron deficit anemia, (iv) pathology of several organ systems by means of 
histology, (v) chemscreen of blood and urine and (vi) the mutagenicity by means of a special 
test (Ames Salmonella Microsome Reverse Mutation Assay). 
One hour after injection, 82.6% of the particles could be detected in the liver and 6.2% in the 
spleen. The concentration of radioactive particles was slowly decreased in the liver (plasma 
half-life 3 days) and the spleen (4 days) and the radioactive iron was incorporated into the 
hemoglobin of erythrocytes. The mean detection time (T2) in the MRI was shorter (2 days), 
since only unchanged particles are capable of inducing enough contrast to be detected. The 
previously induced anemia, however, was successfully treated within a period of 7 days. No 
acute or subacute toxic side effects were found in histology or serologic blood tests, 
although a maximal dosage of 3000 μmol Fe/kg was applied in the dogs and rats. This 
corresponds to a 150 times higher in dosage compared to what is required for diagnostic 
liver tests using MRI. 
Further in vivo tests with SPION based on particles of 100–1000 nm with either dextran, 
anhydroglucose or carbonate coating, and even clinical tests in humans showed excellent 
biocompatibility.194a,202,220 
3.2.3 Surface Charge 
The measured surface charge of SPIONs is related to the electrical potential at the shear 
plane of the double layer, the so-called zeta potential, which is measured through the 
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electrophoretic motility.214 Using electrostatic stabilization of the SPIONs, a high zeta 
potential is needed. 
The zeta potential is dependent on electrolyte concentration of the soluble medium in vitro 
and additionally on the adsorbing plasma proteins in vivo.221 If the zeta potential is lower 
than a given critical value of the particulate system, aggregation and precipitation of the 
particles occurs. 
The surface charge also plays an important role during endocytosis. There should be a 
slower uptake for negatively charged particles due to the negative ‘‘rejection’’ effect of the 
negatively charged cell membrane. However, the endocytosis index in vitro is minimal with a 
zeta potential close to zero.222 In contrast, phagocytosis is increased with a higher surface 
charge independent of whether the charge is negative or positive.211 
The higher the surface charge, the shorter is the residence time of SPIONs in the circulatory 
system.213 
3.2.4 Protein Adsorption Capacity 
If nanoparticles are injected intravenously, immediate interaction with plasma proteins 
occurs. The adsorption of proteins at the particle surface is called opsonization.223 The 
amount of adsorbed proteins is based on the size of the molecules and the charge and 
hydrophobicity of the particle surface. With increasing size, charge and hydrophobicity of 
the particles, the capacity of protein adsorption increases.211 Also hydrophobic interactions 
have an effect on protein adsorption224 such that dehydration of hydrophobic areas results 
in entropy gain which in turn facilitates protein adsorption.225 The adsorbed protein 
components play an important role in the biodistribution, degradation and elimination of 
the nanoparticles.211,226 Proteins that encourage phagocytosis are called opsonins (e.g. 
immunglobulin G (IgG), complement system, fibronectin),207,227 whereas those inhibiting 
phagocytosis are called dysopsonins.223,228 
The adsorption of a variety of proteins on nanoparticle systems has been investigated in 
vitro and in vivo.223,229 The opsonins and dysopsonins as well as other inactive proteins of the 
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blood plasma are responsible for the overall behavior of nanoparticles in vivo. Therefore, it is 
suboptimal to study the adsorption behavior of single proteins with nanoparticles.223 It is 
much more effective to study all plasma proteins present in blood by means of two-
dimensional polyacrylamide gel electrophoresis.211,230 With this method, several thousands 
of plasma proteins can be separated at the same time according to their isoelectric point and 
molecular weight. The main challenge encountered with this method is to identify the 
adsorbed proteins in combination with the particles without creating artifacts.211 Magnetic 
particles in contrast may relatively easily be separated from blood plasma by means of a 
magnetic separation technique. Studies elucidating the pattern of protein adsorption on 
SPIONs with a diameter of 65 nm and carboxydextran coating revealed a 40% IgG and 20% 
fibronectin adsorption of the overall adsorbed protein. In addition, IgM, IgD, complement 
factor C3, apolipoprotein A-1 and three further undefined proteins were detected. These 
particles were quickly eliminated and phagocytosed by Kupffer cells in the liver. 
3.3 In Vitro Use of SPIONs 
SPIONs have proven to be very useful tools for magnetic separation techniques in clinical use 
and have replaced other separation technologies.195,194c,196a,200,231 This is true for 
immunomagnetic cell separation and purification, as solid phase for immunoassays for 
isolation, purification and recognition of proteins.194c,231a,f In addition they are used for 
molecular biology, where they were shown to be useful for the isolation, purification, 
hybridization, synthesis and as markers for DNA/RNA.194c,196a,231a,d,f The isolation and 
detection of microorganisms is easily possible using SPIONs,196a,231a as well as efficient gene 
transfer of nucleotides or gene sequences into cells.198b 
In medical and clinical diagnostics, the interaction of antigens and antibodies is routinely 
used to measure concentrations of biological markers. Traditionally, antibodies and/or 
antigens are immobilized as solid phases on filters, tubular structures, plastic spheres or 
plates. The use of SPIONs as solid phases for these separation techniques has revolutionized 
and simplified this field of clinical chemistry through the development of more sensitive, 
highly efficient and automated immunoassays.194c,195,231b,g,h,232 Also magnetic beads 
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consisting of macroporous polymer particles containing iron oxide magnetic particles within 
the pores (microspheres) are successfully used for this technology of immune magnetic 
separation (IMS).200,231d This technique is an attractive, cost effective alternative for 
fluorescent activated cell sorting (FACS), which in contrast to IMS is less efficient, slower, 
requires a high dilution of the cell suspension and also has problems with sterility.231b IMS 
allows detecting very low concentrations of cells (up to 10 cells/ml) and this is an advantage 
in early diagnostics of cancer in the search of circulating tumor cells in the blood200,231c or 
bone marrow.195,200,231b,e 
Cells,194c,200 proteins, nucleic acids,194c bacteria, virus, parasites196a,231b and fungal agents may 
be well conserved if separated with IMS, and can be cultured in appropriate culture media 
afterwards without having to eliminate the particles.196a 
Most of the commercially available magnetic separation systems function according to the 
same principle: the surface of the SPIONs is labeled with antibodies against epitopes of cells, 
bacteria or other target antigens.233 Thereafter, the labeled particles are mixed with the 
suspension to be tested. After the antigen and antibody reaction, the labeled, 
immunomagnetic cell or bacteria suspension is pipetted in a separation container and a 
magnetic field is applied. While the immunomagnetic labeled cells remain within the 
container, all other substances are washed out. 
Through the development of the so-called ‘‘Microfabricated Flow System’’, the IMS 
technology was refined to the point where a continuous separation in a one-step procedure 
and without complicated washings can be achieved.231b 
SPIONs have also demonstrated their efficiency as non-viral gene vectors that facilitate the 
introduction of plasmids into the nucleus multifold compared to routinely available standard 
technologies. As in cell separation, the applied magnetic field allows transporting the genes 
selectively to the desired local cells within cell cultures. This is possible for the investigation 
of cell differentiating factors in non-gene manipulated neighboring cells within the same cell 
culture.198b 
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3.4 In Vivo Applications of SPIONs 
3.4.1 Magnetic Resonance Imaging (MRI) 
Clinical diagnostics with MRI has become a popular non-invasive method for diagnosing 
mainly soft tissue or recent cartilage pathologies, because of the different relaxation times 
of hydrogen atoms.195,234 SPIONs were developed as contrast agents for MRI and increase 
the diagnostic sensitivity and specificity due to modifications of the relaxation time of the 
protons.195,199b,f,235 The first dextran coated SPIONs were already 10 years ago officially 
registered as contrast agents for MRI of the liver in Europe.199c The efficacy of the SPIONs as 
contrast agent in various tissues depends on their physicochemical properties, such as size, 
charge and coating,213 and can be increased through surface modifications by biologically 
active substances (antibodies, receptor ligands, polysaccharides, proteins, etc.).195,199b,236 
The hydrodynamic diameter of the SPION used with MRI varies between 20 and 3500 nm, 
although intravenously applied particles are relatively small and range between 20 and 150 
nm with, or 5–15 nm without coating.199a,235b Coatings usually are made from derivates of 
dextran and poly(ethyleneglycol),235b but also starch, albumin, silica, etc.199a 
Since most of the particles are ingested from cells of the reticulendothelial system (RES), 
their distribution is most easily made visible in the liver, spleen, bone marrow237 and 
lymphnodes.199a,b,d,235a,d,k,m,238 Renal flow can also be visualized by means of SPIONs.235f,239,240 
Furthermore, SPIONs were used as oral contrast agents for the diagnosis of gastrointestinal 
tumors,199d,e,231d,241 or intravenously for the detection of other tumors in the body 
system,199b,c,201b,235l infarcts in the cardiovascular system,199d,235c,242 experimentally in 
cerebral areas 235j,p,243 with increased permeability of the blood brain barrier.199b,244 SPIONs 
are also predestined for use as combined carrier systems for drug delivery while at the same 
time serving as contrast agent.199b In this way, the kinetics of the pharmaceutical agent could 
be followed by means of MRI. In addition, distribution of particles can be influenced through 
the application of an external magnet.201b 
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3.4.2 Magnetic Drug Targeting (MDT) 
One of the major problems in pharmacotherapy is the delivery of drugs to a specific location 
and maintenance of its location for the desired length of time. The total concentration of 
drugs could be reduced drastically and side effects could be avoided. Using an external 
magnetic field, SPIONs functionalized with reversibly bound drugs could be delivered to 
specific locations and localized in place.194a,c The method of MDT is not only dependent on 
the physical properties, concentration and amount of applied particles, but also on the type 
of binding of the drugs. In addition, the geometry, size and duration of external magnet 
application and route of SPIONs injection, as well as vascular supply of the targeted tissues 
will influence their effect. 
The physiological parameters of the patient, such as body weight, blood volume, cardiac 
output, peripheral resistance of the circulatory system and organ function will also affect the 
efficiency of the external magnet apart from the possibility to place the magnet in close 
vicinity to the location.195,220a MDT, however, is dependent on this external magnetic field 
that in most commercially available magnets a penetration depth of a few millimeters into 
the tissue is achieved. However, newer investigations report about permanent neodymium 
iron boron magnets in combination with SPIONs of excellent magnetic properties that 
increase the depth of the magnetic field up to 10–15 cm.201a,220b 
In vivo SPIONs were successfully applied intravenously and accumulated at specific locations 
by means of external magnets.194a,c,198b,201a,b,220a This is especially attractive for use in cancer 
therapy, where chemo- or radiotherapy is demonstrating serious, extensive side effects 
while only having a small therapeutic margin. 
3.4.3 Hyperthermia with Magnetic Ferrofluids 
Superparamagnetic particles exposed to an alternating magnetic field can be used for heat 
induction.192,245 Through the oscillation of the magnetic moment inside the particles the 
magnetic field energy in the form of heat is liberated and conducted to the tissue 
environment.192,195 SPIONs have a much higher rate of specific absorption compared to 
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larger magnetic particles with several magnetic domains and therefore, are predestinated 
for use in hyperthermia, where the tissue is heated up to 41–46 °C.203,245 If the temperature 
exceeds 56 °C, necrosis, coagulation or carbonization of the tissue is the result; a procedure 
called ‘‘thermoablation’’.245,246 For obvious reasons thermoablation is only of limited value in 
clinical applications.203a 
In contrast, hyperthermia is highly suitable for cancer therapy, since tumor cells are highly 
susceptible to elevated temperatures.192,247 If tumor cells are heated up to 41–45 °C, the 
tissue damage for normal tissue is reversible while the tumor cells are irreversibly damaged. 
This can be an advantage when used in combination with therapies such as radio- and 
chemotherapy.203b,245,248 Interestingly, hyperthermia seems to induce modifications of the 
cell surface receptor molecules and thus, tumor cells are recognized by the immune system 
(killer cells) more easily.249 Furthermore, the blood brain barrier is reduced for 60 min when 
temperatures reach 42.5–43 °C promising an improvement in combined chemotherapies of 
brain tumors.245 
Conventional hyperthermia treatments including microwaves, ultrasound, radiofrequency, 
and infrared, have already been successfully used. However, their disadvantage is based on 
their inability to selectively induce heat formation in specific tumor tissue, inhibition of heat 
conduction through less heat conductive tissue, such as fat and cranial bone, the 
invasiveness of the methods, and temperature distribution inhomogeneities. 
In many in vitro tests with different types of tumor cells and SPIONs, the optimal physical 
properties of the SPIONs,250 antibody mediated tumor adhesion,247,251 particle uptake into 
tumor cells,250 duration and strength of the magnetic field247,250,251 was studied to achieve 
the most efficient tumor cell inactivation. They were then confirmed in animal experiments 
in vivo (mostly in mice) with experimentally induced tumors.203,246,248 
Currently, clinical trials in human patients affected with prostate and brain tumors are 
conducted using local magnetic hyperthermia in combination with radiotherapy.245 
Apart from cancer therapy, local magnetic hyperthermia could be used for blood coagulation 
in small vessels,195 for selective temperature increases in virus infected cells (eg. HIV after 
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coupling of CD4 glycoproteins to SPIONs)192 and as a drug delivery mechanism, where 
substances are coupled to magnetic microspheres or SPIONs.252 
As a summary, the application of SPIONs for local magnetic hyperthermia is a promising tool 
for future therapy where selective, efficient and non-invasive methods for heat induction in 
tissues are warranted. 
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Chapter 4: 
Surface Functionalization of SPIONs 
 
4 Strategies for SPIONs’ Surface Modification 
As previously reported, the main difficulty for the use of magnetic nanoparticles in biological 
fields arises from their chemical instability (oxidation or corrosion phenomena) [see section 
2.5], and from the necessity to obtain proper bionanoconjugates able to exhibit the specific 
biological activity they were designed for, without inducing an immunogenic response [see 
section 3.1]. 
These two tasks are complementary; in fact, to prevent oxidation or corrosion of the metallic 
magnetic core, proper coating are needed. At the same time, to act as bionanoconjugates, 
the nanoparticles must be coated with specific biomolecules, creating a protective shell 
around the metallic surface. We can say that often stabilization, protection and desired 
biological activity of the nanoparticles are closely linked each other. 
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All the surface modification strategies used with SPIONs consist in a core–shell structure, in 
which the naked magnetic nanoparticle as a core is coated by a shell, isolating the core itself 
against the external environment. 
The applied coating strategies can roughly be divided into two major groups: coating with 
organic shells, including surfactant and polymers,139 as well as biomolecules, or coating with 
inorganic components (precious metals, silica, carbon).140,141,142,143,144 
In order to use SPIONs for biomedical applications, the nanoparticle surface must be covered 
with targeting agents, therapeutic drugs or other functional probes. Hence, the need to 
develop efficient synthetic strategies for the conjugation of biomolecules onto SPIONs is an 
important and appealing target. 
The strategies used can involve passive non-covalent adsorption on the outer particle surface 
or the formation of a more stable covalent bond by using appropriate heterobifunctional 
linkers,253 in which one functional group specifically binds the nanoparticle, while the other 
reacts with the biomolecules in order to form the new bionanoconjugates (Figure 6). In 
theory, these kind of linkers can interact first with the nanoparticle surface leaving the 
additional functional group able to couple the biomolecule or, vice versa, can directly react 
with the biomolecule and, subsequently, can be supported onto SPIONs. 
 
Figure 6 - The heterobifunctional linker bears two orthogonal functional groups (FG’ and FG’’) able to 
selectively react with the SPION surface or with the organic molecule that we want to support on 
nanoparticle.  
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The linker plays a crucial role in the design and synthesis of new nanoconjugates; obviously 
this molecule acts as a connection between the inorganic magnetic core and the organic 
biomolecules, but can also acts as protecting shell as well as spacer, with the aim to create 
an organized distribution of biomolecules on the SPIONs surface. 
It’s worthy to note that sometimes biomolecules can directly bear a proper functional group 
able to interact with the nanoparticles, so in these case no linkers are needed. 
Otherwise, in order to act their specific bioactivity, some biomolecules need to be quite far 
away from the SPION surface and the atomic length of the linkers cannot be enough. For 
these reasons an additional spacer is needed. 
4.1 Classical Methodologies for the Surface Modification 
of SPIONs 
As mentioned in section 4, the grafting of organic molecules onto the SPION surface consists 
in the interaction of a proper functional group with the nanoparticles. These interactions are 
possible thanks to the presence of hydroxyl groups exposed on the SPION surface (Figure 
7),152 normally generated by natural passivation during the nanoparticles synthesis. 
 
Figure 7 - Interaction between the first functional group (FG’) of an heterobifunctional linker with the 
surface hydroxyl groups of a SPION. 
To better understand how an organic molecule (either a linker or a biomolecule) can interact 
with the SPION surface, it’s necessary to analyze the nature of the interaction formed. 
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Two kind of interactions are possible: a non-covalent adsorption or a covalent binding. These 
two features will be discussed in the next sections. 
4.1.1 Non-Covalent Adsorption of Organic Molecules onto 
SPIONs 
Chemically speaking, SPIONs are nanoparticles composed of mineral iron oxide, with their 
surface completely covered by hydroxyl groups. 
A particle of a mineral oxide in suspension in an aqueous solution tends to polarize and to be 
electrically charged.254 Most oxides are amphoteric. Thus, the nature and importance of this 
charge are a function of pH of the solution surrounding the particle. 
For example, in an acidic medium, the particle will be positively charged and the principle of 
electroneutrality implies the presence of a layer of ions with opposite charge near this 
particle. The two electric charges compensating each other. If we consider a model in 
agreement with the Gouy-Chapman theory (the diffuse model of electrical double layer in 
which the electric potential decreases exponentially away from the surface to the fluid 
bulk),255,256 counteranions will be thus located around the particle in a thin diffuse layer, as 
shown in Figure 8. 
 
Figure 8 - Schematic representation of the surface polarization of an oxide particle as a function of 
the solution pH. 
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Schematically, the equation of the surface polarization may be written as follows: 
                 
    
where S-OH represents a surface adsorption site and H+A- a mineral acid. 
In a basic medium, the reverse is true. The particle is negatively charged and is surrounded 
by compensating cations. The equation of the surface polarization may be written as follows: 
                           
where B+OH- represents a base. 
 
 
 
One conceives easily that between these two cases, a given value of pH exists at which the 
particle is overall not charged. This value, which is a characteristic of the oxide corresponds 
to its zero point of charge, also called Isoelectric Point (IE.P.). 
 
Oxide IE.P. 
Adsorption 
Capability 
Sb2O5 <0.4 
CATIONS WO3 <0.5 
SiO2 1.0-2.0 
U3O8 ≈4 
CATIONS or 
ANIONS 
MnO2 3.9-4.5 
SnO2 ≈5.5 
TiO2 ≈6 
UO2 5.7-6.7 
γ-Fe2O3 6.5-6.9 
ZrO2 ≈6.7 
CeO2 ≈6.75 
Cr2O3 6.5-7.5 
α,γ-Al2O3 7.0-9.0 
Y2O3 ≈8.9 
ANIONS 
α-Fe2O3 8.4-9.0 
ZnO 8.7-9.7 
La2O3 ≈10.4 
MgO 12.1-12.7 
 
Table 1 - Isoelectric Points (IE.P.) of various 
oxides 
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Given the IE.P. of an oxide, we may estimate in advance the adsorption capability (anionic or 
cationic) of particle surface and roughly what the pH range (acidic or basic) of the 
impregnating solution will be. Nowadays, the IE.P. of a large number of oxides are known 
and available in literature.257 Some examples are reported in Table 1. 
As we can see from the Table 1, γ-Fe2O3 SPIONs are amphoteric and can adsorb both cations 
or anions that are present in the aqueous solution. 
This peculiar property can be exploited in order to support biomolecules onto the SPIONs 
surface by a mild non-covalent interaction. Indeed carboxylic,258 sulfonic259 and phosphonic 
acids,260 dissolved in organic solvent, can interact with the hydroxyl groups of the iron oxide 
nanoparticles leading to the formation of carboxylate, sulfonate or phosphonate species in a 
double layer model as shown in Figure 9. 
 
Figure 9 - Non-covalent adsorption of carboxylic, sulfonic and phosphonic cids onto SPION surface. 
Non-covalent interactions can normally occur with organic acids, while classical organic 
bases (such as amines) are not able to form the double layer system. 
In this research project the use of carboxylate moiety as anchoring group for non-covalent 
adsorption of biomolecules onto superparamagnetic iron oxide nanoparticles have been 
successfully exploited [see section 5.7]. 
 
Chapter 4: Surface Functionalization of SPIONs 
 
91 
 
4.1.2 Covalent Binding of Organic Molecules onto SPIONs 
The surface functionalization of SPIONs can also be carried out by the formation of covalent 
bonds between the surface hydroxyl groups of the nanoparticles and a proper functional 
group present onto an organic molecule, either a simple heterobifunctional linker, an 
organic spacer or a more complex biomolecule. 
As previously reported in section 2.5.4, magnetic nanoparticles can be easily coated with a 
silica shell, thanks to the reaction of TEOS (triethoxysilane) with the nanoparticle surface.170 
In fact, the silane moieties are able to covalently react with the hydroxyl groups exposed on 
the iron oxide surface, leading to a complete coverage of the external magnetic core. 
In an analogous way, covalent surface modification of SPIONs with organic molecules can be 
easily achieved exploiting the reactivity of siloxane moieties towards the hydroxyl groups 
present onto the nanoparticle surface. 
In fact, alkoxysilanes react with SPIONs via a silylation reaction leading to the formation of 
covalent Fe-O-Si and Si-O-Si bonds.261 Furthermore, the presence of an additional orthogonal 
functional group permits to functionalize the nanoparticle surface with a second reactive 
free functional moiety. 
3-Aminopropyl-triethoxysilane (APTES) is the most commonly used alkoxysilane due to the 
presence of three hydrolysable ethoxysilane moieties able to react with the nanoparticle 
surface, but also bearing a terminal free amino group capable to further chemical 
modification (Figure 10a). 
 
Figure 10 - Structural formulas of a) 3-aminopropyl-triethoxysilane (APTES), b) 3-aminopropyl-ethyl-
diethoxysilane (APDES) and c) 3-aminopropyl-diethyl-ethoxysilane (APES). 
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The silylation process is very complex and does not involve a single mechanism. Thus, many 
different intermediates are possible.262 
Varying the nature of the alkoxysilane coating reagent, it’s possible to easily tune the final 
loading of the organic molecules covalently grafted onto the SPION surface, tuning at the 
same time the surface density of the additional free functional groups (e.g. free NH2 
moieties). 
 
Figure 11 - Schematic examples of possible SPIONs surface after coating with a) APTES, b) APDES and 
c) APES alkoxysilanes. It’s to note that free amino moieties can form hydrogen bonds with free OH 
surface groups. 
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As schematically reported in Figure 11, using the same concentration of three different 
alkoxysilanes for the covalent surface functionalization of SPIONs, different results can be 
obtained. 
The polycondensation process was outstanding for the APTES molecule (Figure 11a) thanks 
to its three ethoxy groups, which contributed to a large amino group density. When the 3-
aminopropyl-ethyl-diethoxysilane (APDES, Figures 10b and 11b) or 3-aminopropyl-diethyl-
ethoxysilane (APES, Figure 10c and 11c) were used the loading and the free-amino group 
density were lower due to the presence of ethyl groups that cause steric hindrances onto 
the particle surface, reducing the number of formed Fe-O-Si bond, as well as the capability 
to cross-link (Si-O-Si). 
A decrease in the amino group density may also be related to hydrogen bond formation 
between the anchored amino moieties and neighbor surface hydroxyl groups.261 
As said before, APTES is one of the most used heterobifunctional linker for the covalent 
surface modification of SPIONs; the obtained silicon coating prevents from corrosion 
phenomena and the terminal free amino group can be chemically derivatized in order to 
anchor different kind of biomolecules onto SPIONs. 
4.2 The Discovery of a New Covalent Surface Modification: 
Anchoring of Isocyanates onto SPIONs 
During this Ph.D. research work, both non-covalent and covalent surface interactions were 
investigated in order to obtain new bionanoconjugates. Specifically, we were interested in 
the search for new heterobifunctional linkers able to covalently bind the SPIONs surface, as 
an alternative to the previously used linker APTES (Figure 10a). 
In this work, commercially available γ-Fe2O3 maghemite SPIONs (Alfa Aesar) with an average 
diameter of 10±2 nm were used. 
Generally, APTES functionalized nanoparticles can be easily synthesized as reported in 
Scheme 1.263 
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Scheme 1 - Synthesis of APTES functionalized SPIONs. 
APTES 1 is added to a suspension of naked maghemite SPIONs under sonication; after 4 
hours at 60 °C it is possible to isolate the corresponding NP-APTES 2. The free amino-groups 
can be used to bind proper biomolecules as itself or after a functional group interconversion.  
Using the same strategy, we decided to use the 3-(triethoxysylil)propyl isocyanate (TESPI) 3, 
instead of APTES 1, in order to obtain a new nanoconjugates bearing free NCO-groups on the 
surface (Scheme 2). 
 
Scheme 2 - Reaction between SPIONs and TESPI. 
Unexpectedly, we didn’t obtain the desired product in which the alkoxysilane reacted with 
the SPION surface. From FTIR spectroscopy (Figure 12) and elemental analysis (E.A.) we have 
deduced that the isocyanate group of TESPI 3 had interacted with the SPION surface leading 
to a new species of nanoconjugate. Our hypothesis was that the NCO moiety reacted with 
the surface OH-groups of the nanoparticle, forming carbamate-like bond, affording the new 
nanoconjugate NP-TESPI 4 (Scheme 2). 
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Figure 12 - FT-IR spectra of a) TESPI 3, b) naked SPIONs and c) NP-TESPI 4. In spectrum c) is clearly 
visible the peak at 1635 cm-1 referred to the carbamate-like C=O stretching, while the NCO band at 
2273 cm-1 is absent. 
 
This unexpected result led us to further investigate the reactivity of the isocyanate group 
towards the SPION surface. 
To the best of our knowledge, only two examples of the use of an isocyanate moiety as the 
anchoring group onto nanoparticle materials are reported in literature; in particular, Ma et 
al. reported the use of isophorone diisocyanate in reaction with the silanol groups on the 
surface of nanosilica with formation of a carbamate-like bond,264 while Ou et al. reported 
the covalent interaction of toluene-2,4-diisocyanate with the hydroxyl groups that cover the 
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titania nanoparticles.265 Since in these papers no depth studies were made to demonstrate 
the formation of a carbamate bond between the isocyanate group and the nanoparticles 
surface, and nothing is reported in literature about iron oxide nanoparticle grafting with 
isocyanates, we decided to deep investigate this new anchoring methodology. 
In fact, the generality of the grafting of isocyanate molecules onto SPIONs surface, could be 
exploited as a new anchoring system and a new class of heterobifunctional linkers for 
SPIONs could be proposed. 
The scope of this new possible anchoring strategy was evaluated preparing a small library of 
new nanoconjugates starting from commercially available (5-9) or easily synthesizable (10) 
differently substituted isocyanates, reported in Figure 13. 
 
Figure 13 
Isocyanates 8-10 were endowed with a second functional group which, in principle, could be 
used to support organic molecules to the SPIONs surface through the linker. 
As said before, the (p-maleimido)phenyl isocyanate (PMPI) 10 can be easily synthesized as 
reported in literature and its synthesis is shown in Scheme 3.266 
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Scheme 3 - Synthesis of PMPI 10. 
Starting from the commercially available (p-amino)benzoic acid (PABA) 11 it is possible to 
obtain the (p-maleimido)benzoic acid (PMBA) 12 in 70% yield by reaction with maleic 
anhydride in a three step procedure. PMBA 12 is directly converted in the corresponding (p-
maleimido)benzoyl azide (PMB-azide) 13 using diphenylphosphoryl azide (DPPA) in the 
presence of triethylamine; after chromatographic purification, pure 13 is recovered in 50% 
yield. Then, the labile acyl azide 13 undergoes a Curtius rearrangement affording the desired 
PMPI 10 in quantitative yield. 
To overcome the limiting step (in terms of yield and reaction time) of conversion of 
carboxylic acid 12 into the acyl azide 13, we set up the alternative two step procedure 
reported in Scheme 4. First, 12 was converted into the corresponding (p-maleimido)benzoyl 
chloride (PMB-Cl) 14 by refluxing in thionyl chloride and then, the obtained acyl chloride was 
reacted with sodium azide in order to form the PMB-azide 13 in 70% yield after 
chromatographic purification. 
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Scheme 4 - Alternative synthesis of PMB-azide 13. 
In order to verify the formation of the carbamate bond between –NCO containing molecules 
5-10 and SPIONs, but also the reproducibility of our innovative grafting methodology, a 
general protocol for the synthesis of new nanoconjugates has been set up. 
The general procedure used to anchor isocyanates 5-10 onto the naked SPIONs is shown in 
Scheme 5. 
 
Scheme 5 - Standard procedure for the synthesis of new carbamate-based nanoconjugates. 
The proper isocyanate (0.2, 0.4 or 0.8 millimoles) was added to a suspension of 100 mg of 
naked SPIONs in dry toluene, under sonication at 60 °C for 4 hours. The resulting suspension 
was then centrifugated at 5000 round per minute for 10 minutes; the supernatant was 
eliminated and the solid residue was washed with fresh toluene (3x5 ml) and diethyl ether 
(3x5 ml) affording the desired nanoconjugates 15-20 (Figure 14). 
 
 
Chapter 4: Surface Functionalization of SPIONs 
 
99 
 
 
Figure 14 
All nanoconjugates were characterized by elemental analysis (E.A.) and infrared 
spectroscopy (FTIR), while only some of them have been further characterized by High 
Resolution Magic Angle Spinning NMR technique (HR-MAS NMR). The results obtained 
confirmed us the formation of a stable carbamate-like bond between the isocyanate group 
of the organic molecules and the surface hydroxyl groups of the nanoparticles. These results 
will be fully discussed in the next sections. 
4.2.1 Elemental Analysis Characterization: Determination of the 
Final Loading 
In organic chemistry elemental analysis (E.A.) refers to the determination of the mass 
fractions of carbon, hydrogen and nitrogen of a sample. This information is important to 
help determine the structure of an unknown molecule, as well as to help ascertain the 
structure and purity of a synthesized compound. The most common form of CHN analysis is 
accomplished by combustion analysis. In this technique, a sample is burned in an excess of 
oxygen, and various traps collect the combustion products (carbon dioxide, water, and nitric 
oxide). The masses of these combustion products can be used to calculate the composition 
of the unknown sample. The analysis of results is performed by determining the ratio of 
elements from within the sample, and working out a chemical formula that fits with those 
results. 
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All of the nanoconjugates 15-20 were submitted to E.A., from which the chemical formula of 
the organic residues anchored onto the SPIONs surface was confirmed [for analytical data 
referred to the experimental part, section 4.6.2]. 
The sum of the percentages in weight of carbon, hydrogen and nitrogen obtained from the 
analysis, together with the percentages of other elements calculated on a molar basis from 
nitrogen, has provided us a first value of loading expressed as percentage in weight of the 
organic part anchored onto nanoparticle surface. This total percentage of organic part [Tot 
% org] corresponds to the quantity in milligrams of the organic residue per 100 milligrams of 
nanoconjugates. From the molecular weight of the anchored molecule is therefor possible to 
express the final loading as millimoles of organic part per gram of nanoparticles [mmol/g 
NPs], in an analogous way that’s normally used with solid phase supports. 
The synthetic protocol used to synthesize nanoconjugates 15-20, was set up in order to 
verify the reproducibility of the methodology and the possibility to tune the quantity of 
organic molecule grafted onto the SPIONs surface. For these reasons the final loading of 
each nanoconjugate was determined by E.A. and the results obtained in the three series of 
test reactions with 0.2, 0.4 and 0.8 millimoles of isocyanates per 100 milligrams of naked 
nanoparticles are shown in Table 2, Table 3 and Table 4, respectively. 
R-NCO Nanoconjugate 
0.2 mmol of NCO / 100 mg NPs 
Tot % org mmol/gNPs 
5 15 13.83 1.10 
6 16 15.36 1.28 
7 17 16.62 1.08 
8 18 17.54 0.80 
9 19 22.17 1.21 
10 20 14.42 0.67 
    Average Loading 16.66 1.02 
 
Table 2 - Final loading for nanoconjugates 15-20 in the reaction with 0.2 millimoles of isocyanate per 
100 milligrams of naked SPIONs. 
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R-NCO Nanoconjugate 
0.4 mmol of NCO / 100 mg NPs 
Tot % org mmol/gNPs 
5 15 26.69 2.11 
6 16 26.55 2.21 
7 17 29.83 1.93 
8 18 19.74 0.90 
9 19 25.74 1.41 
10 20 31.07 1.44 
    Average Loading 26.60 1.67 
 
Table 3 - Final loading for nanoconjugates 15-20 in the reaction with 0.4 millimoles of isocyanate per 
100 milligrams of naked SPIONs. 
 
 
R-NCO Nanoconjugate 
0.8 mmol of NCO / 100 mg NPs 
Tot % org mmol/gNPs 
5 15 51.47 4.08 
6 16 43.80 3.65 
7 17 40.33 2.61 
8 18 21.75 0.99 
9 19 35.01 1.92 
10 20 51.81 2.41 
    Average Loading 40.70 2.61 
 
Table 4 - Final loading for nanoconjugates 15-20 in the reaction with 0.8 millimoles of isocyanate per 
100 milligrams of naked SPIONs. 
 
As shown in tables, an average loading of 16.66% (1.02 mmol/gNPs), 26.60% (1.67 mmol/gNPs) 
and 40.70% (2.61 mmol/gNPs) was calculated for the three cases. 
In Figure 15 is reported a loading comparison (in total percentage in weight of loaded 
organic molecule) of the nanoconjugates 15-20 and of the calculated average loading for the 
three sets of reaction with different ratio of starting isocyanate. We can see that for each 
nanoconjugate, the loading increases with a good linearity increasing the amount of the 
corresponding isocyanate. In the case of nanoconjugate 18, the loadings are quite lower 
probably due to the extreme lability of the corresponding starting isocyanate 8. 
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Figure 15 - Loading comparison of nanoconjugates 15-20, express as total percentage in weight of 
organic part loaded onto SPIONs (Tot % org). 
 
The same considerations can be done for the data reported in Figure 16, where the loadings 
are expressed as millimoles of organic part per gram of functionalized nanoparticles. 
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Figure 16 - Loading comparison of nanoconjugates 15-20, express as millimoles of organic part per 
gram of functionalized nanoparticles (mmol/gNPs). 
 
The reproducibility of the reactions of isocyanate with SPIONs was confirmed in the ase of 
PMPI 10. In fact, three experiments in which 0.8 millimoles of 10 were reacted with 100 
milligrams of naked SPIONs, afforded the nanoconjugate 20 with approximately the same 
loading values (Table 5). 
Entry 
0.8 mmol of PMPI / 100 mg NPs 
Tot % org mmol/gNPs 
A 51.81 2.41 
B 52.12 2.42 
C 51.11 2.38 
 
Table 5 - Reproducibility of the loading in the synthesis of nanoconjugate 20. 
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As previously said, the loadings increase with a good linearity. In the graph reported in 
Figure 17, the average loadings expressed in [Tot % org] and [mmol/gNPs] are reported with 
their linear regression trend lines. 
 
Figure 17 - Linear regressions on average loading values. 
 
The correlation coefficients R2 determined on the average loading values are higher than 
0.99, confirming the excellent linearity in which the grafting of isocyanates onto SPION 
surface happens. 
We can conclude that from E.A. it was possible to confirm that the organic residues 
anchored onto the SPIONs surface correspond to the expected chemical formula. 
Furthermore, the reproducibility of the methodology was demonstrated and the final 
loadings increase with the increasing amount of the starting isocyanate with an excellent 
linearity, proving that’s is possible, in principle, to easily tune the desired final loading of a 
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nanoconjugate, just modifying the ratio between the amount of the starting NCO-molecule 
and the naked SPIONs. 
4.2.2 Infrared Spectroscopy: Demonstration of a Carbamate-like 
Bond Formation 
Fourier Transform Infrared Spectroscopy (FTIR) is a common technique used in organic 
chemistry to characterize chemical compounds exploiting the vibrational modes of an “IR 
active” molecule. FTIR was already used in sampling transmission mode to characterize 
magnetite and maghemite nanoparticles, also in the presence of organic coating.258a,267 
In order to prove the grafting of isocyanate molecules onto the SPIONs surface by the 
formation of a carbamate-like bond, the naked SPIONs, the starting isocyanates 5-10 and the 
corresponding nanoconjugates 15-20 were analyzed by FTIR. 
Spectra were acquired on a Spectrum One FTIR spectrophotometer (Perkin Elmer) in the 
range 4000-450 cm-1 in transmittance mode. 0.5 mg of sample were diluted in 150 mg FTIR 
grade KBr and ground in an agate mortar. KBr was previously dried at 125°C under vacuum. 
Then mixed powder was pressed at 9 tons for 3 min to obtain slim semitransparent tablet. 
Spectra were recorded selecting 64 scans and 4 cm-1 resolution. The background of pure KBr 
was separately recorded using the same conditions and automatically subtracted from 
sample spectra. 
Spectra of starting isocyanate were acquired in transmittance mode in the range 4000-600 
cm-1 using NaCl windows as support and selecting 4 scans and 4 cm-1 resolution. 
In Figure 18 is reported the FTIR spectrum of naked SPIONs in which are clearly visible the 
strong broad band at high wavenumber (about 3380 cm-1) due to the presence of the 
nanoparticles surface hydroxyl groups and the strong Fe-O absorption from 650-500 cm-1. 
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Figure 18 - FTIR spectrum of naked SPIONs 
 
In the next figures are reported the superimposed spectra of the starting isocyanates (red 
line), the naked SPIONs (blue line) and the corresponding obtained nanoconjugates (black 
line). 
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Figure 19 - FTIR spectra of a) cyclohexyl isocyanate 5 (red line), b) naked SPIONs (blue line) and c) 
nanoconjugate 15 (black line). The labeled peak at 2258 cm-1 in spectrum a), corresponding to NCO 
stretching, is no longer visible in spectrum c), in which are instead clearly visible all the vibrational 
bands related to the C-H bonds and at 1626 cm-1 the sharp peak of carbamate C=O stretching. At 
about 3300 cm-1, the stretching of carbamate N-H bond is also present. 
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Figure 20 - FTIR spectra of a) phenyl isocyanate 6  (red line), b) naked SPIONs (blue line) and c) 
nanoconjugate 16 (black line). The labeled peak at 2259 cm-1 in spectrum a), corresponding to NCO 
stretching, is no longer visible in spectrum c), in which are instead clearly visible all the vibrational 
bands related to the C-H and C=C bonds and at 1647 cm-1 the sharp peak of carbamate C=O 
stretching. At about 3300 cm-1, the stretching of carbamate N-H bond is also present. 
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Figure 21 - FTIR spectra of a) p-chlorophenyl isocyanate 7 (red line), b) naked SPIONs (blue line) and c) 
nanoconjugate 17 (black line). The labeled peak at 2265 cm-1 in spectrum a), corresponding to NCO 
stretching, is no longer visible in spectrum c), in which are instead clearly visible all the vibrational 
bands related to the C-H and C=C bonds and at 1632 cm-1 the sharp peak of carbamate C=O 
stretching. At about 3300 cm-1, the stretching of carbamate N-H bond is also present. 
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Figure 22 - FTIR spectra of a) (p-chlorosulfonyl)phenyl isocyanate 8 (red line), b) naked SPIONs (blue 
line) and c) nanoconjugate 18 (black line). The labeled peak at 2265 cm-1 in spectrum a), 
corresponding to NCO stretching, is no longer visible in spectrum c), in which are instead clearly 
visible all the vibrational bands related to the C-H and C=C bonds, the classical stretching of O=S=O 
moiety at 1328-1157 cm-1  and at 1699 cm-1 the shouldered peak of carbamate C=O stretching. 
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Figure 23 - FTIR spectra of a) (p-isocyanate)benzoyl chloride 9 (red line), b) naked SPIONs (blue line) 
and c) nanoconjugate 19 (black line). The labeled peak at 2265 cm-1 in spectrum a), corresponding to 
NCO stretching, is no longer visible in spectrum c), in which are instead clearly visible all the 
vibrational bands related to the C-H and C=C bonds, the classical stretching of chloroacyl moiety at 
about 1770 cm-1  and at 1682 cm-1 the  peak of carbamate C=O stretching. 
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Figure 24 - FTIR spectra of a) (p-maleimido)phenyl isocyanate PMPI 10 (red line), b) naked SPIONs 
(blue line) and c) nanoconjugate 20 (black line). The labeled peak at 2306 cm-1 in spectrum a), 
corresponding to NCO stretching, is no longer visible in spectrum c), in which are instead clearly 
visible all the vibrational bands related to the C-H and C=C bonds, the maleimido C=O stretching peak 
at about 1710 cm-1 and at 1693 cm-1 the sharp peak of carbamate C=O stretching. At about 3300 cm-
1, the stretching of carbamate N-H bond is also present. 
 
As an example, we can discuss the FTIR spectra shown in Figure 20, in which the phenyl 
isocyanate 6 and the corresponding nanoconjugate 16 were reported. 
Spectrum a) shows at 2259 cm-1 a typical strong band of isocyanate group stretching. This 
peak is absent in coated nanoparticle spectrum c) that, on the contrary, shows a peak at 
1647 cm-1; this peak is due to C=O stretching of new carbamate group, formed in 
nanoparticles-isocyanate interaction. The presence of iron justifies signal shift at lower 
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frequency compared to a totally organic carbamate. The peak at 3326 cm-1 is related to the 
carbamate N-H stretching, absent in a) e b) and partially covered by broad band of 
nanoparticles surface hydroxyl groups. 
Moreover in c) bands in the region of 1594-1497 cm-1 are associated with C=C of aromatic 
ring stretching and with N-H deformation, while in the region 1314-1230 cm-1 signal are 
related to C-O and Ar-N stretching. Both naked and coated nanoparticles spectra show 
clearly strong Fe-O absorption from 650 to 500 cm-1. [For the complete attribution of 
vibrational bands of each compounds referred to the experimental part, section 4.6.2.] 
The same considerations can be done for each nanoconjugates. 
In Table 6 are summarized the wavenumber for the C=O vibrational stretching bands of the 
starting isocyanate 5-10 and the corresponding nanoparticle-carbamate derivatives 15-20. 
R-NCO Nanoconjugate 
Stretching [cm-1] 
Figure 
-N=C=O C=O carbamate 
5 15 2258 1626 19 
6 16 2259 1647 20 
7 17 2265 1632 21 
8 18 2265 1699 22 
9 19 2265 1682 23 
10 20 2306 1693 24 
 
Table 6 - C=O Stretching values of starting isocyanate and corresponding nanoconjugates. 
 
It’s worthy to note that the final loading of a nanoconjugate plays a crucial role in the 
resolution of the FTIR spectrum. The three series of reaction performed for the synthesis of 
nanoconjugate 20 (0.2, 0.4 and 0.8 millimoles of PMPI 10 per 100 mg of naked SPIONs) were 
characterized by FTIR, and their spectra are reported in Figure 25. 
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Figure 25 - FTIR spectra of nanoconjugate 20 obtained reacting a) 0.2 mmol PMPI 10 / 100 mg NPs 
(blue line), b) 0.4 mmol PMPI 10 / 100 mg NPs (black line) and c) 0.8 mmol PMPI 10 / 100 mg NPs (red 
line). The loading of 20 increases from a) to c). Final loading: a) 14.41% (0.62 mmol/gNPs), b) 31.07% 
(1.34 mmol/gNPs) and c) 51.81% (2.24 mmol/gNPs). 
 
Increasing the final loading, the resolution of the peaks related to the vibrational modes of 
the organic molecule anchored onto the SPIONs surface increases. In Figure 25 is clearly 
shown how the intensity of the peaks related to the organic molecule increases (e.g. the 
carbamate N-H stretching at ca. 3300 cm-1 becomes more visible increasing the final loading 
of the nanoconjugate 20), while the strong absorption bands of the iron oxide become 
weaker. 
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We can conclude that FTIR spectroscopy helps to point out the interaction between the 
isocyanate group and the SPIONs surface, confirming the formation of a carbamate bond for 
all products. Furthermore, FTIR spectroscopy has proved to be the choice technique for the 
analysis of these kind of nanoconjugates. 
4.2.3 High Resolution Magic Angle Spinning NMR: a Further 
Confirmation of the Covalent Adsorption of Isocyanates 
onto SPIONs 
The High Resolution Magic Angle Spinning (HR-MAS) probes have been designed to perform 
solution type experiments, while spinning the sample at the magic angle (54.7°) and are able 
to work with gel samples and semisolid matrices; they have been used successfully for the 
characterization of gels,268 biopsies,269 nanocrystalline proteins,270 metabolic phenotypes of 
entire microorganisms271 and also with intact tissues, with a spectral resolution comparable 
to that observed with extract solutions.272 
As just described in previous works, 1H-NMR resolved spectra of a ligands bound to a 
paramagnetic nanocrystal, like SPIONs, are difficult to perform for many reasons: the large 
broadening effects caused by the paramagnetic material,273 that also measurably changes 
the nuclear magnetic resonance relaxation properties of nearby protons in aqueous solution, 
at distances up to ca. 50 μm;274 the decreased mobility of the ligands on the surface, as well 
as the paramagnetism of the iron oxide, in addition to an inherent broadness in the spectra, 
causes the lack of splitting in the peaks and, in order to obtain a 1H-NMR spectrum with 
conventional NMR probes, with a minimal resolution, the solution has to be extremely 
dilute.275 
Working in this direction, some 1H spectra were initially reported with a quite good signal 
shape273,275 but the resolution was still not enough to clearly show the multiplet’s structure, 
also with very diluted and simple molecules.  
By the way, it was shown263,276 that the HR-MAS NMR technique, could be a powerful tool to 
overcome problems such as the low resolution of the 1H spectra not only against the 
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chemical shift anisotropy problem, but also decreasing the paramagnetic effects, allowing 
the characterization of the structures of different organic ligands bound to 
superparamagnetic iron oxide nanoparticles (both Fe2O3 or Fe3O4 SPIONs) producing 
resolved 1H spectra with structured NMR signals. 
We have just effectively used this NMR technique in a precedent work277 analyzing Peptide 
Nucleic Acid (PNA) strands linked on magnetic maghemite nanoparticles and producing sets 
of 1H resolved spectra. 
In this thesis we have applied again this analytic tool performing different kind of NMR 
experiments, in order to characterize some of the obtained nanoconjugates and, at the same 
time, with the aim to give an additional prove of the carbamate bond formation. 
In Table 7, the HR-MAS experiments performed on nanoconjugates 15-17 and 20 are 
summarized proving the versatility of this technique, while nanoconjugates 18 and 19 were 
not characterized with NMR spectroscopy due to the lability of the additional -SO2Cl and -
COCl moieties. 
Nanoconjugate HR-MAS experiments 
15 1H, 13C, COSY, HSQC 
16 1H, 13C 
17 1H, 13C 
20 1H, DOSY 
 
Table 7 - HR-MAS experiments performed on some nanoconjugates. 
 
The NMR spectrometer with the HR-MAS facility, located in the Big Instrument Center 
(C.I.G.A.), of University of  Milan, is an FT-NMR AvanceTM 500 (Bruker Italia S.r.l.) with a 
superconducting ultrashield magnet of 11.7 Tesla (1H frequency: 500.13 MHz). 
The probe is doubly tuned (1H and 13C), in addition to a 2H lock channel. All three channels 
are operating via a single NMR transmit/receive solenoid coil located inside the MAS turbine. 
The probe is capable of performing either direct or indirect (inverse) detection experiments. 
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The probe allows to perform high resolution MAS experiments at spinning rates of up to 15 
KHz, with 4 mm zirconia oxide rotors, for liquid or liquid-like samples; in our study the 
spinning rates were optimized between 5 KHz and 12 KHz speed values to rich a compromise 
between the needing to have the spinning side bands out of the 1H spectrum, the best 
resolution behaviour and the minimum presence of turbulence or rotational artifacts. 
All the samples were diluted in deuterated methyl sulfoxide (few milligrams in 150-200 μl 
DMSO-d6 100%); the saturated solutions (do to the low solubility of γ-Fe2O3 nanoconjugates) 
of nanoparticles dispersion, after different cycles of vortex/sonication, were decanted by 
night leaving to precipitate the large aggregates and the upper suspension was then 
collected for NMR analysis. A dilution at different levels was sometimes necessary to find the 
concentration limit before the broadening of the NMR signals. The sample temperature it’s 
speed rotation dependent and was so varying from 30 to 35 °C, in different experiments 
performed. 
In Figure 26 is reported the 1H HR-MAS NMR spectrum of nanoconjugate 15. A high resolved 
spectrum was obtained with 4 KHz speed in which are clearly visible the ten CH2 protons of 
the cyclohexyl ring (labeled as 4-8) and a dublet at 5.58 ppm related to the presence of the 
aliphatic carbamate NH proton (2). 
In Figure 27 the 13C HR-MAS NMR spectrum is shown. Also in this case all the carbons of the 
cyclohexyl ring are present at high field, while a deshielded peak at 157 ppm confirms the 
presence of a carbamate C=O carbon atom (1). 
In proton spectrum is no visible the peak related to the CH proton (3) and for this reason 
COSY and HSQC experiments were performed; the results are here reported in Figure 28 and 
Figure 29, respectively. 
In the COSY spectrum, the peak of water shows a double correlation with the NH proton (2) 
and with the most shielded multiplet referred to the CH2 protons of the ring, indicating that 
proton (3) lays under the water signal. This hypothesis was confirmed by HSQC analysis in 
which a direct correlation between the water signal and the tertiary carbon (3) at 48 ppm 
was observed. 
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Figure 26 - 1H HR-MAS NMR spectrum of nanoconjugate 15 in DMSO (4 KHz speed). 
 
 
Figure 27 - 13C all decoupled HR-MAS NMR spectrum of nanoconjugate 15 in DMSO (4 KHz speed). 
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Figure 28 - COSY HR-MAS NMR spectrum of nanoconjugate 15 in DMSO (4 KHz speed). 
 
 
Figure 29 - HSQC HR-MAS NMR spectrum of nanoconjugate 15 in DMSO (4 KHz speed). 
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The proton and the carbon NMR spectra of nanoconjugate 16 are reported in Figure 30 and 
Figure 31. 
 
Figure 30 -  1H HR-MAS NMR spectrum of nanoconjugate 16 in DMSO (6 KHz speed). 
 
In 1H spectrum the peaks of the monosubstituted aromatic ring are present (4-6), together 
with a singlet deshielded peak at 8.64 ppm related to the NH aromatic carbamate proton (2). 
From 13C spectrum is possible to further confirm the formation of a carbamate bond thanks 
to the presence of a quaternary strong deshielded carbon peak at 153 ppm (1). 
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Figure 31 -  13C all decoupled HR-MAS NMR spectrum of nanoconjugate 16 in DMSO (6 KHz speed). 
 
To demonstrate the importance of the spinning rates, in Figure 32 is shown the resolution 
behavior with the MAS speed increasing in different HR-MAS experiments performed on 
nanoconjugate 16.  
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Figure 32 - Array plot of expanded region of nanoconjugate 16 1H spectra acquired at different MAS 
speed rotations. 
 
Also for nanoconjugate 17 1H and 13C spectra were acquired confirming the formation of the 
covalent interaction between the starting isocyanate and the nanoparticle surface. The 
carbamate NH singlet proton (2) at 8.83 ppm and the aryl carbamate C=O carbon peak at 
153 ppm (1) are clearly visible, as well as all the other peaks related to the proton AB system 
and CH carbons of disubstituted aromatic ring (Figure 33 and Figure 34). An array plot of an 
expanded region of the proton spectra at different speed rate was also shown (Figure 35), 
demonstrating how MAS technique can resolved spectra also in presence of 
superparamagnetic metallic core. 
Chapter 4: Surface Functionalization of SPIONs 
 
123 
 
 
Figure 33 -  1H HR-MAS NMR spectrum of nanoconjugate 17 in DMSO (6 KHz speed). 
 
 
Figure 34 -  13C all decoupled HR-MAS NMR spectrum of nanoconjugate 17 in DMSO (6 KHz speed). 
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Figure 35 - Array plot of expanded region of nanoconjugate 17 1H spectra acquired at different MAS 
speed rotations. 
 
Proton HR-MAS spectrum of nanoconjugate 20, reported in Figure 36, clearly shows the AB 
system of the disubstituted phenyl ring and the singlet of the two CH protons of the 
maleimido moiety; the singlet at 8.94 ppm is related to the proton resonance of the 
carabamate NH hydrogen atom (1). 
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Figure 36 -  1H HR-MAS NMR spectrum of nanoconjugate 20 in DMSO (12 KHz speed). 
On this nanoconjugate, preliminary DOSY experiments were also performed. 
4.2.3.1 Diffusion Ordered Nuclear Magnetic Resonance Spectroscopy 
(DOSY) 
Self-diffusion is the random translational motion of molecules driven by their internal kinetic 
energy.278 Translational diffusion and rotational diffusion can be distinguished. Diffusion is 
related to molecular size, as becomes apparent from the Stokes–Einstein equation: 
  
   
  , where D is the diffusion coefficient, kB is the Boltzmann constant, T is the 
temperature, and f is the friction coefficient. 
 
If the solute is considered to be a spherical particle with an effective hydrodynamic radius 
(i.e. Stokes radius) rS in a solution of viscosity η, then the friction coefficient is given by: 
         . 
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Using the pulsed-field gradient (PFG) method, motion is measured by evaluating the 
attenuation of a spin echo signal.279 The attenuation is achieved by the dephasing of nuclear 
spins due to the combination of the translational motion and the imposition of gradient 
pulses. In contrast to relaxation methods, no assumptions concerning the relaxation 
mechanisms are necessary. 
The PFG NMR sequence (Figure 37) is the simplest for measuring diffusion.279 During 
application of the gradient, which is along the direction of the static spectrometer field, B0, 
the effective magnetic field for each spin is dependent on its position. Therefore, the 
precession frequency is also position dependent which leads to the development of position 
dependent phase angles. The 180° pulse changes the direction of the precession. Hence, the 
second gradient of equal magnitude will cancel the effects of the first and refocus all spins, 
provided that no change of position, with respect to the direction of the gradient, has 
occurred. If there is a change of position, the refocusing will not be complete. This results in 
a remaining dephasing which is proportional to the displacement during the period Δ 
between the two gradients. Since diffusion is a random motion, there is a distribution of 
gradient-induced phase angles. These random phase shifts are averaged over the ensemble 
of spins contributing to the observed NMR signal. Hence, this signal is not phase shifted but 
attenuated, with the degree of attenuation depending on the displacement. 
 
Figure 37 - The Stejskal and Tanner pulsed field gradient NMR sequence. Narrow and wide filled bars 
correspond to 90° and 180° pulses, respectively. Open bars with horizontal stripes correspond to 
pulsed-field gradients whose strength is varied during the experiment. The pulse phases are      
and    . Phase cycling can be included to remove spectrometer artifacts. 
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The signal intensity S(2τ) after the total echo time 2τ is given by: 
               
  
  
                
 
 
                 
         
 
 
   
where S(0) is the signal intensity immediately after the 90° pulse, T2 is the spin-spin 
relaxation time of the species, γ is the gyromagnetic ratio of the observed nucleus, g is the 
strength of the applied gradient, and δ and Δ are the length of the rectangular gradient 
pulses and the separation between them, respectively. Typically, δ is in the range of 0.5-5 
ms, the diffusion time Δ is in the range of milliseconds to seconds, and g is up to 20 T/m. 
To determine diffusion coefficients, a series of experiments is performed in which either g, 
δ, or Δ is varied while keeping τ constant to achieve identical attenuation due to relaxation. 
Normally, the gradient strength g is incremented in subsequent experiments. Non-linear 
regression of the experimental data can be used for the determination of D. 
Nowadays, the LED (Longitudinal Eddy current Delay or Longitudinal Encode-Decode) pulse 
sequence (Figure 38) is most often used for measuring diffusion since it allows eddy currents 
to decay and uses bipolar gradients which enables double effective strength as well as 
compensation for imperfections. This sequence is not affected by spin-spin coupling since it 
is based on the stimulated echo sequence. 
 
Figure 38 - The LED pulse sequence using bipolar gradients. Narrow and wide filled bars correspond 
to 90° and 180° pulses, respectively. 
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The signal intensity of the LED sequence is given by: 
            
         
 
 
 
  
 
   
In the chemical shift dimension, Fourier transformation (FT) is applied as usual. For each 
frequency υ, the signal can (in general) have contributions from several components (1,…n) 
which individually decay with their respective diffusion coefficient: 
          
 
   
                 
    
 
 
   
The individual diffusion coefficients Di and the signal intensities Si(0,υ) have to be extracted 
in order to construct the diffusion spectra. The name DOSY (Diffusion Ordered Spectroscopy) 
refers to the presentation of the data obtained in PFG or LED NMR measurements where the 
chemical shift is plotted in one (or two) dimension and the diffusion coefficient in the other 
dimension. This presentation allows the identification of signals belonging to one 
component (or at least to components showing the same diffusion coefficient).280 
To better understand how DOSY techniques can help in the characterization of a mixture of 
compounds, as well as the data obtained are presented, in Figure 39 is reported the 13C 
DOSY spectrum of a mixture of glucose, sucrose and sodium dodecyl sulfate (SDS) as an 
explicative example.281 Diffusion coefficient D increasing from down to up in the 2D map of 
Figure 39. 
Greater the diffusion coefficient D (expressed in square meters per second [m2/s]), higher 
the speed rate of the diffusion of the molecule in solution. 
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Figure 39 - 13C INEPT-DOSY for a mixture containing glucose, sucrose, and SDS in D2O. Dotted lines 
show average diffusion coefficients of each component. The 1D 13C INEPT spectrum of the mixture is 
shown at the top. 
A preliminary DOSY study in MAS experiments was performed on nanoconjugate 20, in order 
to investigate how the presence of a strong magnetic field can influence the diffusion 
coefficient of an organic molecule anchored onto a superparamagnetic metallic core. 
We have already demonstrated that MAS techniques can lead to well resolved spectra 
regardless of the presence of the metallic core exposed to a magnetic field. 
Despite the nanoconjugates are bigger molecular entities and thus lower diffusion 
coefficient are expected, the presence of an external static strong magnetic field, added to 
the pulse field gradients can in theory accelerate the diffusion motion of these 
superparamagnetic systems. 
In Figure 40, the DOSY spectrum of 20 is shown and a single set of diffusion signals are 
present with an average diffusion coefficient of ca. 7.0e-9 m2/s. Diffusion coefficient D 
increasing in this case from up to down in the 2D map of Figure 40. 
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Figure 40 - 1H-DOSY of nanoconjugate 20. 
To evaluate how this value is affected by the presence of the metallic superparamagnetic 
core surrounded by the magnetic field, we decided to compare the obtained diffusion 
coefficient with the one determined by DOSY experiment performed on the most similar 
organic compound not grafted on nanoparticles. 
For this reason, starting from the PMPI 10 has been synthesized the corresponding bis-urea 
21, just adding few amounts of water to a solution of 10 in DMSO.266 The recovered urea 
was then analyzed by 1H HR-MAS NMR (Figure 41) and its diffusion coefficient was 
determined by HR-MAS DOSY experiment (Figure 42). 
Chapter 4: Surface Functionalization of SPIONs 
 
131 
 
 
Figure 41 - 1H HR-MAS of the bis[(p-maleimido)phenyl] urea 21 in DMSO (12 KHz speed). 
 
Figure 42 - 1H-DOSY of bis[(p-maleimido)phenyl] urea 21. 
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The chemical shifts of the urea proton signals are quite the same of that obtained for 
nanoconjugate 20, confirming the nature of the organic residue onto the SPIONs surface, 
while the diffusion coefficient for the free 21 in DMSO solution is ca. 4.0e-9 m2/s, lower than 
the value obtained for the analogue nanoconjugate 20. This result may confirm that the 
magnetic core induce an acceleration in the diffusive phenomenon caused by the stronger 
influence of the NMR magnetic fields (static and pulsed ones). 
In addition 1H-DOSY HR-MAS NMR experiment was also acquired for a mixture of 20 and 21, 
in ratio 2:1 in DMSO (Figure 43). The ratio of the two species in the mixture was chosen in 
order to obtain almost the same intensity signal. 
 
Figure 43 - 1H-DOSY of a mixture of nanoconjugate 20 and bis[(p-maleimido)phenyl] urea 21 in DMSO 
(ratio 2:1). 
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Having almost the same chemical shift, 20 and 21 gave practically a superimposed proton 
projection spectrum on the upper horizontal axis, while in the bidimensional area can be 
recognized two sets of signals (easily visible in the signal at about 7.6 ppm, where a net 
interruption is present). The diffusion coefficients of the two species were also confirmed. 
These are only preliminary results in the use of DOSY experiments for the characterization of 
magnetic nanoconjugates, so further work must be done. 
Concerning the general use of the HR-MAS technique, we can conclude that the results 
obtained demonstrate the grafting of isocyanate molecules onto the SPIONs surface, leading 
to the formation of a carbamate bond. The MAS tool has proved to be versatile and 
furthermore, can be used to overcome all the problems related to the presence of a 
superparamagnetic core. Very nice spectra were obtained and preliminary DOSY 
experiments were performed. 
4.3 Non-Covalent versus Covalent Surface Interactions 
Having established the easy anchoring of isocyanates onto the SPIONs surface by the 
formation of a carbamate bond, we decided to compare the efficiency of this new grafting 
methodology with the already known non-covalent adsorption of carboxylic acid and with 
the most used linker based on siloxane interaction. 
For this purpose we started comparing the loadings of nanoconjugates 16 and 20 (obtained 
by anchoring the phenyl isocyanate 6 and the (p-maleimido)phenyl isocyanate 10, 
respectively) versus the loadings of the nanoconjugates 23 and 24 that have been 
synthesized starting from the corresponding carboxylic compounds, the benzoic acid 22 and 
the (p-maleimido)benzoic acid 12 (Figure 44). Functionalized nanoparticles 23 and 24 bear 
the same organic residue of the analogous nanoconjugates 16 and 20, but differ from the 
anchoring group. 
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Figure 44 - Synthesis of comparable nanoconjugates 16, 20, 23 and 24. In a) and c) 16 and 20 are 
formed by covalent interaction between the starting isocyanates 6 and 10 with SPIONs, while in b) 
and d) a non-covalent adsorption were used to obtain nanoconjugate 23 and 24 from the 
corresponding carboxylic acids 22 and 12. 
 
In order to obtain comparable loading values for the nanoconjugates 23 and 24, the same 
synthetic protocol used for the grafting of isocyanates onto SPIONs, previously shown in 
Scheme 5, was applied. Thus, 0.2, 0.4 and 0.8 millimoles of carboxylic acids 22 e 12 were 
added to a suspension of 100 milligrams of naked SPIONs in toluene. After 4 hours at 60 °C 
under sonication, the desired functionalized nanoparticles 23 and 24 were isolated. The 
loadings were determined by E.A. and FTIR spectra were acquired demonstrating the 
anchoring of the organic carboxylic acid by a non-covalent adsorption with formation of a 
carboxylate species (a strong sharp peak at ca. 1600 cm-1 was obtained for both the 
nanoconjugates, corresponding to the O=C-O- stretching). 
In Table 8 and Table 9 are reported the loading values obtained from E.A. of nanoconjugates 
23 and 24, compared with the ones obtained for compounds 16 and 20 in the three series of 
reaction performed increasing the amount of the organic ligand. 
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Ligand Nanoconjugate 
0,2 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
6 16 15,36 1,28 Covalent 
22 23 6,96 0,58 Non-Covalent 
      
Ligand Nanoconjugate 
0,4 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
6 16 26,55 2,21 Covalent 
22 23 7,64 0,63 Non-Covalent 
      
Ligand Nanoconjugate 
0,8 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
6 16 43,80 3,65 Covalent 
22 23 8,22 0,68 Non-Covalent 
 
Table 8 - Loading values obtained from elemental analysis for the nanoconjugate 23 (non-covalent 
adsorption), compared with the final loadings of nanoconjugate 16 (covalent interaction). 
 
Ligand Nanoconjugate 
0,2 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
10 20 14,42 0,67 Covalent 
12 24 12,63 0,58 Non-Covalent 
      
Ligand Nanoconjugate 
0,4 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
10 20 31,07 1,44 Covalent 
12 24 13,11 0,61 Non-Covalent 
      
Ligand Nanoconjugate 
0,8 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
10 20 51,81 2,44 Covalent 
12 24 14,52 0,67 Non-Covalent 
 
Table 9 - Loading values obtained from elemental analysis for the nanoconjugate 24 (non-covalent 
adsorption), compared with the final loadings of nanoconjugate 20 (covalent interaction). 
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From the loading values obtained, we can note that the covalent grafting of isocyanates 
leads to higher loading compared with the non-covalent interaction of carboxylic acids and 
in Figure 45 and Figure 46 these values are summarized. Furthermore, only a slight increase 
in final loading was observed increasing the amount of the starting carboxylic ligand. 
 
 
Figure 45 - Loading comparison of nanoconjugates 16 and 20 (covalent interaction) versus 23 and 24 
(non-covalent adsorption), express as total percentage in weight of organic part loaded onto SPIONs 
[Tot % org]. 
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Figure 46 - Loading comparison of nanoconjugates 16 and 20 (covalent interaction) versus 23 and 24 
(non-covalent adsorption), express as millimoles of organic part per gram of functionalized 
nanoparticles [mmol/gNPs]. 
 
The same approach was used to compare the amount of isocyanate loaded onto SPIONs 
against the covalent silylation of APTES 1 (Figure 47). 
 
Figure 47 – Synthetic approach for the synthesis of a)  nanoconjugates  2, from the corresponding 
alkoxysylane APTES 1 and b) nanoconjugates 15-20, from starting isocyanates 5-10. The loading 
values obtained for the silyloxy-derivative will be compared with the average loading calculate for the 
new grafting methodology. 
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Nanoconjugate 2 was therefore synthesized accordingly to Schemes 1 and 5, using 0.2, 0.4 
and 0.8 millimoles of 1 per 100 milligrams of naked nanoparticles. The functionalized SPIONs 
were analyzed by E.A. and the loadings obtained were compared with the average loading 
found for the isocyanate covalent interaction (Tables 2-4). The results are reported in Table 
10 and summarized in Figure 48. 
Ligand Nanoconjugate 
0,2 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
1 2 5,27 0,39 Covalent 
Average Loading with R-NCO 16,66 1,02 Covalent 
      
Ligand Nanoconjugate 
0,4 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
1 2 7,59 0,56 Covalent 
Average Loading with R-NCO 26,6 1,67 Covalent 
      
Ligand Nanoconjugate 
0,8 mmol of Ligand / 100 mg NPs 
Interaction 
Tot % org mmol/gNPs 
1 2 13,02 0,97 Covalent 
Average Loading with R-NCO 40,7 2,61 Covalent 
 
Table 10 - Loading values obtained from elemental analysis for the nanoconjugate 2 (Si-O covalent  
interaction), compared with the average loading calculated on nanoconjugate 15-20 (carbamate 
covalent interaction). 
 
Also in this case, lower loading values were obtained for covalent Si-O bond formation 
respect to the carbamate bond interaction. Increasing the amount of alkoxysilane, an 
increase in the final loading was observed for nanoconjugate 2, which reached the 13% with 
0.8 mmol of ligand. This value however is significantly lower than the one obtained when the 
isocyanate was grafted onto the nanoparticles surface. 
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Figure 48 - Loading comparison of nanoconjugate 2 (Si-O covalent interaction) versus the average 
loading calculated on nanoconjugate 15-20 (carbamate covalent interaction). 
 
We may conclude this section by stating that the new methodology developed in this 
research leads to significantly higher loading values if compared to the classical non-covalent 
adsorption of carboxylic acids and also respect to the main used covalent silylation of 
nanoparticles. 
4.4 The Use of Properly Functionalized Isocyanates as 
Heterobifunctional Linkers 
The outstanding functionalization of SPIONs with isocyanates, with formation of a covalent 
carbamate bond, led us to further investigate the possibility of use these organic molecules 
as heterobifunctional linkers. 
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The concepts related to the synthetic strategy that involves proper functionalized organic 
molecules as linker, were already widely explained [see section 4]. 
From the beginning of this research work, we decided to study this new functionalization 
methodology with the final aim of conjugating bioactive molecules onto the SPIONs surface 
thanks to the use of specifically designed linkers. 
For this reason, isocyanates 8-10 were chosen in order to obtain the corresponding 
nanoconjugates 18-20, that bear an additional reactive functional group. 
The chlorosulfonyl and the chloroacyl moieties are highly reactive towards amines and 
alcohols, affording the corresponding amides and esters, while the maleimido group is a 
classical Michael acceptor able to react with strong nucleophiles, as thiols and amines. 
The first step was to demonstrate that the -SO2Cl and -COCl groups are not reactive towards 
the nanoparticles surface. Indeed, the functionalization reaction consists in the direct 
addition of the isocyanates 8 and 9 in a suspension of naked SPIONs in dry toluene so, in 
principle, a possible competitive reaction can occur with formation of the corresponding 
esters with the surface hydroxyl groups. 
To verify this possibility, blank reactions were performed with tosyl chloride 25 and benzoyl 
chloride 26 (Scheme 6 and Scheme 7, respectively). 
 
Scheme 6 - Blank reaction between tosyl chloride 25 and naked SPIONs. 
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Scheme 7 - Blank reaction between benzoyl chloride 26 and naked SPIONs. 
The recovered nanoparticles were analyzed by E.A. and FTIR spectroscopy, but no significant 
interaction with the SPIONs surface was detected. The total percentages of organic part 
were lower than 4 % and, as shown in FTIR spectra reported in Figure 49 and Figure 50, no 
relevant peaks were present. The only intense vibrational bands are related to the strong 
absorption of iron oxide nanoparticles and few peaks (with very low intensity) can be 
associated to an unspecific interaction of sulfonic and carboxylic acid that may be formed by 
partial hydrolysis of the chlorosulfonyl and chloroacyl moieties in the reaction conditions. 
To prove the formation of a non-covalent interaction between the COOH group arising from 
partial hydrolysis of 26 and the nanoparticles, we decided to perform the reaction previously 
shown in Scheme 7, in the presence of water in order to generate in situ the corresponding 
benzoic acid 22 (Scheme 8). From this reaction we obtained the nanoconjugate 23, that has 
been already synthesized starting from the corresponding carboxylic acid 22 [see Figure 
44b]. 
 
Scheme 8 - Blank reaction between benzoyl chloride 26 and naked SPIONs in presence of water. The 
hydrolyzed compound 22 was generated in situ and directly reacted with nanoparticles, affording 23. 
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In Figure 50c is clearly visible the strong sharp peak related to the non-covalent adsorption 
of the carboxylate molecule onto the SPIONs surface, as well as all the vibrational bands 
related to the aromatic ring. 
 
 
Figure 49 - FTIR spectra of a) naked SPIONs (black line) and b) nanoparticles obtained by reaction 
with tosyl chloride 25 (red line). In spectrum b) in the range of 1200-1000 cm-1 are present some 
peaks that can be referred to the chemisorption of sulfonic acid onto the SPIONs surface. 
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Figure 50 - FTIR spectra of a) naked SPIONs (blue line), b) nanoparticles obtained by reaction with 
benzoyl chloride 26 (black line) and c) nanoconjugate 23 obtained by reacting naked SPIONs with 26 
in presence of water. In spectrum b) the peak at 1599 cm-1 is related to the formation of a non-
covalent interaction with formation of a carboxylate species. This is probably due to the partial 
hydrolysis of 26 in the reaction condition. In spectrum c) the unspecific adsorption of the completely 
hydrolyzed 26 (with in situ formation of benzoic acid 22) is clearly visible. To note the strong sharp 
peak at 1600 cm-1 referred to the carboxylate species. 
 
Having established that the chlorosulfonyl and the chloroacyl moieties are not able to 
directly bind the SPIONs surface leading to ester-derivatives, we decided to use the (p-
chlorosulfonyl)phenyl isocyanate 8 and the (p-isocyanate)benzoyl chloride 9 as 
heterobifunctional linkers. Working in inert atmosphere with dry solvent, it is possible to 
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prevent the hydrolysis of -SO2Cl and -COCl groups, as already demonstrated by FTIR 
spectroscopy on nanoconjugates 18 and 19 [see Figure 22 and 23, respectively]. 
To further prove the presence of the chlorine atom, Beilstein tests were performed on 18 
and 19, resulting in an intense and bright green flame typical of halogens. 
The reactivity of nanoconjugates 18 and 19 was then tested reacting them with n-
butylamine, in order to form the corresponding sulfonamide and amide derivatives 27 and 
28 respectively, as shown in Scheme 9 and Scheme 10. 
 
Scheme 9 - Synthesis of n-butylsulfonamide 27. 
 
 
Scheme 10 - Synthesis of n-butylamide 28. 
 
E.A. and FTIR spectroscopy (Figure 51 and Figure 52) confirm the formation of the desired 
product, proving the possibility of use these systems as heterobifunctional linkers for the 
covalent binding of biomolecules onto SPIONs. 
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Figure 51 - FTIR spectra of a) nanoconjugate 18 (black line) and b) nanoconjugate 27 (red line). In 
spectrum b) are clearly visible the stretchings at high wavenumber related to C-H bonds of the butyl 
chain. It’s also clearly visible the C=O band of the carbamate and a significant modification in the 
vibrational bands in the range of 1600-1400 cm-1 referred to the presence of the sulfonamide bond 
and to the bending of N-H and C-H bonds. 
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Figure 52 - FTIR spectra of a) nanoconjugate 19 (black line) and b) nanoconjugate 28 (red line). In 
spectrum b) are clearly visible the stretchings at high wavenumber related to C-H bonds of the butyl 
chain. Are also clearly visible the C=O band of the carbamate (1677 cm-1) and the stretching of the 
C=O amide moiety (1649 cm-1), while the peak related to the Cl-C=O at 1772 cm-1 in spectrum a) 
disappeared in spectrum b). 
 
As reported in section 4.2.1, the loading of nanoconjugate 18 are quite lower with respect to 
other compounds due to the extreme lability of the starting isocyanate 8. For this reason we 
decided to synthesized the n-butylsulfonamide nanoconjugate 27 exploiting an inverse 
synthetic strategy, reported in Scheme 11. 
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Scheme 11 - Synthesis of nanoconjugate 27 exploiting an inverse synthetic strategy. 
 
Starting from the commercially available (p-chlorosulfonyl)benzoic acid 29, the 
corresponding sulfonamide 30 was easily obtained in 86% yield by reaction with an excess of 
n-butylamine; the acyl chloride 31 was then obtained in quantitative yield by refluxing 30 in 
thionyl chloride. 31 was then reacts with sodium azide affording the acyl azide 32 in 90% 
yield after chromatographic purification. Eventually, 32 underwent the Curtius 
rearrangement leading to the corresponding isocyanate 33 in quantitative yield. 
Then, 0.4 millimoles of 33 were reacted with 100 milligrams of naked SPIONs using the same 
synthetic protocol set up for the synthesis of carbamate nanoconjugates. E.A. and FTIR 
spectroscopy confirmed the formation of the desired product. 
The loading obtained using this synthetic strategy can be compared with the previously 
obtained by the direct amidation on nanoparticle, as shown in Figure 53. 
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Figure 53 - Synthetic strategies for the synthesis of nanoconjugate 27. Pathway A: direct amidation of 
nanoconjugate 18. Pathway B: direct grafting of functionalized isocyanate 33 onto SPIONs. 
 
The final loading of 27 in pathway A is strictly dependent from the loading of the starting 
nanoconjugate 18 (that is in turn dependant from the lability of the corresponding 
isocyanate 8). 
In the case of pathway B, the final loading of 27 is only dependant on the efficiency of the 
grafting methodology. Using 0.4 millimoles of isocyanate 33 per 100 milligrams of SPIONs, 
the loading is 39.45%, corresponding to 1.55 mmol/gNPs, value that is perfectly in match with 
the average loading calculated for nanoconjugate 15-20 synthesized with the same reagents 
ratio and reaction conditions, equal to 1.67 mmol/gNPs [see Table 3, section 4.2.1]. 
So, we have proved the versatility and reproducibility of the isocyanate grafting 
methodology but also the versatility of the isocyanate-based heterobifunctional linkers, that 
can be chemically modified directly onto the SPIONs (pathway A) or before the anchoring 
(pathway B), exploiting classical organic reactions. 
Concerning the nanoconjugate 20, the maleimido group cannot interact itself with the 
nanoparticle surface, so it can be used without any problem as unreactive functional group 
during the grafting of the corresponding isocyanate 10. 
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The maleimido moiety is widely used, especially in biological field, as reactive functional 
group for the anchoring on different substrates of a variable kind of molecules such as 
proteins, antibodies, fluorophores, drugs or specific markers. 
Generally, these kind of compounds bear thiol groups (mercaptan chains, as well as cysteine 
residues) able to react with the maleimido moiety by a Michael addition, leading to the 
formation of a new C-S bond. Thus, the PMPI 10 can be exploited as heterobifunctional 
linker thanks to the presence of two functional groups with orthogonal reactivity (Figure 54). 
 
Figure 54 - Use of PMPI 10 as heterobifunctional linker. The isocyanate group reacts with amines or 
alcohols leading to carbamates and ureas, while the maleimido moiety can react with thiols by 
Michael additions. 
 
So, the possibility to cover the SPIONs with maleimido residues, exploiting the selective 
reactivity of the isocyanate group towards the nanoparticle surface, have opened new way 
for the synthesis of a new class of conjugates between magnetic NPs and biomolecules. 
To check the reactivity of the maleimido group once anchored onto SPIONs, nanoconjugate 
20 was first reacted with the commercially available 1-dodecanthiol, (Scheme 12). We have 
chosen this molecule in order to obtain a high infrared response thanks to the presence of 
the long aliphatic chain, while the new C-S bond has no significant vibrational modes. 
 
Scheme 12 - Michael addition of 1-dodecanthiol on 20, affording the new nanoconjugate 34. 
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FTIR spectroscopy confirms the formation of the Michael adduct 34, as clearly visible in 
Figure 55. 
 
Figure 55 - FTIR spectra of a) nanoconjugate 20 (black line) and b) nanoconjugate 34 (red line). In 
spectrum b) are clearly visible the stretching peaks at high wavenumber related to C-H bonds of the 
dodecyl chain. The peaks at about 1200 cm-1 also became more structured thanks to the presence of 
strong bending modes of C-H aliphatic bonds. 
 
Many biomolecules, such as peptides, nucleic acid mimics, proteins or antibodies, already 
bear thiol groups in their chemical structure. Otherwise, a cysteine residue can be easily 
introduced. 
So, a second test reaction was performed on nanoconjugate 20 with N-acetyl-cysteine (N-Ac-
Cys-OH) as Michael donor (Scheme 13). 
Chapter 4: Surface Functionalization of SPIONs 
 
151 
 
 
Scheme 13 - Michael addition of N-Ac-Cys-OH on 20, affording the new nanoconjugate 35. 
Functionalized nanoparticles were isolated and characterized, confirming the formation of 
the desired nanoconjugate 35. 
Given the results obtained, we can conclude that isocyanate-based heterobifunctional 
linkers can be easily used for the supporting of organic molecules onto SPIONs. 
Nanoconjugates 18-20 have so proved to be good candidates for this purpose. 
4.5 Conclusions 
In this chapter we have seen how the mechanism of both non-covalent and covalent 
interaction of organic molecules with SPIONs surface is the crucial factor in the synthesis of 
specifically designed nanoconjugates. 
During this Ph.D. research work, a new covalent grafting methodology, not reported in the 
literature, has been developed, by exploiting the reactivity of isocyanates toward 
nanoparticles. A small library of new nanoconjugates were obtained starting from 
commercially or easily synthesizable isocyanates and deep characterization studies were 
performed. 
By E.A. we were able to demonstrate how the final loading can be tuned in order to obtain a 
proper surface distribution of organic molecules. FTIR spectroscopy has clearly shown the 
formation of a carbamate species, that was further demonstrated by performing HR-MAS 
NMR experiments. 
Having established the easy anchoring of isocyanates onto SPIONs, we compared this new 
methodology with the already well known grafting of organic molecules by formation of 
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carboxylate non-covalent adsorption and of classical covalent silylation reaction, 
demonstrating that it is possible to obtain higher loading using the carbamate bond 
formation. 
Some of the nanoconjugates bear an additional functional group, opening the way for the 
use of isocyanate-based molecules as heterobifunctional linkers for the covalent binding of 
biomolecules onto SPIONs, as will be shown in section 5.8. 
4.6 Experimental Section 
4.6.1 Materials and Methods 
All reagents and solvents were purchased in higher grade from commercial suppliers and 
used without further purification, unless otherwise stated. Dry solvents over molecular 
sieves and other solvents (P.A., ACS reagent) were obtained from Sigma Aldrich. Unless 
otherwise specified, all the reactions were performed in an inert atmosphere under dry 
conditions. 
γ-Fe2O3 SPIONs were purchased from Alpha Aesar and stored away from moisture. 
All weightings of reagents were carried out with analytical balance Mettler Toledo AB135-
S/FACT. 
TLC were run on Kieselgel 60 F254 plates (Fluka), while column chromatography were 
carried out using silica gel 60 (70-230 mesh, Merck). Automated flash chromatography were 
done using SPX instrument from Biotage® with pre-packed columns. 
To dry the nanoparticles was used a rotating vacuum dryer from Büchi. Once dried, the 
nanoparticles are stored in a desiccator filled with anhydrous salts. 
A sonicator Elma Elmasonic S 30H was used to perform reactions with nanoparticles. 
Elemental Analysis were performed in the division of Inorganic, Metallorganic and Analytical 
Chemistry, from the Department of Chemistry in the University of Milan with a Perkin Elmer 
instrument. 
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Infrared spectra of nanoconjugates were acquired on a Spectrum One FTIR 
spectrophotometer (Perkin Elmer) in the range 4000-450 cm-1 in transmittance mode. 0.5 
mg of nanoparticles were diluted in 150 mg FTIR grade KBr and ground in an agate mortar. 
KBr was previously dried at 125°C under vacuum. Then mixed powder was pressed at 9 tons 
for 3 min to obtain slim semitransparent tablet. Spectra were recorded selecting 64 scans 
and 4 cm-1 resolution. The background of pure KBr was separately recorded using the same 
conditions and automatically subtracted from sample spectra. Spectra of non-supported 
organic molecules were acquired in transmittance mode in the range 4000-600 cm-1 using 
NaCl windows as support and selecting 4 scans and 4 cm-1 resolution. These analysis were 
performed in collaboration with the Professor Stradi’s reaserch group in the Laboratory of 
Instrumental Analysis of the division of Organic Chemistry “A. Marchesini”, Department of 
Pharmaceutical Science in University of Milan. 
1H, 13C and 2D NMR experiments were recorded on Bruker AMX300 and Bruker Fourier300 
instruments (both with 1H frequency: 300 MHz) , and the chemical shifts (δ) are reported in 
parts per million relative to solvent peak. 
HR-MAS NMR experiments were acquired with a spectrometer located in the Big Instrument 
Center (C.I.G.A.), of University of Milan. The instrument is an FT-NMR AvanceTM 500 (Bruker 
Italia S.r.l.) with a superconducting ultrashield magnet of 11.7 Tesla (1H frequency: 500.13 
MHz). The probe is doubly tuned (1H and 13C), in addition to a 2H lock channel. All three 
channels are operating via a single NMR transmit/receive solenoid coil located inside the 
MAS turbine. The probe is capable of performing either direct or indirect (inverse) detection 
experiments. The probe allows to perform high resolution MAS experiments at spinning 
rates of up to 15 KHz, with 4 mm zirconia oxide rotors, for liquid or liquid-like samples; in our 
study the spinning rates were optimized between 4 KHz and 12 KHz speed values to rich a 
compromise between the needing to have the spinning side bands out of the 1H spectrum, 
the best resolution behaviour and the minimum presence of turbulence or rotational 
artifacts. All the samples were diluted in deuterated methyl sulfoxide (few milligrams in 150-
200 μl DMSO-d6 100%); the saturated solutions (do to the low solubility of γ-Fe2O3 
nanoconjugates) of nanoparticles dispersion, after different cycles of vortex/sonication, 
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were decanted by night leaving to precipitate the large aggregates and the upper suspension 
was then collected for NMR analysis. A dilution at different levels was sometimes necessary 
to find the concentration limit before the broadening of the NMR signals. The sample 
temperature it’s speed rotation dependent and was so varying from 30 to 35 °C, in different 
experiments performed. The chemical shifts (δ) are reported in parts per million relative to 
solvent peak. 
Acquisition parameters of standard 1H zg NMR sequence were: 90° pulse 1H of 9.0 μs, 
spectral width: sw = 6 KHz (corresponding to 11 ppm), acquisition size: td = 16K, acquisition 
time: aq = 1.3 s, relaxation delay: d1 = 10 s and a number of scans: ns = 24. 
Acquisition parameters of 13C inverse gated (1H all decoupled) NMR sequence were: 90° 
pulse 13C of 9.75 μs, spectral width: sw = 25 KHz (corresponding to 200 ppm), acquisition 
size: td = 16K, acquisition time: aq = 0.32 s, relaxation delay: d1 = 4 s and a number of scans: 
ns = 10700. 
4.6.2 Experimental Procedures 
4.6.2.1 Synthesis of NP-APTES 2 
3-Aminopropyl-triethoxysilane (APTES) 1 (0.2, 0.4 or 0.8 mmol) was added to a suspension of 
naked SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture 
was stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 2 as a 
brown powder. Positive Kaiser test confirm the presence of free amino groups on the 
nanoparticle surface. Loadings from E.A.: 5.27% (equal to 0.39 mmol/gNPs) [0.2 mmol of 
1/100mgNPs]; 7.59% (equal to 0.56 mmol/gNPs) [0.4 mmol of 1/100mgNPs]; 13.02% (equal to 
0.97 mmol/gNPs) [0.8 mmol of 1/100mgNPs]. 
1H HR-MAS NMR (D2O presat, 4 KHz, 500 MHz): 
= 0.55-0.61 (m, 2H, CH2-Si), 1.64-1.70 (m, 2H, CH2), 2.86-2.96 (m, 2H, CH2-N). FTIR (cm
-1) in 
trasmittance (blank KBr): 3390 (υ, N-H), 2930 (υ, C-H), 1550 (δ, N-H), 1490, 1002 (υ, Si-O), 
580 (υ, Fe-O). 
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4.6.2.2 Synthesis of NP-TESPI 4 
3-(Triethoxysylil)propyl isocyanate (TESPI) 3 (0.8 mmol) was added to a suspension of naked 
SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was 
stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 4 as a 
brown powder. Loadings from E.A.: 32.80% (equal to 1.32 mmol/gNPs). FTIR (cm
-1) in 
trasmittance (blank KBr): 3335 (υ, N-H), 2974-2885 (υ, C-H), 1634 (υ, C=O carbamate), 1566 
(δ, N-H), 1443, 1274, 1103, 1078 (υ, Si-O), 1032, 955. 
 
4.6.2.3 Synthesis of (p-Maleimido)benzoic Acid, PMBA 12 
Commercially available p-aminobenzoic acid, PABA 11 (4.26 g, 31 mmol, 1 eq) was 
suspended in 30 ml of acetone and solubilized by the addition of 5 ml of methanol. A 
solution of maleic anhydride (3.66 g, 37 mmol, 1.2 eq) in 10 ml of acetone was added 
dropwise and the resulting precipitate stirred for 20’. The material was suction filtered, 
washed with acetone, and vacuum-dried to afford a yellow powder (6.36 g). This material 
was dissolved in acetic anhydride (13 ml), treated with sodium acetate (1.08 g), and then 
heated with stirring at 50 °C for 2 h. The volatiles were then removed in vacuo, and the 
resulting residue was taken up in 150 ml of water and heated at 70 °C for 2.5 h. The resulting 
white precipitate was suction filtered, washed with water, and vacuum-dried overnight to 
afford compound 12 (4.7 g, 70%). Analysis by silica TLC (10% MeOH in DCM as eluent, 
visualized by UV absorption and/or iodine vapor staining) showed one spot at Rf 0.8. It was 
used without further purification. 1H-NMR (CDCl3 + DMSO-d6, 300 MHz): δ= 10.0-8.5 (br s, 
1H, CO2H), 7.95 (d, J = 9 Hz, 2H, Ar-H ortho to maleimide), 7.32 (d, J = 9 Hz, 2H, Ar-H ortho to 
carboxylic acid), 6.8 (s, 2H, maleimide vinyl). MS (FAB, 3-nitrobenzyl alcohol): m/z 218 (M+ + 
1). 
4.6.2.4 Synthesis of (p-Maleimido)benzoyl Chloride, PMB-Cl 14 
p-Maleimidobenzoic acid, PMBA 12 (500 mg, 2.30 mmol) was suspended in 2 ml of DCM and 
then 10 ml of thionyl chloride were added, leading to a yellowish solution. After refluxing for 
2 h, the solution was vacuum-dried to afford a yellow powder, corresponding to desired 
product 14 (540 mg, quantitative yield). It was used without further purification. 1H-NMR 
(DMSO-d6, 300 MHz): δ= 8.05 (d, J = 8.7 Hz, 2H, Ar-H ortho to maleimide), 7.51 (d, J = 8.7 Hz, 
2H, Ar-H ortho to acyl chloride), 7.22 (s, 2H, maleimide vinyl). 
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4.6.2.5 Synthesis of (p-Maleimido)benzoyl Azide, PMB-azide 13, starting 
from 12 
A stirred suspension of compound 12 (4.3 g, 20 mmol, 1 eq) in 150 ml of dry toluene was 
treated with triethylamine (3.04 ml, 22 mmol, 1.1 eq) and then DPPA (4.7 ml, 22 mmol, 1.1 
eq). After stirring at room temperature for 2 days, the volatiles were removed in vacuo, and 
the resulting residue was chromatographed on silica with DCM as eluent. The product 13, 
elutes as a pale yellow band and is isolated upon evaporation of solvent to afford a pale 
yellow crystalline mass (2.14 g, 50%). A recrystallized sample from DCM showed the 
following behavior in a melting point apparatus: 115-120 °C, sample appears to “pop”; 125-
130 °C decomposition with vigorous gas evolution. Analysis by silica TLC (DCM as eluent, 
visualized by UV absorption and/or iodine vapor staining) showed one spot at Rf 0.45. 1H 
NMR (CDCl3, 300 MHz): δ= 8.0 (d, J = 8 Hz, 2H, ArCH ortho to maleimide), 7.45 (d, J = 8 Hz, 
2H, ArCH ortho to acyl azide), 6.75 (s, 2H, maleimide vinyl). FTIR (cm-1) in trasmittance 
(blank KBr): 3110, 2160 (υ C=O acyl azide), 1720, 1690, 1600, 1510, 1400, 1380, 1310, 1275, 
1210, 1180, 1150, 1120, 1070, 1040, 1010, 850, 830, 690. MS (FAB, 3-nitrobenzyl alcohol): 
m/z 215 (M+ + 1). 
 
4.6.2.6 Synthesis of (p-Maleimido)benzoyl Azide, PMB-azide 13, starting 
from 14 
To a stirred suspension of compound 14 (500 mg, 2.12 mmol, 1 eq) in 5 ml of acetone at 0 °C 
were added 3 ml of DCM, in order to obtain a yellowish solution. Solid NaN3 (689 mg, 10.60 
mmol, 5 eq) was added in three portions. The suspension was stirred at 0 °C and then raised 
to room temperature. After stirring at r.t. for 4 h, the volatiles were removed in vacuo, and 
the resulting residue was chromatographed by automated flash chromatography on pre-
packed silica column with DCM as eluent. The product 13, elutes as a pale yellow band and is 
isolated upon evaporation of solvent to afford a pale yellow crystalline mass (359 mg, 70%). 
The product was characterized, confirming the data reported in procedure 4.6.2.5. 
 
4.6.2.7 Synthesis of (p-Maleimido)phenyl Isocyante, PMPI 10 
A solution of compound 13 (300 mg, 1.24 mmol) in dry toluene (10 ml) is refluxed under 
nitrogen for 1.5 h and then evaporated in vacuo. This quantitatively affords compound 10 as 
yellow micro needles (265 mg). Mp: 121-123 °C. This compound should be stored in a sealed 
vial, protected from light and moisture, in a freezer. 1H-NMR (CDCl3, 300 MHz): δ= 7.2 (d, J = 
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9 Hz, 2H, ArCH ortho to maleimide), 7.02 (d, J = 9 Hz, 2H, ArCH ortho to isocyanate), 6.7 (s, 
2H, maleimide vinyl). FTIR (cm-1) in trasmittance (blank KBr): 3380, 3360, 3120, 3080, 2306 
(υ, C=O isocyanate), 1720, 1690 shoulder, 1520, 1390, 1150, 830, 690. 
 
4.6.2.8 Synthesis of NP-Cyclohexyl Carbamate 15 
Cyclohexyl isocyanate 5 (0.2, 0.4 or 0.8 mmol) was added to a suspension of naked SPIONs 
(100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, 
under sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated 
at 5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day, to afford 15 as a brown powder. Loadings from 
E.A.: 13.83% (equal to 1.10 mmol/gNPs) [0.2 mmol of 5/100mgNPs]; 26.69% (equal to 2.11 
mmol/gNPs) [0.4 mmol of 5/100mgNPs]; 51.47% (equal to 4.08 mmol/gNPs) [0.8 mmol of 
5/100mgNPs]. 
1H HR-MAS NMR (DMSO-d6, 4 KHz, 500 MHz): = 5.57 (d, J = 5, 1H, NH 
carbamate), 3.33 (signal covered by water, assigned by 2D experiments, 1H, CH-N), 1.74-0.93 
(m, 10H, CH2). 
13C all decoupled HR-MAS NMR (DMSO-d6, 4 KHz, 125 MHz): = 157.08 (C=O 
carbamate), 47.97 (CH), 36.71 (CH2), 33.81 (CH2), 25.79 (CH2), 25.10 (CH2), 24.92 (CH2). FTIR 
(cm-1) in trasmittance (blank KBr): 3326 (υ, N-H), 2928, 2850 (υ, C-H), 1626 (υ, C=O 
carbamate), 1573 (δ, N-H), 1311, 1243 (υ, C-O and C-N), 1088 (δ, C-H), 640-562 (υ, Fe-O). 
 
4.6.2.9 Synthesis of NP-Phenyl Carbamate 16 
Phenyl isocyanate 6 (0.2, 0.4 or 0.8 mmol) was added to a suspension of naked SPIONs (100 
mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, under 
sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated at 
5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day, to afford 16 as a brown powder. Loadings from 
E.A.: 15.36% (equal to 1.28 mmol/gNPs) [0.2 mmol of 6/100mgNPs]; 26.55% (equal to 2.21 
mmol/gNPs) [0.4 mmol of 6/100mgNPs]; 43.80% (equal to 3.65 mmol/gNPs) [0.8 mmol of 
6/100mgNPs]. 
1H HR-MAS NMR (DMSO-d6, 6 KHz, 500 MHz): = 8.64 (s, 1H, NH carbamate), 
7.46 (d, J = 10, 2H, ArCH ortho to carbamate), 7.29 (m, JA = 5, JB = 10, 2H, ArCH meta to 
carbamate), 6.97 (m, JA = 5, JB = 10, 1H, ArCH para to carbamate). 
13C all decoupled HR-MAS 
NMR (DMSO-d6, 6 KHz, 125 MHz): = 153.01 (C=O carbamate), 140.17 (ArCH-N), 129.25 
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(ArCH ortho to carbamate), 122.28 (ArCH para to carbamate), 118.67 (ArCH meta to 
carbamate). FTIR (cm-1) in trasmittance (blank KBr): 3326 (υ, N-H), 3282, 3192 (υ, ArC-H), 
1647 (υ, C=O carbamate), 1594, 1551 (δ, N-H), 1497, 1447, 1439 (υ, C=C), 1314, 1231 (υ, C-O 
and C-N), 753, 696 (δ, C-H out of plane), 640-560 (υ, Fe-O). 
 
4.6.2.10 Synthesis of NP-(p-Chloro)phenyl Carbamate 17 
(p-Chloro)phenyl isocyanate 7 (0.2, 0.4 or 0.8 mmol) was added to a suspension of naked 
SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was 
stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 17 as a 
brown powder. Loadings from E.A.: 16.62% (equal to 1.08 mmol/gNPs) [0.2 mmol of 
7/100mgNPs]; 29.83% (equal to 1.93 mmol/gNPs) [0.4 mmol of 7/100mgNPs]; 40.33% (equal to 
2.61 mmol/gNPs) [0.8 mmol of 7/100mgNPs]. 
1H HR-MAS NMR (DMSO-d6, 6 KHz, 500 MHz): 
= 8.83 (s, 1H, NH carbamate), 7.48 (d, J = 10, 2H, ArCH meta to carbamate), 7.33 (d, J = 10, 
2H, ArCH ortho to carbamate). 13C all decoupled HR-MAS NMR (DMSO-d6, 6 KHz, 125 MHz): 
= 152.81 (C=O carbamate), 139.01 (ArCH-N), 129.09 (ArCH meta to carbamate), 125.98 
(ArCH-Cl), 120.32 (ArCH ortho to carbamate). FTIR (cm-1) in trasmittance (blank KBr): 3294 
(υ, N-H), 1632 (υ, C=O carbamate), 1590, 1559 (δ, N-H), 1491, 1439 (υ, C=C), 1395, 1298, 
1236 (υ, C-O and C-N), 1085, 1012 (υ, ArCH-Cl), 823 (δ, C-H out of plane), 637-561 (υ, Fe-O). 
 
4.6.2.11 Synthesis of NP-(p-Chlorosulfonyl)phenyl Carbamate 18 
(p-Chlorosulfonyl)phenyl isocyanate 8 (0.2, 0.4 or 0.8 mmol) was added to a suspension of 
naked SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture 
was stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 18 as a 
brown powder. Beilstein test: positive (bright green flame). Loadings from E.A.: 17.54% 
(equal to 0.80 mmol/gNPs) [0.2 mmol of 8/100mgNPs]; 19.74% (equal to 0.90 mmol/gNPs) [0.4 
mmol of 8/100mgNPs]; 21.75% (equal to 0.99 mmol/gNPs) [0.8 mmol of 8/100mgNPs]. FTIR (cm
-
1) in trasmittance (blank KBr): 3294 (υ, N-H), 1699 (υ, C=O carbamate), 1589, 1533 (δ, N-H), 
1495, 1402 (υ, C=C), 1328 (asym υ, SO2), 1156 (sym υ, SO2), 633-556 (υ, Fe-O). 
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4.6.2.12 Synthesis of NP-(p-Chloroacyl)phenyl Carbamate 19 
(p-Isocyanate)benzoyl chloride 9 (0.2, 0.4 or 0.8 mmol) was added to a suspension of naked 
SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was 
stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 19 as a 
brown powder. Beilstein test: positive (bright green flame). Loadings from E.A.: 22.17% 
(equal to 1.21 mmol/gNPs) [0.2 mmol of 9/100mgNPs]; 25.74% (equal to 1.41 mmol/gNPs) [0.4 
mmol of 9/100mgNPs]; 35.01% (equal to 1.92 mmol/gNPs) [0.8 mmol of 9/100mgNPs]. FTIR (cm
-
1) in trasmittance (blank KBr): 3297 (υ, N-H), 1772 (υ, C=O acyl chloride), 1681 (υ, C=O 
carbamate), 1593, 1531, 1512 (δ, N-H), 1410 (υ, C=C), 1316, 1237 (υ, C-O and C-N), 1176 (δ, 
C-H), 634-579 (υ, Fe-O). 
 
4.6.2.13 Synthesis of NP-(p-Maleimido)phenyl Carbamate 20 
(p-Maleimido)phenyl isocyanate PMPI 10 (0.2, 0.4 or 0.8 mmol) was added to a suspension 
of naked SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the 
mixture was stirred, under sonication, at 60 °C for 4 h. After this time the obtained 
suspension was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The 
solid residue was first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 20 as a 
brown powder. Loadings from E.A.: 14.42% (equal to 0.67 mmol/gNPs) [0.2 mmol of 
10/100mgNPs]; 31.07% (equal to 1.44 mmol/gNPs) [0.4 mmol of 10/100mgNPs]; 51.81% (equal 
to 2.41 mmol/gNPs) [0.8 mmol of 10/100mgNPs]. 
1H HR-MAS NMR (DMSO-d6, 12 KHz, 500 
MHz): = 8.94 (s, 1H, NH carbamate), 7.63 (d, J = 10, 2H, ArCH ortho to carbamate), 7.31 (d, J 
= 10, 2H, ArCH meta to carbamate), 7.21 (s, 2H, maleimide vinyl). 1H HR-MAS DOSY NMR 
(DMSO-d6, 12 KHz, 500 MHz): D ≈ 7.0e-9 m2/s. FTIR (cm-1) in trasmittance (blank KBr): 3383 
(υ, N-H), 3096 (υ, ArC-H), 1707 (υ, C=O imide), 1692 (υ, C=O carbamate), 1605, 1552 (δ, N-
H), 1513 (υ, C=C), 1398 (υ, Ar-N), 1313 (υ, C-N imide), 1239-1175 (υ, C-O and C-N), 831 (δ, C-
H), 689-559 (υ, Fe-O). 
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4.6.2.14 Synthesis of N,N’-bis(p-Maleimidophenyl)urea 21 
A stirred room temperature solution of PMPI 10 (100 mg, 0.47 mmol) in DMSO (2 ml) was 
treated dropwise with 100 μl of water. After 5 min, excess water was added (10 ml) to 
precipitate the product, which was isolated by suction filtration. After vacuum-drying, 
compound 21 was obtained as a white powder (175 mg, 93% yield). 1H HR-MAS NMR 
(DMSO-d6, 12 KHz, 500 MHz): = 8.92 (s, 1H, NH carbamate), 7.58 (d, J = 10, 2H, ArCH ortho 
to carbamate), 7.25 (d, J = 10, 2H, ArCH meta to carbamate), 7.18 (s, 2H, maleimide vinyl). 1H 
HR-MAS DOSY NMR (DMSO-d6, 12 KHz, 500 MHz): D ≈ 4.0e-9 m2/s. MS (EI): m/z 402 (M+). 
 
4.6.2.15 Synthesis of NP-Phenyl Carboxylate 23 
Benzoic acid 22 (0.2, 0.4 or 0.8 mmol) was added to a suspension of naked SPIONs (100 mg) 
in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, under 
sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated at 
5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day, to afford 23 as a brown powder. Loadings from 
E.A.: 6.96% (equal to 0.58 mmol/gNPs) [0.2 mmol of 22/100mgNPs]; 7.64% (equal to 0.63 
mmol/gNPs) [0.4 mmol of 22/100mgNPs]; 8.22% (equal to 0.68 mmol/gNPs) [0.8 mmol of 
22/100mgNPs]. FTIR (cm
-1) in trasmittance (blank KBr): 3369 (υ, FeO-H), 3058-2929 (υ, ArC-
H), 1599 (υ, CO2
-), 1524,1447, 1404 (υ, C=C), 1176, 1025, 634-564 (υ, Fe-O). 
 
4.6.2.16 Synthesis of NP-(p-Maleimido)phenyl Carboxylate 24 
(p-Maleimido)benzoic acid PMBA 12 (0.2, 0.4 or 0.8 mmol) was added to a suspension of 
naked SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture 
was stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 24 as a 
brown powder. Loadings from E.A.: 12.63% (equal to 0.58 mmol/gNPs) [0.2 mmol of 
12/100mgNPs]; 13.11% (equal to 0.61 mmol/gNPs) [0.4 mmol of 12/100mgNPs]; 14.52% (equal 
to 0.67 mmol/gNPs) [0.8 mmol of 12/100mgNPs]. FTIR (cm
-1) in trasmittance (blank KBr): 3326 
(υ, FeO-H), 3075 (υ, ArC-H), 1709 (strong υ, C=O imide), 1604 (strong υ, CO2
-), 1515 (υ, C=C), 
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139o (υ, Ar-N), 1319-1298 (υ, C-N imide), 1178 (υ, C-O and C-N), 828 (δ, C-H), 634-583 (υ, Fe-
O). 
 
4.6.2.17 Blank Reaction between SPIONs and Tosyl Chloride 25 
Tosyl chloride 25 (153 mg, 0.8 mmol) was added to a suspension of naked SPIONs (100 mg) 
in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, under 
sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated at 
5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day. The recovered nanoparticles (brown powder) were 
analyzed by E.A. and FTIR spectroscopy. Loadings from E.A.: lower than 4%, no match with 
any chemical formula. FTIR (cm-1) in trasmittance (blank KBr): 3390 (strong and broad υ, 
FeO-H), 1626 (residual absorption of CO2 and water), 1187-1126 (weak sym υ, SO2), 633-568 
(strong υ, Fe-O). 
 
4.6.2.18 Blank Reaction between SPIONs and Benzoyl Chloride 26 
Benzoyl chloride 26 (92 μl, 0.8 mmol) was added to a suspension of naked SPIONs (100 mg) 
in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, under 
sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated at 
5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day. The recovered nanoparticles (brown powder) were 
analyzed by E.A. and FTIR spectroscopy. Loadings from E.A.: lower than 4%, no match with 
any chemical formula. FTIR (cm-1) in trasmittance (blank KBr): 3390 (strong and broad υ, 
FeO-H), 1599 (υ, COO- from hydrolysis of acyl chloride), 1412 ( weak υ, C=C), 633-568 (strong 
υ, Fe-O). 
 
4.6.2.19 Blank Reaction between SPIONs and Benzoyl Chloride 26, in 
Presence of Water: Synthesis of NP-Phenyl Carboxylate 23 
Benzoyl chloride 26 (92 μl, 0.8 mmol, 1 eq) was added to a suspension of naked SPIONs (100 
mg) in PhCH3 (5 ml), previously sonicated at 60 °C for 30’. Water (29 μl, 1.6 mmol, 2 eq) was 
added dropwise to the mixture under sonication. After 4 h at 60 °C, the obtained suspension 
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was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue 
was first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day. The recovered 
nanoparticles (brown powder) were analyzed by E.A. and FTIR spectroscopy, confirming the 
formation of nanoconjugate 23. Loadings from E.A.: 7.93% (equal to 0.66 mmol/gNPs). FTIR 
(cm-1) in trasmittance (blank KBr): 3369 (υ, FeO-H), 3058-2929 (υ, ArC-H), 1599 (υ, CO2
-), 
1524,1447, 1404 (υ, C=C), 1176, 1025, 634-564 (υ, Fe-O). 
 
4.6.2.20 Synthesis of NP-[p-(N-butylsulfamoyl)phenyl] Carbamate 27 
n-Butylamine (45 μl, 0.45 mmol, 5 eq) was added to a suspension of functionalized 
nanoparticles 18 (100 mg, loading 19.74% equal to 0.90 mmol/gNPs, 1 eq) in dry PhCH3 (5 ml), 
previously sonicated at 60 °C for 30’; the mixture was stirred, under sonication, at 60 °C for 4 
h. After this time the obtained suspension was centrifugated at 5000 r/min for 10’ and the 
supernatant was removed. The solid residue was first washed with fresh PhCH3 (3x5 ml), 
then with Et2O (2x5 ml) and vortex/sonication/centrifugation were cyclic repeated for each 
washing. Functionalized NPs were dried on air for a night and then in a rotating vacuum drier 
for a day, to afford 27 as a brown powder. Loadings from E.A.: 26.36% (equal to 1.03 
mmol/gNPs). FTIR (cm
-1) in trasmittance (blank KBr): 2961-2874 (υ, aliphatic C-H), 1699 (υ, 
C=O carbamate), 1589, 1532 (υ, C=C), 1493, 1396 (δ, SO2N-H), 1311 (asym υ, SO2NH), 1152 
(sym υ, SO2NH), 1122, 1031 (δ, C-H), 633-558 (υ, Fe-O). 
 
4.6.2.21 Synthesis of NP-[p-(N-butylcarbamoyl)phenyl] Carbamate 28 
n-Butylamine (95 μl, 0.96 mmol, 5 eq) was added to a suspension of functionalized 
nanoparticles 19 (100 mg, loading 35.01% equal to 1.92 mmol/gNPs, 1 eq) in dry PhCH3 (5 ml), 
previously sonicated at 60 °C for 30’; the mixture was stirred, under sonication, at 60 °C for 4 
h. After this time the obtained suspension was centrifugated at 5000 r/min for 10’ and the 
supernatant was removed. The solid residue was first washed with fresh PhCH3 (3x5 ml), 
then with Et2O (2x5 ml) and vortex/sonication/centrifugation were cyclic repeated for each 
washing. Functionalized NPs were dried on air for a night and then in a rotating vacuum drier 
for a day, to afford 28 as a brown powder. Loadings from E.A.: 31.80% (equal to 1.45 
mmol/gNPs); the loading was lower than the expected, may due to the losses of highly 
functionalized nanoparticles that remain in the supernatant during the isolation process. By 
the way, CHN values perfectly match the expected chemical formula. FTIR (cm-1) in 
trasmittance (blank KBr): 3324 (υ, N-H carbamate), 3193 (υ, N-H amide), 3037 (υ, ArC-H), 
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2962-2874 (υ, aliphatic C-H), 1678 (υ, C=O carbamate), 1649 (υ, C=O amide), 1596, 153o (υ, 
C=C), 1505 (δ, N-H), 1398, 1313, 1237 (υ, C-O and C-N), 1176 (δ, C-H), 632-577 (υ, Fe-O). 
 
4.6.2.22 Synthesis of (p-Butylsulfamoyl)benzoic Acid 30 
The commercially available (p-chlorosulfonyl)benzoic acid 29 (253 mg, 1.15 mmol, 1 eq) was 
suspended in 5 ml of DCM at room temperature. n-Butylamine (680 μl, 6.90 mmol, 6 eq) was 
added dropwise, leading to the formation of a yellowish solution. After 2 h under stirring, an 
aqueous solution of HCl 1M was added till pH 1. The aqueous phase was extracted with 
AcOEt (2x5 ml) and the combined organic phases were washed with water (3x5 ml), dried on 
anhydrous Na2SO4 and filtered. The solvent was removed under reduced pressure, affording 
a white crystalline product, corresponding to 30 (254 mg, 86%). No further purifications 
were needed. Mp: 216-217 °C (Et2O). 
1H-NMR (DMSO-d6, 300 MHz): δ= 13.42 (s, 1H, CO2H), 
8.12 (d, J = 6 Hz, 2H, Ar-H ortho to carboxylic acid), 7.90 (d, J = 6 Hz, 2H, Ar-H ortho to 
sulfonamide), 7.74 (t, 1H, NH sulfonamide), 2.76 (q, 2H, CH2-N), 1.32 (m, 2H, CH2), 1.22 (m, 
2H, CH2), 0.79 (t, 3H, CH3). 
 
4.6.2.23 Synthesis of (p-Butylsulfamoyl)benzoyl Chloride 31 
(p-Butylsulfamoyl)benzoic acid 30 (250 mg, 0.97 mmol) was suspended in 5 ml of DCM at 
room temperature and then 10 ml of thionyl chloride were added, leading to a colorless 
solution. After refluxing for 2 h, the solution was vacuum-dried to afford a white powder, 
corresponding to desired product 31 (265 mg, quantitative yield). It was used without 
further purification. 1H-NMR (DMSO-d6, 300 MHz): δ= 8.21 (d, J = 6 Hz, 2H, Ar-H ortho to 
acyl chloride), 8,01 (d, J = 6 Hz, 2H, Ar-H ortho to sulfonamide), 7.78 (t, 1H, NH sulfonamide), 
2.76 (q, 2H, CH2-N), 1.32 (m, 2H, CH2), 1.22 (m, 2H, CH2), 0.79 (t, 3H, CH3); no residual peak 
of carboxylic acid was present. 
 
4.6.2.24 Synthesis of (p-Butylsulfamoyl)benzoyl Azide 32 
To a stirred solution of compound 31 (265 mg, 0.96 mmol, 1 eq) in 8 ml of acetone at 0 °C, 
solid NaN3 (312 mg, 4.81 mmol, 5 eq) was added in three portions. The suspension was 
stirred at 0 °C for 30’ and then raised to room temperature. After stirring at r.t. for 1.5 h, the 
volatiles were removed in vacuo, and the resulting residue was chromatographed by 
automated flash chromatography on pre-packed silica column with methylene chloride as 
eluent. The product 32 is isolated upon evaporation of solvent to afford a white powder (243 
mg, 90%). Analysis by silica TLC (pure DCM as eluent, visualized by UV absorption and/or 
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iodine vapor staining) showed one spot at Rf 0.50. 1H NMR (CDCl3, 300 MHz): δ= 8.16 (d, J = 
9 Hz, 2H, Ar-H ortho to acyl azide), 7.95 (d, J = 9 Hz, 2H, Ar-H ortho to sulfonamide), 4.55 (t, 
1H, NH sulfonamide), 2.99 (q, 2H, CH2-N), 1.45 (m, 2H, CH2), 1.30 (m, 2H, CH2), 0.85 (t, 3H, 
CH3). FTIR (cm
-1) in trasmittance (NaCl windows): 3288, 2965, 2938, 2868, 2190, 2145 (υ 
C=O acyl azide), 1687, 1432, 1399, 1330, 1256, 1162, 1090, 997, 890, 750, 679. 
 
4.6.2.25 Synthesis of (p-Butylsulfamoyl)phenyl Isocyante 33 
A solution of compound 32 (243 mg, 0.861 mmol) in dry toluene (5 ml) is refluxed under 
nitrogen for 1.5 h and then evaporated in vacuo. This quantitatively affords compound 33 as 
white needles (218 mg). This compound should be stored in a sealed vial, protected from 
light and moisture, in a freezer. 1H-NMR (CDCl3, 300 MHz): δ= 7.83 (d, J = 6 Hz, 2H, ArCH 
ortho to isocyanate), 7.22 (d, J = 6 Hz, 2H, ArCH ortho to sulfonamide), 4.55 (broad s, 1H, NH 
sulfonamide), 2.95 (q, 2H, CH2-N), 1.45 (m, 2H, CH2), 1.30 (m, 2H, CH2), 0.85 (t, 3H, CH3). 
13C 
all decoupled NMR (CDCl3, 75 MHz): δ= 137.90 (Cq), 137.41 (Cq), 128.89 (ArCH), 125.81 (Cq, 
C=O isocyanate), 125.47 (ArCH), 43.08 (CH2-N), 31.72 (CH2), 19.80 (CH2), 13.65 (CH3). FTIR 
(cm-1) in trasmittance (NaCl windows): 3274, 3103, 3069, 2956, 2933, 2872, 2278 (υ, C=O 
isocyanate), 1647, 1589, 1515, 1425, 1321, 1285, 1157, 1108, 875, 838, 758, 660. 
 
4.6.2.26 Synthesis of NP-[p-(N-butylsulfamoyl)phenyl] Carbamate 27, 
starting from 33 
(p-Butylsulfamoyl)phenyl isocyanate 33 (102 mg, 0.4 mmol) was added to a suspension of 
naked SPIONs (100 mg) in dry PhCH3 (5 ml), previously sonicated at 60 °C for 30’; the mixture 
was stirred, under sonication, at 60 °C for 4 h. After this time the obtained suspension was 
centrifugated at 5000 r/min for 10’ and the supernatant was removed. The solid residue was 
first washed with fresh PhCH3 (3x5 ml), then with Et2O (2x5 ml) and 
vortex/sonication/centrifugation were cyclic repeated for each washing. Functionalized NPs 
were dried on air for a night and then in a rotating vacuum drier for a day, to afford 27 as a 
brown powder. Loadings from E.A.: 39.45% (equal to 1.55 mmol/gNPs). It’s to note the the 
loading obtained is higher than the one obtained for the same compound synthesized by 
amidation of previously functionalized nanoparticles [see procedure 4.6.2.20] FTIR (cm-1) in 
trasmittance (blank KBr): 3336 (υ, SO2N-H), 3271 (υ, N-H carbamate), 2957-2872 (υ, 
aliphatic C-H), 1699 (υ, C=O carbamate), 1589, 1532 (υ, C=C), 1493, 1396 (δ, SO2N-H), 1327-
1311 (asym υ, SO2NH), 1157 (sym υ, SO2NH), 1122, 1031 (δ, C-H), 631-551 (υ, Fe-O). 
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4.6.2.27 Synthesis of NP-[p-(3-(dodecylthio)-2,5-dioxopyrrolidin-1-yl)phenyl] 
Carbamate 34 
1-Dodecanthiol (232 μl, 0.964 mmol, 10 eq) was added to a suspension of functionalized 
nanoparticles 20 (40 mg, loading 51.81% equal to 2.41 mmol/gNPs, 1 eq) in CH3CN (5 ml), 
previously sonicated at 60 °C for 30’; the mixture was stirred, under sonication, at 60 °C for 4 
h. After this time the obtained suspension was centrifugated at 5000 r/min for 10’ and the 
supernatant was removed. The solid residue was first washed with fresh CH3CN (3x5 ml), 
then with Et2O (2x5 ml) and vortex/sonication/centrifugation were cyclic repeated for each 
washing. Functionalized NPs were dried on air for a night and then in a rotating vacuum drier 
for a day, to afford 34 as a brown powder. FTIR (cm-1) in trasmittance (blank KBr): 3394 (υ, 
N-H), 3102 (υ, ArC-H), 2921-2852 (υ, aliphatic C-H), 1707 (υ, C=O imide), 1692 (υ, C=O 
carbamate), 1605, 1552 (δ, N-H), 1513 (υ, C=C), 1398 (υ, Ar-N), 1313 (υ, C-N imide), 1239-
1175 (υ, C-O and C-N), 1176 (δ, C-H), 831 (δ, C-H out of plane), 689-559 (υ, Fe-O). 
 
4.6.2.28 Synthesis of NP-[p-(3-((R)-N-acetylcysteine)-2,5-dioxopyrrolidin-1-
yl)phenyl] Carbamate 35 
(R)-N-acetylcysteine (78.66 mg, 0.482 mmol, 10 eq) was added to a suspension of 
functionalized nanoparticles 20 (20 mg, loading 51.81% equal to 2.41 mmol/gNPs, 1 eq) in 
CH3CN (5 ml), previously sonicated at 60 °C for 30’; the mixture was stirred, under 
sonication, at 60 °C for 4 h. After this time the obtained suspension was centrifugated at 
5000 r/min for 10’ and the supernatant was removed. The solid residue was first washed 
with fresh CH3CN (3x5 ml), then with Et2O (2x5 ml) and vortex/sonication/centrifugation 
were cyclic repeated for each washing. Functionalized NPs were dried on air for a night and 
then in a rotating vacuum drier for a day, to afford 35 as a brown powder. Loadings from 
E.A.: 60.32% (equal to 1.60 mmol/gNPs); the loading was lower than the expected, may due 
to the losses of highly functionalized nanoparticles that remain in the supernatant during the 
isolation process. By the way, CHN values perfectly match the expected chemical formula. 
FTIR (cm-1) in trasmittance (blank KBr): 3360 (broad υ, CO2H and N-H), 3073 (υ, ArC-H), 
2970-2923 (υ, aliphatic C-H), 1777 (υ, C=O amide), 1709 (υ, C=O imide), 1692 (shoulder, C=O 
carbamate), 1604, 1549 (δ, N-H), 1512 (υ, C=C), 1393 (υ, Ar-N), 1314 (υ, C-N imide), 1233-
1180 (υ, C-O and C-N), 1175 (shoulder δ, C-H), 834 (δ, C-H out of plane), 689-585 (υ, Fe-O). 
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Chapter 5: 
New SPION-PNA Nanoconjugates 
 
5 Synthesis of New SPION-PNA Nanoconjugates for 
Biomedical Applications 
In this chapter will be discussed the synthesis of specifically modified Peptide Nucleic Acids 
(PNAs) and their conjugation with superparamagnetic iron oxide nanoparticles (SPIONs), 
both by non-covalent adsorption or covalent interaction with the nanoparticles surface. 
After an introduction about what PNAs are, their general properties, characteristics and 
applications, the discussion will be focused on the synthesis of new SPION-PNA 
nanoconjugates [see sections 5.7 and 5.8]. 
5.1 Peptide Nucleic Acids 
Peptide Nucleic Acids (PNAs), first introduced in 1991 by Nielsen and co-workers282 at 
Copenhagen University, are a remarkable example of a simple, neutral and achiral whole 
backbone replacement, that has suppressed, in many ways, other attempts to mimic the 
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native nucleic acid structures in terms of molecular recognition properties. PNAs are 
synthetic nucleic acid analogues with an achiral pseudopeptide backbone in which the 
phosphodiester backbone is replaced by repetitive units of N-(2-aminoethyl)glycine. On the 
backbone the purine and pyrimidine bases are attached via a methyl carbonyl linker (Figure 
56). 
 
Figure 56 - PNA (blue) versus DNA (black) oligomeric structures. In squared brackets are shown the 
repeating units. 
The PNA backbone maintains approximately the same length per repeating unit as in DNA or 
RNA. The appended nucleobases projects from the backbone to form stable double or triple 
helical complexes with target nucleic acids.283 The internucleobase distance in PNA is 
conserved, so that it can bind to the target DNA or RNA sequences with high sequence 
specificity and affinity. Therefore, chemical terms they are neither proteins nor nucleic acids. 
The amide (or peptide) bonds in PNA are sufficiently different from the α-amino acid peptide 
bonds present in proteins, resulting that PNA is biologically stable. These non-natural 
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characteristics make PNA oligomers highly resistant to protease and nuclease attacks.284 
Because PNAs have a neutral backbone, hybridization with target nucleic acids is not 
affected by the interstrand negative charge electrostatic repulsions.285 In addition, the 
absence of a repetitive charged backbone prevents PNAs from binding to proteins that 
normally recognize polyanions, avoiding a major source of nonspecific interactions. 
5.1.1 PNA Interactions with Single Strand Nucleic Acids 
5.1.1.1 Duplex 
PNAs are able to hybridize to both complementary DNA and RNA targets in a sequence-
specific manner to form PNA/DNA286 (Figure 57) or PNA/RNA duplex structures, according to 
Watson-Crick hydrogen binding rules (Figure 58).283,287,288. 
 
Figure 57 - PNA/DNA duplex. 
 
 
Figure 58 - PNA/DNA duplex Watson-Crick hydrogen bonding paring rules. 
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PNAs bind DNA/RNA in either parallel or antiparallel modes, the later being slightly preferred 
over the former. The antiparallel mode refers to the instance when the PNA ‘N’ terminus lies 
towards the 3’-end and the ‘C’ terminus lies towards the 5’-end of the complementary 
DNA/RNA oligonucleotides. Likewise, the parallel mode of binding is said to occur when the 
PNA ‘N’ terminus lies towards the 5’-end and the ‘C’ terminus towards the 3’-end of the 
complementary DNA/RNA oligonucleotide (Figure 59). 
 
Figure 59 - PNA/DNA binding in parallel (top) and antiparallel (bottom) modes. 
5.1.1.2 Triplex 
Homopyrimidinic PNAs strongly bind to target homopurine nucleic acids and sequence 
specifically, forming of 2:1 PNA2/DNA triplex (Figure 60).
289 
 
Figure 60 - PNA/DNA triplex. 
This complex can be formed thanks to the ability of the homopyrimidine strand to bind 
PNA/DNA duplex by Hoogsteen hydrogen bonding scheme (Figure 61). 
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Figure 61 - PNA/DNA triplex Hoogsteen and Watson-Crick hydrogen bonding paring rules. 
5.1.1.3 Quadruplex 
G-quadruplexes are four-stranded structures formed from DNA sequences that contain 
stretches of contiguous guanine bases, usually in the presence of alkali metal cations.290 G-
quadruplex DNA has been recently in focus because of its putative existence and its 
biological function at telomeres, which affects replication,291,292 and in promoter sites 
influencing transcription.293 The guanine bases in G-quadruplexes form G-tetrads where four 
G bases hydrogen bond via the Hoogsteen sites in a cyclic fashion (Figure 62). 
 
Figure 62 - G-quadruplex in presence of an alkali metal cation. 
In 2003 Prof. Datta reported294 that homologous G-rich PNA and DNA oligomers hybridize to 
form a PNA2-DNA2 quadruplex. The hybrid quadruplex exhibits high thermodynamic stability 
and expands the range of molecular recognition motifs for PNA beyond duplex and triplex 
formation. After this study many research groups have reported the synthesis of PNA based 
G-quadruplex structures with different topologies,295,296 for instance a PNA4 G-quadruplex,
297 
a structure obtained from PNA-DNA chimeras298 and even a PNA/RNA quadruplex.299 
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5.1.2 PNA Interactions with Double Strands Nucleic Acids 
The interaction of single-stranded PNA with double-stranded DNA is interesting not only 
because of his potential applications in antigene strategy but also for the possible use of PNA 
in different biotechnological applications (as discussed later). Various modes of interaction 
are possible, depending on sequences and conditions. Figure 63 illustrates the triplex and 
duplex invasion modes, in which the targeting PNA breaks up the double helix and 
complexes with the complementary DNA strand. 
 
Figure 63 - Duplex and triplex invasion modes. 
Duplex invasion (Figure 63A) can result if the target DNA is a homopyrimidine and the PNA 
has a homopurine sequence. Instead, if the DNA target is a homopurine sequence, it can 
result a very stable triplex invasion (Figure 63D) complex. Synthesizing pyrimidine-PNAs as a 
palindrome sequence with a flexible linker in the middle creates a so-called bisPNA or "PNA 
clamp", allowing triplex formation in optimal directions with the Watson-Crick base pairing 
in an antiparallel and Hoogsten bonding in a parallel orientation.300,301 However, the triplex 
invasion complex is very slow to form at neutral pH, unless the cytosines in the "Hoogsteen-
pairing" strand are exchanged to pseudo-isocytosines, also called J bases.300 For practical 
applications, the rate of formation can be increased by using cationic PNAs (e.g., with extra 
lysines linked) or by linking the PNA to an intercalating molecule such as 9-aminoacridine.302 
The most successful method to obtain a double-duplex invasion (Figure 63B) is to use a 
pseudo-complementary PNA (pcPNA) in which nucleobases adenine (A) and thymine (T) in 
conventional PNA are replaced with modified bases 2,6-diaminopurine (D) and 2-thiouracil 
(Us).303 
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5.1.3 Stability of PNAs and PNA Complexes 
Compared to normal DNA and RNA oligonucleotides, PNAs are much more stable inside 
cells. PNAs are very resistant to nuclease and protease digestion since nuclease cannot 
digest their altered backbones.284 Furthermore, duplexes between PNA and DNA or RNA are 
in general more thermally stable than the corresponding DNA/DNA or DNA/RNA 
duplexes.304,305 The stability of PNA/DNA duplexes was studied by differential scanning 
calorimetry.306 PNA/DNA duplexes show increased stability when the purines are in the PNA 
strand. It is also observed that the thermal stability of PNA/PNA duplexes exceeds that of 
PNA/RNA duplexes, that are already more stable than PNA/DNA duplexes. As a general rule, 
the Melting Temperature Tm (the temperature at which half of the PNA or DNA strands are 
in the double-helical state and half are in the random coil state) of a PNA/DNA duplex is 1 °C 
higher per base pair than the Tm of the corresponding DNA/DNA duplex. Very important, 
the stability of PNA/DNA duplexes are almost unaffected by the ionic strength of the 
medium.283 PNA/DNA/PNA triplexes exhibit extraordinarily high stability (the thermal 
stability for a decamer is typically up to 70 °C). 
5.1.4 Solubility of PNAs 
As it said, PNAs are charge-neutral compounds and hence have poor water solubility 
compared with DNA. Neutral PNA molecules tend to aggregate, depending on the sequence 
of the oligomer. PNA solubility is also related to the length of the oligomer and to the 
purine/pyrimidine ratio.304 Some recent modifications, including the incorporation of 
positively charged lysine residues (carboxyl-terminal or backbone modification in place of 
glycine), have shown improvements in solubility.307 Negative charges may also be 
introduced, especially in PNA/DNA chimeras, which will enhance the water solubility.308 
5.2 PNA Applications 
This chapter will briefly discuss, some possible applications of PNAs. The potential 
applications of PNAs can be divided in three different field: diagnostics, molecular biology 
and therapy. 
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It is important to notice that new techniques are continuously being developed and that this 
chapter could not be exhaustive. However, some techniques are very important because 
they represent “historically” steps in the development and use of PNAs. 
5.2.1 Diagnostics 
PNAs have found application in the detection of genetic mutations and in the analysis of 
mismatches in the Watson-Creek hydrogen bonding. Their particular affinity towards DNA 
and RNA, their high sequence specificity and their capacity to perform strand displacements 
make PNAs powerful tools for diagnostic purposes. 
One of the best features of PNAs is the possibility to detect the Single Nucleotide 
Polymorphism (SNP) by measuring the variations of the melting temperature. Some 
techniques have been developed for this target, for example the PCR and capillary 
electrophoresis.309 
5.2.1.1 Single Base Polymorphism: “PCR Clamping” 
The Polymerase Chain Reaction (PCR) technique is considered one of the most valuable step 
in the detection of genetic diseases. The high specificity of PNA to bind DNA, the greater 
stability of PNA-DNA duplexes than DNA-DNA ones and the inefficiency of PNA to act as 
primer for DNA polymerases are the bases for this novel techniques. 
This strategy includes a distinct annealing step involving the PNA targeted against one of the 
PCR primer sites. This step is carried out at a higher temperature than that for conventional 
PCR primer annealing where the PNA is selectively bound to the DNA molecule. The 
PNA/DNA complex formed at one of the primer sites effectively blocks the formation of a 
PCR product.310 PNA is also able to discriminate between fully complementary and single 
mismatch targets in a mixed target PCR. Sequence-selective blockage by PNA allows 
suppression of target sequences that differ by only one base pair. Also, this PNA clamping 
was able to discriminate three different point mutations at a single position.311 
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5.2.1.2 Screening for Genetic Mutations by Capillary Electrophoresis 
In capillary electrophoresis, the separation is generally carried out using a long, thin fused 
silica capillary (typically 50–80 cm long, inner diameter 10–300 mm). A portion of the 
coating, closed at one end of the capillary, is removed to allow optical detection of the 
analyte. The analyte passes the detection window during a separation process and can be 
visualized by online, automated, UV, or laser-induced fluorescence (LIF) detection systems. 
Capillary electrophoresis is capable of analyzing minute amounts of sample (typically in the 
order of picograms to femtograms). However, it is not possible to analyze more than one 
sample at a time, which is regarded as the major disadvantage compared to slab gel 
electrophoresis. 
A new diagnostic method for the detection of genetic mutations using PNA as a probe for 
capillary electrophoresis has been reported by Carlsson et al.312 The method is sensitive 
enough to detect a single mismatch in the sample DNA. The model system consisted of four 
50-mer, single-stranded DNA fragments representing a part of the cystic fibrosis 
transmembrane conductance regulator gene, one wild-type and three mutant sequences, 
and a 15-mer PNA probe having a sequence complementary to the wild-type oligomer.  
The probe PNA only binds the fully matched DNA, and the presence of this duplex is 
detected using free solution capillary electrophoresis. Separation of full-match from 
mismatch duplexes was accomplished at a high temperature (70 °C) and 50 mM ionic 
strength. At this temperature and ionic strength, only the hybrid duplex carrying the wild-
type DNA sequences remains stable, while the hybrid complex carrying single mismatch DNA 
will be melted. Free PNA binds to the capillary wall and is not detected.312 
Another application involves the use of fluorescent labelled PNAs. PNA probes with 
fluorescent tags offer sensitive detection and require only a very low concentration of the 
sample. At high temperatures (as described above), the LIF detection system will generate a 
signal for the bound PNAs, since free PNA is efficiently removed. Maybe it will be possible in 
the future to establish a universal screening strategy for any genetic disease with a known 
spectrum of mutations by developing a PNA probe library, possibly using multiple 
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fluorescent tags for multiplex testing of one or more exons. Other electrophoretic 
techniques (also in gel phase) are possible: the RNA binding properties of PNAs have also 
been characterized using capillary gel electrophoresis.313,314 
5.2.1.3 PNA as a Probe for Nucleic Acid Biosensor 
The DNA biosensor technology holds promises for a rapid and cost-effective detection of 
specific DNA sequences. A single-stranded nucleic acid probe is immobilized onto optical, 
electrochemical, or mass-sensitive transducers to detect the complementary (or mismatch) 
strand in a sample solution. The response from the hybridization event is converted into a 
useful electrical signal by the transducer. The use of PNAs based probes is a powerful 
alternative to DNAs based ones in different techniques. 
5.2.1.3.1 BIAcore (Biomolecular Interaction Analysis) 
The main background of this technique is the effect called SPR (Surface Plasmon Resonance). 
The PNA hybridization and corresponding mismatch analysis can be studied using a BIAcore 
instrument, which can evaluate a real-time biomolecular interaction analysis using optical 
detection technology. The real-time interactions are monitored on a sensor (surface) chip, 
which constitutes the core part of a BIAcore instrument. The probe molecule is attached 
directly to the surface and the analyte molecule is free in solution. The detection principle in 
BIA uses surface plasmon resonance. The response signal of the BIAcore apparatus is 
proportional to the change in the refractive index at the surface and is assumed to be 
proportional to the mass of substance bound to the chip (Figure 64).315 
 
Figure 64 - Schematic representation of BIAcore. 
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Jensen et al. used this technique to study the interactions between PNA and DNA or RNA. 
The sensor chip used in this case was basically a thin gold surface covered with a layer of 
dextran and containing streptavidin chemically coupled to the dextran. A biotinylated PNA 
probe was immobilized on the surface by using the strong coupling between biotin and 
streptavidin. The amount of bound substance (fully complementary as well as various singly 
mismatched RNA and DNA oligonucleotides) was measured as a function of time when a 
solution containing the complementary strands passed over the chip surface. In this way 
both the association (annealing) and dissociation (melting) kinetics could be studied.316 
5.2.1.3.2 QCM (Quartz Crystal Microbalance) 
The quartz crystal microbalance has been used for some time to monitor the mass or the 
thickness of thin films deposited on surfaces, to study gas adsorption and the deposition on 
surfaces in the monolayer and submonolayer regimes317. Only recently, this sensitive mass 
measuring device has begun to be used in the area of biochemistry and biotechnology, such 
as for studying the hybridization of nucleic acids on surface.318,319,320 The resonant frequency 
of the crystal changes due to a minute weight increases on the surface. It is expected that 
immobilized PNA strands (or probes) would show an improved distinction between the 
closely related target sequences compared to an immobilized DNA probe. A recent report by 
Wang and co-workers on quartz crystal microbalance biosensor, based on peptide nucleic 
acid probes, showed that the system can differentiate between a full complementary and 
single mismatch oligonucleotide. A rapid and sensitive detection of mismatch sequences is 
possible by monitoring the frequency/time response of the PNA-QCM biosensor. The PNA 
probes used in the above-mentioned study, which formed the monolayer onto the gold QCM 
surface, contained a cysteine attached to the PNA core with the help of an ethylene glycol 
unit.321  The remarkable specificity of the immobilized probe provides a rapid hybridization 
with corresponding oligonucleotides. Such a mismatch sensitivity of PNA-immobilized QCM 
biosensors could be of great importance for diagnostic applications, particularly for genetic 
screening and diagnosis of malignant diseases. 
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5.2.1.3.3 MALDI-TOF Mass Spectrometry 
MALDI-TOF mass spectrometry has been used successfully in PNA-based diagnostic research 
to study discrimination of single-nucleotide polymorphisms (SNPs) in human DNA. The 
human genome and the mitochondrial DNA contain many SNPs that may be linked to 
diseases.322 Rapid and accurate screening of important SNPs, based on high-affinity binding 
of PNA probes to DNA, is possible by using MALDI-TOF mass spectroscopy. The captured, 
single-stranded DNA molecules are PCR-amplified and thereafter hybridized with PNA 
probes in an allele-specific fashion. MALDI-TOF can rapidly and accurately detect (identify) 
these hybridized PNA probes. This provides a straightforward, rapid, accurate, and specific 
detection of SNPs in amplified DNA.323 The detection of multiple point mutations using 
allele-specific, mass-labelled PNA hybridization probes is also possible by using a direct 
MALDI-TOF-MS analysis method.324 The mass spectra will show peaks of distinct masses 
corresponding to each allele, and in this way a mass spectral ‘fingerprint’ of each DNA 
sample can be obtained.309 This technique can also be applied to analyse microarrays (Figure 
65). 
 
Figure 65 - Application of MALDI-TOF in the analysis of microarrays. 
5.2.1.3.4 Potentiometric Measurements 
Wang et al.325 have also reported the use of PNA as a recognition probe for the 
electrochemical detection of the hybridization event using chronopotentiometric 
measurements. The method consists of four steps: probe (PNA) immobilization onto the 
transducer surface, hybridization, indicator binding, and chronopotentiometric transduction. 
A carbon paste electrode contains the immobilized DNA or PNA probe. The hybridization 
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experiment was carried out by immersing the electrode into the stirred buffer solution 
containing a desired target, followed by measurement of signal. It is important to remember 
that similar techniques could be used to prepare microarray with electrochemical detection 
systems. 
5.2.1.4 Microarray 
Microarrays are small chips carrying on their surface row and column of ordered molecular 
probes (spot). Each of them is able to bind a specific target molecule. The success of 
microarrays in screening mRNA expression profiles of thousands of genes simultaneously has 
prompted researchers in bioorganic chemistry to explore this format for screening small 
molecules. From an analytical perspective, the prospect of screening thousand of analytes in 
a few microlitres is attractive. Microarrays can be prepared by several techniques including 
photolithography, contact printing and inkjet to generate arrays with densities ranging from 
1000 to 500 000 features per square centimetre. To date, a number of chemistries have 
been developed to derivatize glass surfaces to immobilize proteins, oligosaccharides, and 
small molecules in the microarray format. Many of these methods require the attachment of 
the protein or small molecule to the glass slide and likewise require that screening with the 
biological sample would also be performed on the surface. A supramolecular attachment, 
based on sequence specific hybridization of peptide nucleic acid (PNA), allows the use of the 
libraries as a mixture in solution that can then be converted to an organized microarray in 
one step by a self-sorting process.326 
The microarray could be treated with the sample and the entity of the response of every 
single spot leads to the determination of the sample structure. This technique is already 
successfully applied for nucleic acids sequences screening: in this case the complementary 
DNA sequences of all known polymorphism are spotted on the chip (Figure 66).327 
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Figure 66 - Schematic representation of microarrays. 
The microarrays technology is very interesting in biochemistry especially because it can be 
miniaturized; this feature makes the microarray the best choice to study the interaction 
between proteins and ligands or to check enzymatic activities in biological unpurified 
mixtures. 
PNAs can represent an useful and advantageous probe, especially for their peculiar 
chemical, physical and biochemical properties. Different type of PNA based microarrays have 
been developed, with a variety in terms of its modes of action, especially with respect to 
detection.328 
5.2.2 Tools in Molecular Biology 
PNAs show good features to be used as new tools in molecular biology. Some example are 
illustrated in the following sections. 
5.2.2.1 PCR 
The polymerase chain reaction (PCR) has been widely used for various molecular genetic 
applications including the amplification of variable number of tandem repeat (VNTR) loci for 
the purpose of genetic typing.309 However, in some cases preferential amplification of small 
allelic products relative to large allelic products may be problematic. This results in an 
incorrect typing in a heterozygous sample.329 PNA has been used to achieve an enhanced 
amplification of VNTR locus D1S80.330 Small PNA oligomers are used to block the template, 
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and the latter becomes unavailable for intra- and interstrand interaction during 
reassociation. On the other hand, the primer extension is not blocked; during this extension, 
the polymerase displaces the PNA molecules from the template and the primer is extended 
toward completion of reaction. This approach shows the potential of PNA application for 
PCR amplification where fragments of different sizes are more accurately and evenly 
amplified. Since the probability of differential amplification is less, the risk of 
misclassification is greatly reduced. Misra et al. demonstrated that PNA–DNA chimera 
lacking the true phosphate backbone are capable of acting as primers for polymerase 
reactions catalyzed by DNA polymerases.331,332  The chimera (PNA)19-TPG-OH, consisting of a 
19 base PNA part linked to a single phosphate-containing dinucleotide (TPG-OH) with a free 
3’-OH terminus, when annealed with a complementary RNA or DNA template strand works 
as an efficient primer to catalyze the addition of nucleotide by polymerase enzymes. The 
primer is also recognized by reverse transcriptase and by the Klenow fragment of E. coli DNA 
polymerase I. The results suggested that the diameter of the duplex region rather than the 
presence of phosphate backbone of the template primer is the critical factor for a proper 
template-primer reaction and accommodating the enzyme within the binding domain. It also 
appears that the primer phosphate backbone may not be essential, at least not in this case, 
for the polymerase recognition and binding. 
5.2.2.2 PNA Hybridization as Alternative to Southern Hybridization 
Southern hybridization is perhaps one of the most widely used techniques in molecular 
biology. Despite its great potential to predict both size and sequence information and 
information regarding the genetic context, there are certain disadvantages of this process. It 
requires a laborious multistep washing procedure and sometimes the sequence 
discrimination between closely related species. PNA pre-gel hybridization simplifies the 
process of Southern hybridization by reducing the required time, as the cumbersome post 
separation, probing, and washing steps are eliminated. Labelled (fluoresceinated) PNA 
oligomers are used as probes and allowed to hybridize to a denatured DNA sample at low 
ionic strength. The mixture is thereafter subjected directly to electrophoresis for size 
separation and single stranded DNA fragments separated on the basis of length. The charge-
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neutral PNA allows hybridization at low ionic strength and renders higher mobility to the 
complex, compared to the excess unbound PNA. The DNA-PNA hybrids are blotted 
(transferred) onto a nylon membrane, dried, UV cross-linked, and detected using standard 
chemiluminescent techniques.333 Alternatively, the bound PNA can be detected by using 
capillary electrophoresis, which uses the direct fluorescence detection method. Under the 
same conditions, a normal DNA–DNA duplex will tend to disrupt, here as the PNA-DNA 
duplex will remain intact due o the strong binding of PNA to DNA. This allows specific 
sequence detection with simultaneous size separation of the target DNA following a simple 
and straightforward protocol. Consequently, the analysis is much faster than conventional 
the Southern hybridization technique.309 
5.2.2.3 PNA-Assisted Rare Cleavage 
The DNAs of bacteria have specific sites that are the target of restriction enzymes and 
methylases. Methylases are particular enzymes that can add a methyl group to a specific 
DNA site to protect that site against the cutting by some endonucleases. 
Peptide nucleic acids, in combination with methylases and other restriction endonucleases, 
can act as rare genome cutters.334 The method is called PNA-Assisted Rare Cleavage (PARC) 
technique. It uses the strong sequence-selective binding of PNAs, preferably bis-PNAs, to 
short homopyrimidine sites on large DNA molecules, e.g., yeast or λ DNA.309 The PNA target 
site is experimentally designed to overlap with the methylation/restriction enzyme site on 
the DNA, so that a bound PNA molecule will efficiently shield the host site from enzymatic 
methylation whereas the other unprotected methylation/restriction sites will be methylated. 
After the removal of bis-PNA, followed by restriction digestions, it is possible to cleave the 
whole DNA by enzymes into limited number of pieces.334 DNA is efficiently protected from 
enzymatic digestion due to methylation in most of the sites except for those previously 
bound to PNA. Thus, short PNA sequences, particularly positively charged bis-PNAs, in 
combination with various methylation/restriction enzyme pairs can constitute an 
extraordinary new class of genome rare cutters. 
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5.2.2.4 Artificial Restriction Enzyme 
S1 nuclease cleaves single-stranded nucleic acids releasing 5’-phosphoryl mono- or 
oligonucleotides. It removes the single-stranded overhangs of DNA fragments and can be 
used in RNA transcript mapping and construction of unidirectional deletions. PNA in 
combination with S1 nuclease can work as an “artificial restriction enzyme” system. 
Homopyrimidine PNA oligomers hybridize to the complementary targets on dsDNA via a 
strand invasion mechanism, leading to the formation of looped-out non complementary 
DNA strands. The enzyme nuclease S1 can degrade this single-stranded DNA part into well 
defined fragments. If two PNAs are used for this purpose and allowed to bind to two 
adjacent targets on either the same or opposite DNA strands, it will essentially open up the 
entire region, making the substrate accessible for the nuclease digestion and thereby 
increasing the cleavage efficiency.335 
5.2.2.5 Determination of Telomere Size 
The conventional method for the determination of telomere length involves Southern blot 
analysis of genomic DNA and provides a range for the telomere length of all chromosomes 
present. The modern approach uses fluorescein-labelled oligonucleotides and monitor in situ 
hybridization to telomeric repeats. However, a more delicate approach resulting in better 
quantitative results is possible by using fluorescein-labelled PNAs, as shown by Lansdorp et 
al.336 This PNA-mediated approach permits accurate estimates of telomeric length. In situ 
hybridization of fluorescein-labelled PNA probes to telomeres is faster and requires a lower 
concentration of the probe compared to its DNA counterpart. Low photobleaching and an 
excellent signal-to-noise ratio make it possible to quantitate telomeric repeats on individual 
chromosomes in this way. Experiments suggest that variations of this approach can possibly 
be applied to other repetitive sequences. 
5.2.2.6 Nucleic Acids Purification 
Based on its unique hybridization properties, PNAs can also be used to purify target nucleic 
acids. PNAs carrying six histidine residues have been used to purify target nucleic acids using 
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nickel affinity chromatography.337 Also, biotinylated PNAs in combination with streptavidin-
coated magnetic beads may be used to purify Chlamydia trachomatis genomic DNA directly 
from urine samples. However, it appears that this simple, fast, and straightforward 
“purification by hybridization” approach has certain drawbacks. It requires the knowledge of 
the target sequence and depends on a capture oligomer to be synthesized for each different 
target nucleic acid. Such target sequences for the short pyrimidine PNA, i.e., the most 
efficient probe for strand invasion, are prevalent in large nucleic acids. Thus, short PNAs can 
also be used as generic capture probes for purification of large nucleic acids. It has been 
shown that a biotintagged PNA-thymine heptamer could be used to efficiently purify human 
genomic DNA from whole blood by a simple and rapid procedure.309 
5.2.2.7 Gene Expression Induction 
Although most of the focus on PNA applications have revolved around antisense strategies, 
several groups have studied the ability of PNAs to turn on gene expression. When PNA 
triplex structures are formed on one strand of the DNA duplex, the opposing DNA strand is 
displaced to form a D-loop. When sufficiently large, this D-loop resembles a transcriptional 
bubble or an initiation/elongation loop. Using bacterial and rat spleen-cell nuclear extracts 
and triplex-forming PNAs that bound to adjacent sites on a DNA template, Møllegaard and 
colleagues found that transcription was more efficient if two adjacent PNAs were bound to 
the same strand of DNA, thus giving rise to a 26 base D-loop. In this case, transcript initiation 
sites mapped to a site just downstream of PNA binding.338,339 
More recently, the work from the Wang laboratory has extended these findings and has 
shown that PNAs can be used in cultural cells to activate endogenous gene expression.340 
Using promoter-less GFP reporter constructs containing homopurine PNA target sites just 
upstream of the GFP initiation codon, Wang was able to demonstrate specific transcriptional 
initiation in vitro using HeLa cell extracts. In these experiments, designed to explore gene 
therapy approaches for sikle cell disease and thalassemias, the homopurine target sequence 
was from the 300 region of the human Gγ-globin promoter. As seen by Møllegaard,338 
transcript start sites mapped to the PNA target site and used the D-loop strand as template. 
When the PNAs were hybridized to the reporter plasmid under low salt conditions and 
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microinjected into the nuclei of cells, GFP expression was detected within 20 h of injection. 
By contrast, no GFP expression was detected in cells microinjected with plasmid alone. Wang 
also demonstrated that K562 erythroleukemia cells could be efficiently transfected with 
PNAs using electroporation and inducing the endogenous γ-globin gene threefold over 
background. Upregulation of γ-globin gene expression, normally suppressed in adults to 
<1%, can help in the treatment of β-thalassemia disease, in which it may partially act in place 
of the mutated defective γ-globin. Moreover, this induction was clearly a specific effect of 
the PNAs since the start sites for the transcripts mapped to both the endogenous promoter 
and to the PNA binding sites, 300 bp upstream. Thus, despite the presence of physiological 
salt concentrations and potential chromatin structures, the PNAs were able to bind to their 
target sites in the chromosome and promote transcription initiation, providing proof of 
principle for this approach of gene therapy. It is somewhat surprising that γ-globin 
transcription was induced not only at the PNA binding site, but also from its native promoter 
region.340 Probably the transcription of the γ-globin gene from the sequences upstream also 
makes the native promoter more accessible for RNA polymerase. In the cellular context PNA-
mediated arrest of transcription is interpreted as an inability of the transcription machinery 
to dissociate PNA/DNA or PNA2/DNA helices, more specifically, by the inability of the DNA 
helicase to unwind these structures. Indeed, specific studies show that bis-PNAs can 
significantly reduce DNA unwinding activity of the UL9 helicase.341,342 
5.2.3 Gene Therapy 
Peptide nucleic acids have promise as candidates for gene therapeutic drugs design. They 
require well identified targets and a well-characterized mechanism for their cellular delivery. 
In principle, two general strategies can be adapted to design gene therapeutic drugs. 
Oligonucleotides or their potential analogs are designed to recognize and hybridize to 
complementary sequences in a particular gene whereby they should interfere with the 
transcription of that particular gene (antigene strategy, Figure 67). 
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Figure 67 - Antigene strategy. 
Alternatively, nucleic acid analogs can be designed to recognize and hybridize to 
complementary sequences in mRNA and thereby inhibit its translation (antisense strategy, 
Figure 68). PNAs are chemically and biologically stable molecules and have significant effects 
on replication, transcription, and translation processes, as revealed from in vitro 
experiments. Moreover, no sign of any general toxicity of PNA has so far been observed.309 
 
Figure 68 - Antisense strategy. 
5.2.3.1 Antigene Strategy 
Peptide nucleic acids should be capable of arresting transcriptional processes thanks to of 
their ability to form a stable triplex structure or a strand-invaded or strand displacement 
complex with DNA. Such complexes can create a structural hindrance to block the stable 
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function of RNA polymerase and thus are capable of working as antigene agents. Evidence 
from in vitro studies supports the idea that such complexes are indeed capable of affecting 
the process of transcription involving both prokaryotic and eukaryotic RNA polymerases. 
PNA targeted against the promoter region can form a stable PNA-DNA complex that restricts 
the DNA access of the corresponding polymerase. PNA strand displacement complexes, 
located far downstream from the promoter, can also efficiently block polymerase 
progression and transcription elongation and thereby produce truncated RNA transcripts; 
the PNA (DNA poly-purine) target must be present in the gene of interest.343 Nielsen et al. 
have demonstrated that even an 8-mer PNA (T8) is capable of blocking phage T3 polymerase 
activity.344 The presence of a PNA target within the promoter region of IL-2Ra gene has been 
used to understand the effect of PNA binding to its target on this gene expression.345,346 The 
PNA2/DNA triplex arrests transcription in vitro and it is capable of acting as an antigene 
agent. Unfortunately one of the major obstacles to use PNA as an antigene agent is that the 
strand invasion or the formation of strand displacement complex is rather slow at 
physiological salt concentrations.347 Several modifications of PNA have shown improvements 
in terms of binding. Modifications of PNA by chemically linking the ends of the Watson-Crick 
and Hoogsteen PNA strands to each other, introducing pH-independent pseudoisocytosines 
into the Hoogsteen strand,348 incorporating intercalators,349 or positively charged lysine 
residues348,350 in PNA strands can drastically increase the association rates with dsDNA. Lee 
et al. have demonstrated that PNA, as well as the PNA-DNA chimera, complementary to the 
primary site of the HIV-I genome can completely block priming by tRNA3Lys.351 
Consequently, in vitro initiation of the reverse transcription by HIV-1 RT is blocked. Thus, 
oligomeric PNAs targeted to various critical regions of the viral genome are likely to have a 
strong therapeutic potential for interrupting multiple steps involved in the replication of HIV-
1.351 It has been found that under physiological salt conditions, binding of PNA to 
supercoiled plasmid DNA is faster compared to linear DNA.350 This result is relevant to the 
fact that the transcriptionally active chromosomal DNA usually is negatively supercoiled, so 
it can be better target for PNA binding in vivo. It has also been found that the binding of PNA 
to dsDNA is enhanced when the DNA is being transcribed. This transcription-mediated PNA 
binding occurs about threefold as efficiently when the PNA target is situated on the non-
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template strand instead of the template strand. As transcription mediates template strand-
associated (PNA)2/DNA complexes, which can arrest further elongation, the action of RNA 
polymerase results in repression of its own activity, i.e., suicide transcription.352 These 
findings are highly relevant for the possible future use of PNA as an antigene agent. We wish 
to refer to reports describing the ability of PNA to activate transcription, although this is not 
actually related to its antigene effect. Møllegaard et al.338 have efficiently demonstrated that 
the looped-out single-stranded structure formed as a result of strand invasion is also capable 
of acting as efficient initiation sites for Escherichia coli and mammalian RNA polymerases in 
which the polymerase might start transcription using the single-stranded loop as a 
template.346 This is consistent with the affinity of RNA polymerase for single-stranded DNA 
and its ability to transcribe single-stranded DNA. 
The nuclear localisation signal (NLS) of SV40 has been shown to translocate 17-mer anti-myc 
PNA over the plasma membrane into the cytosol and further convey into nuclei of Burkitt’s 
lymphoma derived cell-lines. A 17-mer antigene PNA, that is complementary to a unique 
sequence located at the start of the second exon of c-myc, was delivered into BRG and BJAB 
cells by both NLS peptide and peptide with a scrambled NLS sequence. However, the nuclear 
transport of PNA was achieved only with a PKKKRKV peptide that corresponds to the 
active/wild type NLS (NLSwt).353 Inside the nuclei the rhodamine-labelled PNA-NLS was 
visualised as a small number of highly fluorescing bright spots associated with clumped 
chromatin material. Twenty four hours after application of 10 M antimyc NLSwt-PNA 
constructs, MYC expression was inhibited by 75% and cell viability decreased by 25%, 
respectively. MYC expression in treated cells decreased progressively and after 72 h the 
protein concentration was below the level of detection. The level of myc mRNA was reduced 
by 35% after 7 h of treatment and by 60% after 18 h, suggesting that MYC expression was 
also inhibited at the level of transcription. However, reduction of protein concentration 
upon PNA-NLSwt construct treatment seems to slightly precede the decrease in the mRNA 
concentration. This discrepancy can be explained by general difficulties in quantifying exactly 
the Western and Northern blot analyses. On the other hand, this hints that antimyc PNA-
NLSwt acts not only on a transcriptional, but on a translational level as well. 
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The potential applicability of receptor mediated intracellular translocation of PNA (from 
cytosol into the nucleus) was demonstrated in prostatic carcinoma cells. 
Dihydrotestosterone coupled to anti-gene PNA induced nuclear uptake in LNCaP cells that 
express the androgen receptor gene (AR), but not in DU145 cells where its receptor gene is 
silent. The cellular/cytoplasmic uptake of rhodamine labelled antimyc PNA is, however, 
detectable in both cell-lines, but in DU145 cells the uptake is strictly cytoplasmic only.354 
Coupling of dihydrotestosterone adds hydrophobicity to PNA oligomer molecules and that 
seems to facilitate the uptake of PNA by cells, as compared to unmodified PNA. 
5.2.3.2 Antisense Strategy 
In the antisense strategy the target of the PNA strand is the mRNA (instead the antigene 
where the target is the DNA double strand). The basic mechanism of the antisense effect by 
oligodeoxynucleotides is considered to be either a ribonuclease H (RNase H) mediated 
cleavage of the RNA strand in oligonucleotide-RNA heteroduplex or a steric blockage in the 
oligonucleotide-RNA complex of the translation machinery.355 Oligodeoxynucleotide analogs 
such as phosphorothioates activate RNase H and thus hold promise of working as antisense 
agents.356 However, they also exhibit some non-specificity in their action. PNA/RNA 
duplexes, on the other hand, cannot act as substrates for RNase H. Normally, the peptide 
nucleic acid antisense effect is based on the steric blocking of either RNA processing, 
transport into cytoplasm, or translation. It has been concluded from the results of in vitro 
translation experiments involving rabbit reticulocyte lysates that both duplex- (mixed 
sequence) and triplex-forming (pyrimidine-rich) PNAs are capable of inhibiting translation at 
targets overlapping the AUG start codon.355 Triplex-forming PNAs are able to hinder the 
translation machinery at targets in the coding region of mRNA. However, the translation 
elongation arrest requires a (PNA)2–RNA triplex and thus needs a homopurine target of 10-
15 bases. In contrast, duplex-forming PNAs are incapable of doing the same. Triplex-forming 
PNAs can inhibit translation at initiation codon targets and ribosome elongation at codon 
region targets. 
Mologni et al. showed effects of three different types of antisense on the in vitro expression 
of PML/RARα gene.357 The first one was complementary to the first AUG (initiation) site. The 
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second could bind to a sequence in the coding region that includes the second AUG, the 
starting site for the synthesis of an active protein. The third PNA was targeted against the 
59-untranslated region (UTR) of the mRNA, the point of assembly of the translation 
machinery. Together, these three PNAs could efficiently inhibit translation even at a 
concentration much below the critical concentration used for each individual. The result 
suggests that the PNA targeting of RNA molecules like PML/RARα requires the effective 
blocking of different sequences on the 59 part of the messenger. A 59-UTR PNA target can 
also be used as efficiently as an initiation (AUG) target to achieve an antisense activity of 
PNA, and a more effective translation inhibition can be achieved by combining PNA directed 
toward 59-UTR and AUG regions. 
Triple helix-forming PNAs can also hinder the translation process. Bis-PNA or clamp-PNA 
structures are capable of forming internal triple helical constructs. In principle, if targeted 
against the coding region of mRNA, PNA2/RNA triple helix-forming derivatives can also cause 
a stop in translation, which can be easily verified by the detection of a truncated protein.355 
However, this methodology requires a sequence optimization for each new target. Recent 
studies show that E. coli cells are somewhat permeable for PNA molecules. Good and 
Nielsen 358,359 have shown that it is possible to achieve PNA antisense effects in the ‘leaky’ 
mutant strains of E. coli. PNAs targeted against the AUG region of the mRNA corresponding 
to β-galactosidase and β-lactamase genes were indeed capable of down-regulating the 
expression of these two genes.358 Another study demonstrated the effect of two bis-PNAs, 
targeted against the homopurine stretches in rRNA, either in the peptidyl transferase center 
or in the α-sarcin loop, in inhibiting the ribosome function in a cell-free system.359 The 
translation was arrested at submicromolar range of PNA concentration. The growth of a 
mutant strain of E. coli, namely, AS19, was also inhibited by using the same PNAs at low 
micromolar concentration. 
5.2.3.3 Inhibition of Replication 
It is also possible by using PNA to inhibit the elongation of DNA primers by DNA polymerase. 
Further, the inhibition of DNA replication should be possible if the DNA duplex is subjected 
to strand invasion by PNA under physiological conditions or if the DNA is single stranded 
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during the replication process. Efficient inhibition of extrachromosomal mitochondrial DNA, 
which is largely single-stranded during replication, has been demonstrated by Taylor et al.360 
The PNA-mediated inhibition of the replication of mutant human mitochondrial DNA is a 
novel (and also potential) approach toward the treatment of patients suffering from 
ailments related to the heteroplasmy of mitochondrial DNA. Here wild-type and mutated 
DNA are both present in the same cell. Experiments have shown that PNA is capable of 
inhibiting the replication of mutated DNA under physiological conditions without affecting 
the wild-type DNA in mitochondria. 
5.2.3.4 Interaction of PNA with enzymes 
It was observed that PNAs are able to interact with several enzymes. 
5.2.3.4.1 RNase H 
Despite their remarkable nucleic acid binding properties, PNAs are not generally capable of 
stimulating RNase H activity on duplex formation with RNA. However, recent studies have 
shown that DNA/PNA chimeras are capable of stimulating RNase H activity. On formation of 
a chimeric RNA double strand, PNA/DNA can activate the RNA cleavage activity of RNase H. 
Cleavage occurs at the ribonucleotide parts basepaired to the DNA part of the chimera. 
Moreover, this cleavage is sequence specific in such a way that certain sequences of 
DNA/PNA chimeras are preferred over others.361 They are also reported to be taken up by 
cells to a similar extent as corresponding oligonucleotides. Thus, PNA/DNA chimeras appear 
by far the best potential candidates for antisense PNA constructs. 
5.2.3.4.2 Polymerase and reverse transcriptase 
In general, there is no direct interaction of PNA with either DNA polymerase or reverse 
transcriptase. However, different groups have shown indirect involvement of PNA in 
inhibiting these enzyme functions (activity) under in vitro conditions. For example, PNA 
oligomers are capable of terminating the elongation of oligonucleotide primers by either 
binding to the template strand or directly competing with the primer for binding to the 
template. Primer extension by MMLV reverse transcriptase has been shown to be inhibited 
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by introducing a PNA oligomer.345 In another experiment, Nielsen et al.362demonstrated that 
the primer extension catalyzed by Taq-polymerase can be terminated by incorporating a 
PNA oligomer (PNA-H(t)10) into the system. The latter can bind to a (dA)10 sequence in the 
template and thereby terminate the primer extension. Moreover, uncharged PNA primers 
with only a single 59-amino-29,59-dideoxynucleoside at the carboxyl terminus can be 
recognized by the Klenow fragment for DNA pol I and VentDNA polymerase (Thermococcus 
litoralis), and a linear amplification is possible with the use of an excess of PNA-DNA primer 
and suitable thermostable polymerases.363 Moreover, the reverse transcription of gag gene 
of HIV I is also inhibited in vitro by PNAs.364 The inhibition has been achieved by using a bis-
PNA construct, which is more efficient than the corresponding mono PNA construct.357 Also, 
the reverse transcription can be completely inhibited by a pentadecameric antisense PNA, 
using a molar ratio of 10:1 (PNA/RNA), without any noticeable RNase H cleavage of the 
RNA.364 
5.2.3.4.3 Telomerase 
Human telomerase, a ribonucleoprotein complex consisting of a protein with DNA 
polymerase activity and an RNA component, synthesizes (TTAGGG)n repeats at the 39 end of 
DNA strands. PNA oligomers that are complementary to the RNA primer binding site can 
inhibit the telomerase activity. Studies have shown that the telomerase inhibition activity of 
PNA is better than that of corresponding activity of phosphorothioate oligonucleotides. This 
is mainly due to a higher binding affinity of PNA compared to phosphorothioates.365 Corey 
and co-workers have demonstrated an efficient inhibition of telomerase after lipid-mediated 
delivery of template- and nontemplate- directed PNA into the cell.366 
5.2.3.5 Mutagen Action of PNA 
One consequence of the tight binding of triplex-forming oligonucleotides and PNAs to 
cellular homopurine DNA targets is that they can induce DNA repair pathways within the 
cell. Thus, the PNA2/DNA complex can be interpreted by the cell to be a DNA lesion in need 
of repair. One possible outcome of this is the production of site-specific mutants at, or 
proximal to, the site of PNA binding.367 Faruqi ad co-workers reported that PNAs with 
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binding affinities of around 10-7 M were able to be taken up by streptolysin-O permeabilized 
murine fibroblast, bind to their target sites within SupF1 reporter gene integrated into the 
genome, and induce point mutations or single base deletions or insertions in the target 
sequence or within 5 bp of the site.368 
The frequency of mutagenesis observed with the PNAs was 8x10-4, compared to a 
background mutagenesis frequency of 9x10-5. Similar results have been obtained with tightly 
binding triplex-forming phosphorothioates, leading to the prediction that triplex complexes 
in general can induce transcription-coupled DNA repair pathways.369 Presently, this 
mutagenic capacity is being developed as a technique to selectively mutagenize and repair 
single point mutations that are crucial in certain genetic diseases, including sickle cell 
disease.339 
5.3 Modified PNAs 
The major limitations of the therapeutic applications of PNAs are their poor solubility in 
aqueous media due to self-aggregation and an insufficient cellular uptake. In order to 
improve PNA solubility in aqueous media, the cellular uptake, the binding selectivity towards 
RNA versus DNA, or to stabilise duplex or triplex structures, several analogues have been 
synthesised over the years.370 
5.3.1 PNAs with Modified Nucleobases 
Inhibition of gene expression by antisense or antigene approaches relies on the formation of 
stable duplex and triplex structures.371,372 In this context, the use of modified nucleobases 
represents an obvious way to control recognition between nucleic acids. The non-standard 
nucleobases employed so far with PNA are limited, compared with the repertoire of 
backbone modifications described. Structures of nucleobase-modified PNA are illustrated in 
Figure 69. 
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Figure 69 - Structures of nucleobase-modified PNA. 
Substitution of natural bases for analogues can be used for interfering with the hybridization 
process; for example, N4-benzoyl cytosine (Figure 69a) has been shown to cause inhibition of 
triplex formation, whereas E-base (Figure 69b), rationally designed to recognise T-A base 
pair, stabilises a triplex even when the target strand contains one or two pyrimidine 
residues.373,374 In fact, triplex formation is generally restricted to oligopurine strands 
whereas a substantial destabilisation is observed when pyrimidine residues are introduced. 
However, the binding affinity of E•T-A triplet is far from optimal, which might partially be 
due to excessive flexibility of the linker between the backbone and the nucleobase. In order 
to address the issue of flexibility, a conformationally constrained E-base analogue (Figure 
69c), was synthesised.375 Surprisingly, no improvement was found, a result that could mean 
that local flexibility has only little influence on the thermodynamics of oligonucleotide 
hybridization. As said, 2-Thiouracil (Figure 69d) along with 2,6-diaminopurine (Figure 69e) 
was used as a non-natural base pair in PNA-DNA recognition and was shown, for the first 
time, to lead to a phenomenon termed as “double duplex invasion”. Pyrimidines which have 
extended aromatic moieties as a means of increasing the stacking energy and hence the 
stability of the hybridized complexes represent another class of modified nucleobases. 
  Chapter 5: New SPION-PNA Nanoconjugates 
 
197 
 
Incorporation of tricyclic phenothiazine (Figure 69f) as a substitute for cytosine and 
bicyclic/tricyclic naphthyridinones (Figure 69g-h) as substitutes for thymine showed a 
modest affinity increase, whereas tricyclic cytosine analogues based on the phenoxazine 
gave the highest increase in affinity and sequence specificity towards targets.376 This result 
demonstrates that factors other than mere molecular stacking overlap, such as electronic 
factors, contribute to base pair stacking stabilities. 
Interesting modification on nucleobases have also been carried out to yield fluorescent PNA 
monomers and oligomers (Figure 70). 
 
Figure 70 - Structures of fluorescent nucleobase-modified PNA. 
2-Aminopurine, being intrinsically fluorescent, can be used to study PNA-DNA interaction 
dynamics.377 O4-(o-nitrophenyl)thymine (Figure 70b) PNA monomer was reported as 
valuable intermediate for the introduction of fluorescent compounds into PNA oligomers.378 
Thiazole orange (Figure 70c) is the first base to fulfill the demands desired for a fluorescent 
universal base.379 Thanks to its remarkable base stacking ability, it pairs well against all four 
canonical DNA bases maintaining duplex stability. In addition to this, the sensitivity of its 
fluorescence to a neighbouring base mismatch, it is suitable for homogeneous single-
nucleotide-polymorphism detection.380 
5.3.2 PNAs with Modified Backbone 
Since the first report of aegPNA, many research groups have started the synthesis of 
backbone modified peptide nucleic acids in order to improve or modify the chemico-physical 
properties, in particular the solubility, and the binding affinity of classical PNA. 
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Improvement of the aqueous solubility of PNAs has been achieved by the introduction of 
charges in the molecule, or by the introduction of ether linkages in the backbone. PNAs are 
endowed of positive charges by linking a terminal lysine residue381 (Figure 71a), by the 
introduction of a positive charge in the backbone, or by replacing the acetamide linker to the 
nucleobase by a flexible ethylene linker (Figure 71b).382 
 
Figure 71 - Positively charged modified backbone. 
Cationic guanidinium linkages (Figure 72) have also recently been introduced into PNA and 
were found to improve its binding affinity with complementary nucleic acid sequences.383 
 
Figure 72 - Positively charged guanidinium modified backbone. 
Making the PNA anionic also aided in increasing its water-solubility as in the case of the 
phosphonate analogues (Figure 73), but was accompanied by a decrease in the binding 
affinity to complementary nucleic acid sequences.384 
Efimov et al.384a have described the synthesis of homopyrimidine pPNA oligomers containing 
N-(2-hydroxyethyl)phosphonoglycine (pPNA-O), or N-(2-aminoethyl)phosphono glycine 
(pPNA-N). These oligomers did form complexes with complementary DNA/RNA, but with a 
much lower stability than PNA. 
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Figure 73 - Anionic charged modified backbone. 
Increased water solubility was also achieved by putting an ether linkage in the PNA 
backbone (Figure 74).385 
 
Figure 74 - O-ether modified backbone. 
In the attempt to make the backbone rigid, alkyl and cyclic substituents have been 
introduced.386 3-, 5- and 6-member rings have been appended in various position of the 
backbone. The rationale behind the design of such constrained PNA is to obtain a 
preorganised structure with high selectivity in the binding of DNA/RNA. As the presence of 
rotamers around the tertiary amide bond in aegPNA interferes with the hybridization 
process, it was postulated that connecting the nucleobase to the cycle inhibits the rotation, 
overcoming the problem of the rotamers. Examples of conformationally blocked PNA (Figure 
75) are represented by the aminoprolyl PNA (ap-PNA), aminoethylprolyl PNA (aep-PNA), 
aminoethylpyrrolidinone PNA (aepone-PNA), pyrrolidine PNA, cyclopropane (cpr), 
cyclopentyl (cp) and cyclohexyl (ch) PNA. 
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Figure 75 - Rigid modified backbone. 
Introduction of a single ap-PNA in a PNA sequence results in a stabilisation of the PNA/DNA 
duplex, whereas homothymine ap-PNA do not bind to the target sequence; stereochemistry 
affects the preference for parallel or antiparallel binding.387 Aep-PNAs are obtained 
protecting the hydroxyproline carboxyl as an ester, derivatising the nitrogen with an 
ethylamine moiety and then replacing the OH with the nucleobase. These derivatives bear a 
positive charge; homothymine decamer binds polyadenilic acid to form 2:1 hybrids, with 
high affinity and specificity. When hybridized to DNA, they show higher affinity for the 
antiparallel hybridization than for the parallel.388 Aepone-PNAs also stabilise formation of 
triple helical structures with DNA partners, while destabilise triplexes formed with polyA.389 
(2R,4S) Pyrrolidine-PNA oligomers form very stable hybrids with complementary DNA and 
RNA; protonation of the nitrogen does not affect the stability of the hybrids. On the 
contrary, (2S,4S) isomers do not stabilise the formation of hybrids with DNA and RNA.390 Cp-
PNAs show higher affinity towards RNA than DNA; the (1R,2S) enantiomers form higher 
affinity complexes with DNA than the (1S,2R) enantiomers. Both stabilise PNA2:DNA and 
PNA2:RNA triplexes.
391 Cyclohexyl PNAs were synthesized in the forms (1S,2S), (1R,2R), 
(1S,2R), (1R,2S); although the presence of S,S isomers does not affect the thermal stability of 
DNA and RNA hybrids, introduction of R,R isomers results in a destabilisation of the 
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PNA/DNA or RNA complexes. PNA including the (1R,2S) isomer exhibits higher hybrid 
stability and ability to discriminate between DNA and RNA.392 
5.3.3 PNAs with Fluorescent Probes 
The introduction of fluorescent probes in biomolecules may constitute a valuable tool to 
study their structures and biological activity, opening the possibility to design new 
fluorescent bioactive molecules that can exploit their peculiar properties for diagnostics or 
therapeutic applications. For more than thirty years, the conjugation of fluorescent markers 
to DNA or proteins have been successfully applied and more recently also with PNAs. 
In literature are now reported different examples of fluorescent PNAs and their cellular up-
take, as well as their capability to hybridize specific DNA or RNA sequences, have been 
widely studied. 
The introduction of a fluorescent molecule in the PNA oligomer can be achieved or by 
classical reaction in solution, or by solid phase reactions while the oligomer is still attached 
to the resin support. 
In 1996 Kremsky et al.393 reported the functionalization of PNA oligomers with biotin and a 
fluorescein derivative, with the aim to set up a synthetic protocol to support specific markers 
in solid phase synthesis. 
Fluorescein is one of the most used fluorescent probe and finds wide applications in 
bioanalytical chemistry,394 molecular biology and pharmacokinetic studies.395 
As shown in Figure 76, fluorescein itself cannot be directly used in solid phase synthesis 
(SPS), while its derivatives bearing a carboxylic group are suitable for classical peptide bond 
formation. 
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Figure 76 - Fluorescein and its carboxy-derivatives. 
Carboxyfluorescein derivatives, as pure isomer, are commercially available but are quite 
expensive; thus a mixture of the two isomers 5- and 6- carboxyfluorescein (61:39) were 
practically used in SPS.396 
It’s also commercially available the isothiocyanate derivative (FITC, Figure 77), that allows 
the outstanding reaction with free amino groups, by formation of stable thiourea bond. 
 
Figure 77 - Fluorescein isothiocyanate (FITC). 
In molecular biology, also rhodamine and its derivatives were widely used, as an alternative 
to fluorescein (Figure 78). 
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Figure 78 - Rhodamine and rhodamine B. 
More recently, Englund et al397. have introduced in the PNA backbone a lysine-based 
monomer, exploiting the terminal ε-amino group to bind the 9-fluorenacetic acid as a 
fluorescent probe. 
5.4 PNA Oligomers Synthesis 
Thanks to their pseudopeptide backbone, PNA monomers can be assembled using synthetic 
methods developed for the peptide synthesis both in solid phase or in solution. Different 
synthetic strategies have been reported in the literature, but the most used are based on: 
 Boc/Cbz protected monomers (Figure 79); 
 Fmoc/Bhoc protected monomers. 
In our laboratories the first strategy is routinely used for the synthesis of PNA oligomers, 
both by manual as automated SPS, starting from commercially available aegA, aegC and 
aegG monomers, while aegT one is generally synthesized by ourselves. 
 
Figure 79 - Aminoethylglycine A, C, G and T monomers with Boc/Cbz protections. 
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The solid support is usually functionalized polystyrene with a cleavable linker. The choice of 
the linker is very important and depends on the protecting group strategy used. For the 
Boc/Cbz strategy, the best support is the MBHA resin (Figure 80a), in which the acid labile 
linker can be cleaved with a mixture of trifluoroacetic and trifluoromethanesulfonic acid. In 
the Fmoc/Bhoc strategy, an acid labile linker can be used, for example the RinkAmide (Figure 
80b), but best results in the Fmoc chemistry are achieved using a polyethylene glycol 
derivatized polystyrene resin (PEG-PS) that provides a “solution like” environment for the 
synthesis. The typical linkers used with this resin are the XAL or PAL linkers (Figure 80c and 
d). 
 
Figure 80 - Most used solid phase supports for the synthesis of PNAs. 
 
Independently from the strategy, the solid phase oligomers synthesis (Scheme 14) proceeds 
with the following standard synthetic steps: 
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Scheme 14 - Cyclic synthetic protocol for the SPS of PNA oligomers. 
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 Downloading: this step consists in the coupling of the first monomer or a properly 
protected-amino acid (e.g. PG1-Lysine-Nε-PG2, generally used to improve the solubility 
in water of the final oligomer), to the resin. This reaction is performed using a smaller 
amount of the monomer with respect to the loading of the resin, in order to avoid the 
interaction among the oligomer chains on a bead. A typical loading used in the PNA 
oligomers synthesis is 0,2 mmol/g. 
 Deprotection: to built the oligomer is necessary to remove the protecting group on the 
PNA monomer (or amino acid) attached on the resin. For the Boc/Cbz strategy, the Boc 
group is removed using trifluoroacetic acid (TFA) in presence of m-cresol (ratio 95:5). 
The m-cresol was added to function as a scavenger for the tert-butyl cations in order to 
avoid alkylation of the nucleobases. 
 Coupling: this step is the key step of the chain elongation. Using typical condensing 
agent (HBTU or HATU gave best results) the carboxylic acid function of a monomer is 
coupled with the amino group of the monomer attached on the resin and previously 
deprotected. 
 Capping: this step is performed in order to avoid that unreacted amino groups can 
react in the next coupling steps giving mistaken sequence that are more difficult to 
purify. The preferred capping reagent is acetic anhydride, which reacts very fast with 
the free amino groups. 
Once the oligomer synthesis is completed, the chain is cleaved using the more appropriate 
reagent (for MBHA resin, TFA and trifluoromethanesulfonic acid -TFMSA- mixture in 
presence of m-cresol and thioanisole). Usually, in the final cleavage also the protecting group 
of the exocyclic amino moieties of the nucleobases are removed. At last, semipreparative 
HPLC purification were done to isolate the desired PNA oligomer. 
As mentioned above, HBTU and HATU gave the highest coupling yields in PNA synthesis. 
However, uronium salts react with primary amines to form guanidinium saIts, and this 
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reaction has been shown to cap free α-amines in peptide synthesis efficiently. The capped 
products are easily identified by mass spectroscopy by the presence of M+100 masses. The 
higher pKa value of the 2-ethylamine in PNA and the fact that it is less steric hindered makes 
PNA monomers even more prone to this reaction (Scheme 15). Therefore, pre-activation of 
the monomers and a slight excess or monomer over HATU are employed in the protocol. 
 
Scheme 15 - Side reaction between condensing agent and aegPNA monomer. 
5.5 Binding Affinity Evaluation of PNAs 
Like other non-covalent structures, the DNA complexes (duplex or triplex) are unstable at 
high temperatures. When the temperature is increased gradually, this process of heat 
denaturation, also called melting, begins in areas with a high A-T content. A-T base pairs can 
be separated more easily than G-C base pairs. The Melting Temperature (Tm) is defined as 
the temperature at which half of the DNA strands are in the double-helical state and half are 
in the single strand states (Figure 81). 
 
Figure 81 - Thermal denaturation process of dsDNA. 
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The best ways to determine the melting temperature and to evaluate the PNA/DNA 
interactions are by spectroscopic techniques, as described in the following paragraph, or by 
Differential Scanning Calorimetry (DSC). 
5.5.1 Spectroscopic Techniques for Studying PNA/DNA 
Interactions 
Monitoring the UV absorption at 260 nm as a function of temperature has been extensively 
used to study the thermal stability of nucleic acid systems and consequently, PNA/DNA 
hybrids as well. Increasing the temperature perturbs this system, inducing a structural 
transition by causing disruption of hydrogen bonds between the base-pairs, diminished 
stacking between adjacent nucleobases, and larger torsional motions in the backbone 
leading to a loss of secondary and tertiary structure. This is evidenced by an increase in the 
UV absorption at 260nm, termed as ‘hyperchromicity’. The magnitude of hyperchromicity is 
a measure of the extent of the secondary structure present in nucleic acids. The process is 
cooperative and the plot of the absorbance at 260 nm versus the temperature is sigmoidal 
and the inflexion point corresponds to the Tm (Figure 82). This also represents a two-state 
“all or none” model for nucleic acid melting, i.e. the nucleic acids exist in only two states, 
either as duplexes or as single strands and at varying temperatures, the relative proportions 
change. A non-sigmoidal (e.g., linear) transition with low hyperchromicity is a consequence 
of non-duplexation (non-complementation). In many cases, the transitions are broad and the 
exact Tm are obtained from the peak in the first derivative plots. This technique has 
provided valuable information regarding complementary interactions in nucleic acid hybrids 
involving DNA, RNA and PNA. Generally homothymine PNAs (aeg[T]10-PNA) binds 
complementary DNA (with formation of a triplex) with strong affinity, as demonstrate from 
its Tm of 72 °C, while standard sequence PNAs (aeg[STD]-PNA) form stable duplex with 
natural nucleic acid with a Tm of 53 °C.398 
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Figure 82 - Example of thermal denaturation plot and Tm values for reference PNAs reported in 
literature. 
5.6 Magnetic Peptide Nucleic Acids 
Peptide Nucleic Acids (PNAs), as we have already seen, are mimics of natural 
oligonucleotides, in which each ribose phosphate unit is replaced by an aminoethylglycine 
unit. PNAs bind complementary DNA and RNA strands with an excellent affinity and 
sequence specificity due to the absence of electrostatic interference of their neutral chain 
with polyanionic backbone oligonucleotide. In addition, PNAs exhibit greater mismatch 
selectivity and chemical and enzymatic stability compared to natural oligonucleotides. All of 
these features have attracted significant interest, which has arisen in view of their potential 
in gene diagnosis and therapy. However, the first generation of PNAs suffers from some 
drawbacks, which hamper the full exploitation of them in gene therapy, including low cell 
uptake and some low solubility in physiological media. To overcome these problems, and to 
improve their physical-chemical properties, many modified PNAs have been synthesized in 
recent years following different strategies as previously reported. Along with the recent 
advances in DNA technology, the integration with nanostructured systems is expected to 
improve PNA properties and applicabilities. 
In this context, superparamagnetic iron oxide nanoparticles attracted our attention because 
of their unique magnetic properties, which can be controlled rigorously and activated easily 
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by applying an external magnetic field. In most cases, specific surface biofunctionalization is 
required for the successful utilization of SPIONs in biomedicine. In several instances, single-
stranded DNA was successfully supported on magnetic nanoparticles and tested in 
hybridization experiments and single-nucleotide polymorphism analysis.399 In contrast, PNAs 
have been seldom considered and, to our knowledge, only two examples have been 
reported so far. In the first study, PNA was connected to the γ-Fe2O3 nanoparticles by 
exploiting the largely adopted thiol chemistry. Hybridization and mismatch experiments with 
ssDNA were conducted by surface-enhanced Raman scattering (SERS).400 More recently, the 
synthesis of gold coated cobalt ferrite nanoparticles functionalized with thiol-PNAs was 
reported.401 However, we are aware that the interest in SPION-PNA nanoconjugate could 
spread well beyond this preliminary information, eventually conditioning the potential of 
PNA in biology and medicine. Several PNA applications, which are characteristic of DNA 
technology, would benefit from such an innovation, including cell uptake and site-directed 
delivery, control and tunability of the degree of PNA loading on nanoparticle surface, size 
and morphology of nanoconjugates, and rapid and reliable assessment of DNA hybridization 
by T2 relaxation measurements complemented by conventional determination of the 
melting temperature of hybrids. 
In our laboratories, we discovered a versatile, effective synthetic platform for the 
development of monomer and decamer PNA nanoconjugates, starting from synthetic PNA 
and nanometer-sized maghemite.277 Some SPION-PNA nanoconjugates have been already 
synthesized and their structures are reported in Figure 83.402 The sequence-selective DNA 
recognition and sequestration ability of the resulting SPION-PNA were assessed according to 
their capability of enhancing the T2 relaxation response in aqueous solutions under 
conventional hybridization conditions with complementary DNA.277 
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Figure 83 - Library of SPION-PNA nanoconjugates that have been already synthesized in our 
laboratories. 
As generally reported in literature, two main decamers were used as reference compounds: 
a homothymine [T]10 and a so called standard sequence [STD] PNAs. The standard sequence 
has the characteristic to present all the four nucleobases in the oligomer. The repeating 
aegPNA monomer units are shown in Figure 84. 
 
Figure 84 - Repeating aegPNA monomer units. 
The current strategies to anchor PNAs onto SPIONs can involve passive non-covalent 
adsorption on the outer particle surface (by a carboxylate group for instance, Figure 83a and 
e) or the formation of a more stable covalent bond by using appropriate linkers between the 
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nanoparticles and the biomolecule (e.g. by sylilation reaction, Figure 83b-d and f-h). These 
surface functionalization methodologies have been already widely explained in Chapter 4. 
All these nanoconjugates demonstrated to be able to bind with strong affinity the 
complementary DNA, regardless of the presence of the SPIONs. Melting temperature where 
determined confirming the value reported in literature for the same PNA oligomers non-
grafted onto nanoparticle surface. 
One of the main drawback of PNAs is their low solubility in physiological media and, as 
explained before [see section 5.1.4], one solution consists in the introduction of positive 
charges thanks to the presence of lysine residues in the oligomeric chain. 
In previous research works, 403 we were able to synthesize new modified PNAs bearing one 
or more lysine residues at the C-terminus; these oligomers show higher solubility in water 
than the corresponding non-modified PNAs (Figure 85a-e). At the same way, we investigate 
the solubility of [T]10 and [STD] PNAs anchored onto SPIONs (Figure 85f and g). As expected, 
the solubility of the nanosystems is lower than the corresponding non-supported decamers, 
but are very promising values, if we consider the presence of the magnetic metallic core. The 
introduction of lysine residues has so demonstrated to be a simple and very efficient tool to 
overcome solubility problems. 
 
Figure 85 - Solubility of some homothymine and standard sequence PNAs in water. Positive charges 
derive from strong acidic cleavage condition (TFA/TFMSA mixture). 
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5.7 New Fluorescent Magnetic PNAs 
As reported in section 5.3.3, the introduction of fluorescent probes in PNAs may be a 
powerful tool to study their structures and biological activity, as well as to employ them in 
diagnostics. 
In this Ph.D. Thesis we decided to synthesize new fluorescent PNA nanoconjugates that 
combine the presence of a magnetic metallic core, PNA strands and a fluorescent probe. 
For this purpose we synthesized the two new nanoconjugates 36 and 37, reported in Figure 
86, in which a homothymine and a standard sequence decamers were modified with a 
succinic linker at the N-terminus and with a lysine at the C-terminus. The free carboxylic 
moiety can be exploited to bind in a non-covalent interaction the SPION surface, while the ε-
free amino group of the lysine residue can be used to bind the fluorescent probe, in this case 
the fluorescein isothiocyanate (FITC, Figure 77), leading to the formation of the 
corresponding thiourea (FITU, Figure 86). 
 
Figure 86 - New fluorescent PNA nanoconjugates 36 and 37. 
The synthetic protocol for the synthesis of 36 and 37 is reported in Scheme 16. 
The MBHA resin was manually downloaded with the N(α)-Boc-N(ε)-Fmoc-L-lysine in order to 
obtain the functionalized resin 38 with a final loading of 0.2 mmol/g. Then, automated solid 
phase synthesis with Boc strategy was conducted on a peptide synthesizer “ABI 433A”, 
according to Apllied Biosystems ABI 433A peptide synthesis 3 ml reactor vessel user’s 
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manual. Boc-deprotection, coupling and capping reactions were cyclically performed, till the 
desired PNA oligomers were obtained. Manual Boc-deprotection of the N-terminus was 
achieved, affording the supported PNAs 39 and 40, that after neutralization with DIPEA were 
coupled with succinic anhydride. PNAs 41 and 42, endowed with the succinic linker, undergo 
Fmoc-deprotection of the ε-lysine amino group and then were directly reacted on solid 
phase with fluorescein isothiocyanate (FITC), leading to the formation of the corresponding 
fluorescein isothiourea derivatives (FITU). After total cleavage from the resin and HPLC 
purification, PNAs 43 and 44 were supported onto SPIONs by formation of a non-covalent 
interaction. Nanoconjugates 36 and 37 were isolated and characterized by E.A., FTIR and UV-
Vis spectroscopy to confirm the grafting of the fluorescent PNAs onto the nanoparticles 
surface. Furthermore, to confirm the ability of 36 and 37 to recognize and bind 
complementary DNA, the melting temperature Tm of the hybrids formed were determined. 
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Scheme 16 - Synthesis of new fluorescent PNA nanoconjugates 36 and 37. 
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5.7.1 Determination of the Final Loading of Nanoconjugate 36 
and 37 
As previously mentioned in section 4.2.1, from E.A. is possible to obtain important 
information about the quantity of organic molecules adsorbed onto the SPIONs surface. In 
an analogous way, 36 and 37 were analyzed by E.A. and the corresponding loadings were 
determined (Table 11). 
Nanoconjugate 
Loading 
Tot % org mmol/gNPs N°molecules/NP 
36 14.08 0.042 ≈ 80 
37 26.78 0.080 ≈ 170 
 
Table 11 - Loading of nanoconjugates 36 and 37. 
In the case of bionanoconjugates could be quite interesting to know how many bioactive 
molecules are grafted onto a single nanoparticle. So, in order to determine the number of 
organic molecules per one nanoparticle, a calculation method was set up starting from two 
main approximation: i) the nanoparticles must be considered completely composed by iron 
(III) oxide and ii) the nanoparticles have a uniform spherical shape. 
Commercially available SPIONs used in this work have a dimension of 10±2 nm of diameter 
and given density for Fe2O3 is 4.90x10
6 g/m3. Thus, the volume of a single SPION is 5.24x10-25 
m3 and its mass corresponds to 2.57x10-18 g. 
E.A. gives us the total percentage in weight of the organic part loaded onto SPIONs [Tot % 
org], from which is possible to determine the mass of a single nanoconjugate using the 
following equation: 
                     
                        
     
  
        
   
 
Then, knowing the mass of a single nanoconjugate and the mass of a single naked 
nanoparticle, we can calculate the mass of the organic part loaded onto the SPION: 
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At last, the approximate number of organic molecules loaded onto a single SPION can be 
obtained from the following equation, in which MW is the molecular weight of the organic 
molecule and NA the Avogadro number (6.023x10
23 molecules/mol): 
        
           
  
  
                   
   
 
     
            
  
           
   
  
In this way was possible to calculate the number of PNA strands on each SPION and the 
results are reported in Table 11. 
5.7.2 FTIR Characterization of 36 and 37 
FTIR spectroscopy has demonstrated to be a powerful tool to verify the effective grafting of 
organic molecules onto SPIONs. So, nanoconjugates 36 and 37 were analyzed in 
transmittance mode (blank KBr) and the spectra obtained are here reported in Figure 87 and 
Figure 88, respectively. 
In both spectra are clearly visible the main vibrational modes referred to the presence of 
PNA strands grafted onto the nanoparticle surface; in particular are shown the strong broad 
band at high wavenumber related to the FeO-H and N-H stretchings, the peaks in range 
2970-2930 cm-1 of aliphatic C-H stretchings, the strong band referred to C=O vibrational 
modes (1678 and 1658 cm-1, respectively) and the characteristic absorption of Fe-O bonds at 
low frequencies. 
Thanks to this technique we were able to confirm the effective grafting of homothymine and 
standard sequence PNAs onto SPIONs. 
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Figure 87 - FTIR spectrum of nanoconjugate 36. 
 
 
Figure 88 - FTIR spectrum of nanoconjugate 37. 
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5.7.3 UV-Vis Spectroscopy Characterization 
Naked SPIONs in diluted aqueous solution (the dilution serves to prevent the precipitation of 
nanoparticles), under UV-Vis irradiation in the range of 200-800 nm, are not able to absorb 
the incident light and, as results, scattering phenomena occur. This is clearly visible from the 
UV-VIS spectrum of naked SPIONs, reported in Figure 89a (black line), in which the 
interference scattering signal is recorded. 
 
Figure 89 - UV-Vis spectra of a) naked SPIONs (black line), b) a classical aegPNA decamer (blue line) 
and c) a SPION-PNA nanoconjugate (red line) in water. 
The classical 4 nucleobases (A, T, C and G) have a characteristic absorption at 260 nm, and 
their extinction coefficients are the following: 
 ε[260 nm] Adenine: 13.7 mM
-1cm-1; 
 ε[260 nm] Cytosine: 6.6 mM
-1cm-1; 
 ε[260 nm] Guanine: 11.7 mM
-1cm-1; 
 ε[260 nm]Thymine: 8.6 mM
-1cm-1. 
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Thus, PNAs have a strong absorption peak centered at 260 nm (Figure 89b, blue line) and 
their extinction coefficients can be calculated as the arithmetic sum of those of the 
individual bases that comprise the oligomeric chains: 
 ε[260 nm] homothymine PNA ([T]10): 86 mM
-1cm-1; 
 ε[260 nm] standard sequence PNA ([STD], GTAGATCACT): 101.78 mM
-1cm-1. 
When a strong “UV-Vis active” molecule is loaded onto the nanoparticle surface, its 
characteristic absorption peaks can be clearly visible despite of the presence of the 
nanoparticles scattering. In Figure 89c (red line), the UV-Vis spectrum of a SPION-PNA 
nanoconjugate is compared with naked SPIONs and free PNAs UV-Vis absorptions in water 
solution. A slight diagnostic bathochromic effect of 10 nm was detected when PNA 
oligomers are grafted onto SPIONs (maximum absorption at ca. 270 nm). 
PNAs 36 and 37 were so characterized by UV-Vis spectroscopy, considering that in addition 
they bear a fluorescein moiety with a strong visible absorption at about 500 nm. 
To do this, few milligrams of nanoconjugates were diluted in distilled water and the 
saturated solutions, after different cycles of vortex/sonication, were decanted for at least 
one hour leaving to precipitate the large aggregates. The upper suspensions were then 
collected for UV-Vis analysis. 
The results obtained for nanoconjugates 36 and 37, are shown in Figure 90 and 91, 
respectively. 
In both cases, beyond the scattering of nanoparticles in suspension, clearly comes out the 
absorption peak at about 270 nm typical of the PNA oligomers that, once loaded onto 
SPIONs show the bathochromic shift of ca. 10 nm; while at about 500 nm a peak related to 
the fluorescein molecule is also present. These data confirm the formation of the fluorescent 
SPION-PNA nanoconjugates. 
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Figure 90 - UV-Vis spectrum of nanoconjugate 36 in water. 
 
 
Figure 91 - UV-Vis spectrum of nanoconjugate 37 in water. 
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5.7.4 Hybridization of 36 and 37 with Complementary DNAs: 
Determination of the Melting Temperatures 
In order to evaluate the binding affinity of nanoconjugates 36 and 37 towards the 
complementary DNAs, denaturation experiments were conducted on the hybrids formed 
and melting temperature Tm were determined monitoring the variation of the absorbance 
at 260 nm against the temperature. 
PNA complexes with the corresponding complementary nucleic acid oligomers were 
constituted by mixing together stoichiometric quantities of the involved oligomers with the 
DNA strands in a pH 7 buffer of 100 mM NaCl, 10 mM sodium phosphate, 0.1 mM EDTA to 
achieve a final concentration of 2.5 μM for 37, homoadenine and standard sequence DNAs, 
while 5 μM concentration was obtained for 36 (homothymine PNA forms PNA2:DNA triplex 
with complementary DNA, so a double concentration of PNA is needed). 
The samples were annealed by first heating at 90 °C in a sand bath for 10 minutes followed 
by slow cooling to room temperature. They were then kept at room temperature for at least 
half an hour and refrigerated overnight prior to running the melting experiments. 
UV-melting experiments were carried out by a spectrophotometer connected to a Peltier 
temperature controller [for more details on the method, refereed to section 5.9.1]. The 
collected absorbance data were plotted against the temperature values and denaturation 
curves were obtained. 
Nanoconjugate 36 was so hybridized with the complementary homoadenine DNA (5’-
AAAAAAAAAA-3’) and the heating and cooling curves obtained are reported in Figure 92. 
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Figure 92 - Denaturation curves for PNA2:DNA hybrid formed between nanoconjugate 36 and 
homoadenine DNA. 
The heating curve does not present a net inflection point, maybe due to the low presence of 
triplex species in solution generated during the annealing process. Despite this, by fist 
derivative calculation a relative maximum was obtained at 61 °C. This value is lower than the 
reported one for classical homothymine PNA, equal to 72 °C [see section 5.5.1], but we have 
to consider that 36 is supported onto a metallic nanoparticle core and also bears a strong 
hydrophobic group, like fluorescein. As a consequence of this new heating cycle, the 
following cooling curve (corresponding to the formation of triplex complexes) shows a net 
inflection point at 52 °C, sign that triplex species were now effectively formed. It’s to note 
that denaturation process are characterized by hysteresis phenomenon, so the cooling curve 
always present a lower Tm respect to the heating one. 
In the same way, nanoconjugate 37 was hybridized with the complementary antiparallel 
standard sequence DNA (5’-AGTGATCTAC-3’), with the formation of duplex PNA:DNA. 
Denaturation curves are here reported in Figure 93. 
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Figure 93 - Denaturation curves for PNA:DNA hybrid formed between nanoconjugate 37 and 
antiparallel standard sequence DNA. 
Classical standard sequence PNA:DNA hybrid has a Tm of 53 °C [see section 5.5.1], value that 
was confirmed by the denaturation of the duplex formed between 37 and its 
complementary DNA. In fact, from the heating curves was possible to obtain a Tm of 51 °C, 
an outstanding results if consider that 37 is grafted onto SPION surface and bear a 
fluorescein probe. Cooling curve was also recorded obtaining an inflection point at 50 °C, 
further confirming the formation of duplex species. 
5.7.5 Conclusions 
Concerning the synthesis of new fluorescent SPION-PNA nanoconjugates, we can conclude 
that an efficient synthetic protocol for the synthesis of this new class of nanocompounds 
was set up. Two new supported PNAs, 36 and 37, were synthesized and characterized 
confirming the grafting by a non-covalent interaction between a succinic linker and the 
nanoparticle surface, while a lysine residue can be efficiently used to bind different kind of 
probes, such as fluorescein, directly with SPS. 
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Denaturation experiments were performed on 36 and 37, with formation of the 
corresponding PNA2:DNA and PNA:DNA hybrids, respectively. The Tm values obtained are 
very encouraging, if we consider that strong binding affinity were obtained regardless of the 
presence of a strong hydrophobic fluorescent probe and despite the anchoring onto SPIONs. 
5.8 Synthesis of New SPION-PNA Nanoconjugates 
Exploiting NCO-based Heterobifunctional Linkers 
In section 5.7, we have just seen how PNAs can be easily modified introducing during SPS 
amino acid residues, linkers or probes, as well as how these oligomers can be grafted by a 
non-covalent interaction onto a nanoparticle surface. 
Having established the easy anchoring of isocyanate onto the SPIONs surface and having 
demonstrated that simple properly orthogonal functionalized NCO-based molecules can be 
efficiently used as heterobifunctional linkers [see section 4.2], we decided to use this new 
anchoring methodology in the synthesis of new SPION-PNA nanoconjugates. 
So, in this Ph.D. research project the N-terminus cysteine modified homothymine and 
standard sequence PNA oligomers were supported onto functionalized nanoparticles 20 [see 
section 4.4], in order to obtained the two new NCO-based SPION-PNA nanoconjugates 45 
and 46 (Figure 94). 
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Figure 94 - New NCO-based SPION-PNA nanoconjugates 45 and 46. Are also shown the structures of 
the starting functionalized nanoparticles 20 and of the N(α)-Boc-S-tbutylmercapto cysteine. 
PNA oligomers were so synthesized as reported in Scheme 17. 
The MBHA resin was manually downloaded with the thymine monomer in order to obtain 
the functionalized resin 47 with a final loading of 0.2 mmol/g. Always by manual SPS, the 
other PNA monomers were cyclically coupled following the Boc-deprotection, coupling and 
capping steps, till the desired oligomers were obtained. Boc-deprotection of the N-terminus, 
coupling with N(α)-Boc-S-tbutylmercapto cysteine and capping of the unreacted chains, 
followed by total cleavage from the resin led to the desired modified PNAs 48 and 49. 
Thanks to the strong acidic condition of the cleavage step, the removal of cysteine 
protecting groups was simultaneously achieved, obtaining the free thiol group necessary for 
Michael addition on the maleimido moiety of nanoconjugate 20. Finally, PNAs 48 and 49 
were supported onto SPIONs 20 by formation of a covalent C-S bond, affording the two new 
nanoconjugates 45 and 46 that were isolated and characterized by E.A., FTIR and UV-Vis 
spectroscopy to confirm the grafting of the oligomers onto the nanoparticles surface. 
Furthermore, to check the ability of 45 and 46 to recognize and bind complementary DNAs, 
the melting temperature Tm of the hybrids formed were determined. 
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Scheme 17 - Synthesis of new NCO-based SPION-PNA nanoconjugates 45 and 46. 
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5.8.1 Determination of the Final Loading of Nanoconjugate 45 
and 46 
As previously mentioned in section 5.7.1, E.A. were conducted on nanoconjugates 45 and 46 
and the corresponding loadings were determined (Table 12). 
Nanoconjugate 
Loading 
Tot % org mmol/gNPs N°molecules/NP 
45 54.33 0.18 ≈ 610 
46 34.65 0.11 ≈ 270 
 
Table 12 - Loading of nanoconjugates 45 and 46. 
The high loading value of the starting nanoconjugate 20 (31.07%, equal to 1.44 mmol/gNPs) 
permits to efficiently graft a higher number of molecules per nanoparticle than those 
obtained for nanoconjugates 36 and 37, in which a direct non-covalent adsorption onto the 
nanoparticle surface occurs. 
So, having demonstrated the possibility to easily tune the loading of the NCO-based 
heterobifunctional linker onto the SPIONs surface, we can also easily modulate the amount 
of bioactive molecules covalently bonded to the linker. 
5.8.2 FTIR Characterization of 45 and 46 
In order to confirm the grafting of PNA oligomers onto SPIONs, nanoconjugates 45 and 46 
were analyzed by FTIR in transmittance mode (blank KBr) and the spectra obtained are here 
reported in Figure 95 and Figure 96, respectively. 
In both spectra, at high wavenumbers, are present the broad vibrational band corresponding 
to FeO-H and N-H stretchings and the aromatic and aliphatic C-H stretching modes. Classical 
strong bands at low frequency values (in the range 640-550 cm-1, υ Fe-O) confirm the 
presence of the iron oxide core. 
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In the case of homothymine PNA (Figure 95), the strong broad band at 1674 cm-1 
corresponds to all the stretching modes of carbonyl groups, as amides, imides and 
carbamate. Also C-O and C-N stretching peaks are well visible at 1227-1101 cm-1. 
 
Figure 95 - FTIR spectrum of nanoconjugate 45. 
 
For supported standard sequence PNA (Figure 96), a partially covered peak related to the 
C=O of the imide moieties (1710 cm-1) comes out from the broad band related to the amides 
and the carbamate C=O groups (1644 cm-1). Thanks to the presence of all the four 
nucleobases in the sequence, and consequently thanks to the higher number of C-O, C-N, 
C=C and aromatic C-H groups, nanoconjugate 46 shows, with higher intensity, the classical 
vibrational modes referred to these kind of bonds. 
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Figure 96 - FTIR spectrum of nanoconjugate 46. 
From these results we can state that the N-terminus cysteine PNAs 48 and 49 have 
effectively reacted with the functionalized nanoparticles 20, affording the desired 
nanoconjugates 45 and 46. 
5.8.3 UV-Vis Spectroscopy Characterization 
In section 5.7.3, we have clearly seen how SPION-PNA nanoconjugates can be easily 
characterized by UV-Vis spectroscopy thanks to the presence of the strong absorption of the 
nucleobases. 
As done for nanoconjugates 36 and 37, the UV-Vis absorption spectra in water of the new 
SPION-PNA nanosystems 45 and 46 were recorded (Figure 97 and 98, respectively). 
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Figure 97 - UV-Vis spectrum of nanoconjugate 45 in water. 
 
 
Figure 98 - UV-Vis spectrum of nanoconjugate 46 in water. 
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Both spectra clearly show the strong absorption peak of PNA strands grafted onto SPIONs at 
about 270 nm, while from 320 nm the broad shouldered scattering of the nanoparticles is 
present. The scattering phenomena, together with the bathochromic shift of the PNA 
absorption peak, confirmed also in these cases, the presence of the PNA oligomers onto the 
SPION surface. 
5.8.4 Hybridization of 45 and 46 with Complementary DNAs: 
Determination of the Melting Temperatures 
As previously done for nanoconjugates 36 and 37, the binding affinity of nanoconjugates 45 
and 46 towards the complementary DNAs was evaluated by denaturation experiments and 
melting temperature Tm were determined monitoring the variation of the absorbance at 
260 nm against the temperature. 
PNA2:DNA (for the homothymine sequence) and PNA:DNA complexes were prepared as 
previously explained and UV-melting experiments were carried out, collecting absorbance 
data against the temperature variations. 
Nanoconjugate 45 was so hybridized with the complementary homoadenine DNA (5’-
AAAAAAAAAA-3’) and the heating and cooling curves obtained are reported in Figure 99. 
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Figure 99 - Denaturation curves for PNA2:DNA hybrid formed between nanoconjugate 45 and 
homoadenine DNA. 
The heating curve shows an inflection point at 70 °C, that perfectly matches the reported 
value for classical homothymine PNA, equal to 72 °C [see section 5.5.1]; the following cooling 
curve also present a net inflection point at 52 °C. As stated, the denaturation process are 
characterized by hysteresis phenomenon, so the cooling curve always present a lower Tm 
respect to the heating one, but the presence of the inflection point during the cooling 
process is the confirmation that effectively 45 is able to recognize the complementary DNA. 
In the same way, nanoconjugate 46 was hybridized with the complementary antiparallel 
standard sequence DNA (5’-AGTGATCTAC-3’), with the formation of duplex PNA:DNA. 
Denaturation curves are here reported in Figure 100. 
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Figure 100 - Denaturation curves for PNA:DNA hybrid formed between nanoconjugate 37 and 
antiparallel standard sequence DNA. 
Classical standard sequence PNA:DNA hybrid has a Tm of 53 °C [see section 5.5.1], value that 
was confirmed by the denaturation of the duplex formed between 46 and its 
complementary DNA. In fact, from the heating curves was possible to obtain a Tm of 54 °C, 
an outstanding results if consider that 46 is covalently anchored onto nanoparticles surface. 
Cooling curve was also recorded obtaining an inflection point at 52 °C, further confirming the 
formation of duplex species. 
5.8.5 Conclusions 
Concerning the use new NCO-based heterobifunctional linkers, we have demonstrated that 
properly modified PNA can be efficiently loaded onto functionalized SPION. So, two new 
covalently supported PNAs, 45 and 46, were synthesized and characterized.  
Denaturation experiments were performed on 45 and 46, with formation of the 
corresponding PNA2:DNA and PNA:DNA hybrids, respectively. The Tm values obtained 
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confirm the strong affinity binding capacity of these nanoconjugates towards the 
complementary DNAs, regardless of the presence of nanoparticles. 
5.9 Experimental Section 
5.9.1 Materials and Methods 
All reagents and solvents were purchased in higher grade from commercial suppliers and 
used without further purification, unless otherwise stated. Dry solvents over molecular 
sieves, solvents for peptide synthesis and HPLC solvents (P.A., ACS reagent or Chromasolve 
Grade) were obtained from Sigma Aldrich. 
γ-Fe2O3 SPIONs were purchased from Alpha Aesar and stored away from moisture. 
The Boc-aegPNA-OH monomers were purchased from ASM Research Chemicals; Boc-aegT-
OH monomer can be also prepared as reported in literature. 
The complementary DNA oligonucleotides were purchased from Primm Srl. 
All weightings of reagents were carried out with analytical balance Mettler Toledo AB135-
S/FACT. 
Vials ALLTECH of 1.5 ml, 4 ml, 8 ml, 25 ml and 50 ml with frits of PTFE were used as reactor 
for manual solid phase synthesis. Automated solid phase syntheses were performed with 
peptide synthesizer “ABI 433A” of Applera Italia, according to Applied Biosystems ABI 433A 
Peptide Synthesis 3 mL Reaction Vessel User’s Manual for the MBHA (4-
methylbenzhydrylamine hydrochloride salt) resin. The software for peptide synthesis is 
Syntassist 2.0, installed on the PC unit linked to the synthesizer. 
Commercially available MBHA resin (VWR International) with a 0.63 mmol/g loading, was 
downloaded to 0.2 mmol/g with the proper amino acid (e.g. N(α)-Boc-N(ε)-Fmoc-L-lysine, 
MBHA resin 38) or PNA monomer (e.g. Boc-aegT-OH, MBHA resin 47) following the 
procedure recommended on the ABI 433A instrument manual, as follow: 
1. Wash 1.0 g MBHA resin twice in DCM. 
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2. Wash the resin with 5% DIPEA in DCM for 3 minutes. 
3. Wash the resin twice in DCM. The resin is now neutralized. 
4. Dissolve 0.20 mmol (amino acid or PNA monomer) in 2.5 ml NMP. 
5. Add 0.4 mmol DIPEA to the monomer solution. 
6. Dissolve 75 mg (0.19 mmol) HBTU in 2.5 ml NMP, and add this to the 
monomer solution. 
7. Activate the monomer for 2 minutes. 
8. Add the activated monomer solution to the neutralized resin. 
9. Allow the reaction to proceed for at least 1 hour. 
10. Filter the resin. 
11. Wash the resin with 1xNMP. 
12. Prepare 50 ml of capping solution using a 1:2:2 ratio of acetic anhydride, 
pyridine and NMP. 
13. Add the capping solution to the resin and allow the reaction to proceed for 1 
hour. Successful capping will produce a negative Kaiser test. 
14. Wash the resin with DMF. 
15. Wash the resin with 4xDCM. 
16. Wash the resin with 5% DIPEA in DCM. 
17. Wash the resin with 4xDCM. 
18. Dry the resin in vacuum. 
The cleavage procedure to remove PNA oligomers from the MBHA resin is the following: 
1. Wash the resin 2xTFA. 
2. Make 1 ml of cleavage solution TFA/TFMSA/m-cresol/thioanisole 6:2:1:1. 
3. Add the cleavage solution to the resin and allow the reaction to proceed for 1 
hour on a orbital shaker. 
4. Filter the resin and recover the solution in a centrifuge tube. 
5. Wash the resin with TFA. 
6. Filter the resin and add this solution to the one recovered at point 4. 
7. Repeat point 5 and 6 three times. 
  Chapter 5: New SPION-PNA Nanoconjugates 
 
237 
 
8. Remove volatiles by nitrogen stream to afford a black/brown oil. 
9. Add cold diethyl ether to the tube and mix. A white precipitate forms. 
10. Put the tube at -20 °C for 1 hour to complete the precipitation. 
11. Centrifuge and remove the supernatant. 
12. Wash the solid with fresh ether, mix, centrifuge and remove the solution. 
13. Repeat point  12 four/five times. 
14. Dry the crude PNA first by nitrogen stream and then in vacuum. 
HPLC of PNA oligomers were performed with a HPLC AGILENT 1100 Series, using an 
analytical column DISCOVERY® BIO WIDE PORE C18 (15 cm x 4.6 mm, 5 μm) and a semi-
preparative column DISCOVERY® BIO WIDE PORE C18 (25 cm x 10 mm, 10 μm). 
MALDI-TOF spectra were recorded with a Bruker Daltonics Omniflex. A pulsed nitrogen laser 
(337 nm) were used to generate ions that have been accelerated in a 20 kV field. The 
instrument was calibrated in the range from 0 to 20 KDa. Generally, sinapinic acid and 2,5-
dihydroxybenzoic acid (DHB) matrixes were used. 
A lyophilizer Telstar Cryodos were used to isolate pure PNA oligomers from aqueous 
solutions. 
To dry the nanoparticles was used a rotating vacuum dryer from Büchi. Once dried, the 
nanoparticles are stored in a desiccator filled with anhydrous salts. 
A sonicator Elma Elmasonic S 30H was used to perform reactions with nanoparticles. 
UV-Visible spectrophotometer Thermo Electron Corporation “Evolution 500” was used to 
analyze PNA oligomers and SPION-PNA nanoconjugates in water. The concentration of the 
PNA oligomers was calculated based on their absorption at 260nm. 
Elemental Analysis were performed in the division of Inorganic, Metallorganic and Analytical 
Chemistry, from the Department of Chemistry in the University of Milan with a Perkin Elmer 
instrument. 
Infrared spectra of nanoconjugates were acquired on a Spectrum One FTIR 
spectrophotometer (Perkin Elmer) in the range 4000-450 cm-1 in transmittance mode. 0.5 
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mg of nanoparticles were diluted in 150 mg FTIR grade KBr and ground in an agate mortar. 
KBr was previously dried at 125°C under vacuum. Then mixed powder was pressed at 9 tons 
for 3 min to obtain slim semitransparent tablet. Spectra were recorded selecting 64 scans 
and 4 cm-1 resolution. The background of pure KBr was separately recorded using the same 
conditions and automatically subtracted from sample spectra. These analysis were 
performed in collaboration with the Professor Stradi’s reaserch group in the Laboratory of 
Instrumental Analysis of the division of Organic Chemistry “A. Marchesini”, Department of 
Pharmaceutical Science in University of Milan. 
UV-melting experiments were carried out by a Peltier Agilent 9090A connected to a 
spectrophotometer Agilent 8453. The absorbance at 260 nm was recorded following this 
protocol: from 19.5 °C to 20 °C (2’ hold time), from 20 °C to 94 °C (1 °C per 0.2’ hold time), 
from 94 °C to 95 °C (4’ hold time) and then 95 °C to 20 °C (-1 °C per 0.2’ hold time). The Tm 
of the PNA2:DNA and PNA:DNA complexes was automatically calculated by the 
“Denaturation Program” installed in the PC unit connected to the instrument, as the 
inflection point of the heating and cooling curves in the plot of absorbance vs temperature. 
5.9.2 Experimental Procedures 
5.9.2.1 Synthesis of Amino-aeg[T]10-Lys(Fmoc)-MBHA Resin, Trifluoroacetic 
Salt 39 
Starting from the downloaded Lys(Fmoc)-MBHA resin 38, automated solid phase synthesis 
with Boc-strategy was performed in order to obtain the supported homothymine PNA 
decamer 39. A control cleavage was done on a small amount of the resin, to check the 
formation of the desired product. HPLC (reverse phase): retention time 20.90 min, elution 
gradient from water (+ 0.1% TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 3028.9 [M] 
(calculated 3028.97). 
 
5.9.2.2 Synthesis of N-succinylamide-aeg[T]10-Lys(Fmoc)-MBHA Resin 41 
After neutralization of supported PNA 39 with DIPEA 5% in DCM, succinic anhydride (20 eq 
respect to the theoretical free amino groups) dissolved in 1 ml of NMP was added to the 
resin and left under vigorous shaking for 4 hours. The resin was then washed with 9xNMP 
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and 5xDCM, affording the succinic modified homothymine PNA decamer 41. A control 
cleavage was done on a small amount of the resin, to check the formation of the desired 
product. HPLC (reverse phase): retention time 20.92 min, elution gradient from water (+ 
0.1% TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 3130.1 [M] (calculated 3130.05). 
 
5.9.2.3 Synthesis of N-succinylamide-aeg[T]10-Lys(FITU)-CONH2 Decamer 43 
Fmoc-deprotection of 41 was achieved washing the resin with 20% piperidine in DMF (3x2 
ml, 5’ shaking each time). After deprotection, the resin was washed with 5xDMF and then 
treated with a fluorescein isothiocyanate (FITC) solution in DMF (4 eq respect to the 
theoretical free lysine amino groups) and DIPEA (8 eq) and left overnight at the orbital 
shaker. The resin was so washed with 5xDMF and 5xDCM, affording the supported desired 
PNA oligomer. A control cleavage was done on a small amount of the resin, to check the 
formation of 43. Having confirmed the formation of the product, total cleavage and 
semipreparative HPLC on reverse phase were done, affording 43 as a yellow fluorescent 
solid. HPLC (reverse phase): retention time 8.22 min, elution gradient from water (+ 0.1% 
TFA)/AcN 80:20 to pure AcN in 80 min. MALDI-TOF: 3298.2 [M] (calculated 3299.20). 
 
5.9.2.4 Synthesis of NP-succinylamide-aeg[T]10-Lys(FITU)-CONH2 SPION-PNA 
Nanoconjugate 36 
The modified fluorescent homothymine PNA 43 (16 mg, 0.005 mmol) was added to a 
suspension of naked SPIONs (16 mg) in dry PhCH3 (5 ml), previously sonicated at 40 °C for 
30’; the mixture was stirred, under sonication, at 40 °C for 4 h. After this time the obtained 
suspension was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The 
solid residue was first washed with fresh PhCH3 (3x5 ml), then with MeOH (2x5 ml) and at 
last with Et2O (3x5 ml) and vortex/sonication/centrifugation were cyclic repeated for each 
washing. Functionalized NPs were dried on air for a night and then in a rotating vacuum drier 
for a day, to afford 36 (20 mg) as a light brown powder. Loadings from E.A.: 14.08% (equal 
to 0.043 mmol/gNPs, ≈80 molecules/NP). FTIR (cm
-1) in trasmittance (blank KBr): 3401 (υ, 
FeO-H and N-H), 2962-2931 (υ, aliphatic C-H), 1679 (broad υ, C=O imides, amides and 
carboxylate), 1457, 1385, 1208-1141 (υ, C-O and C-N), 842-803 (δ, C-H), 633-584 (υ, Fe-O). 
UV-Vis (λmax, nm) in water: 269 (PNA), 498 (fluorescein). Tm (complementary homoadenine 
DNA) in water at 260 nm: 61 °C (heating), 52° C (cooling). 
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5.9.2.5 Synthesis of Amino-aeg[STD]-Lys(Fmoc)-MBHA Resin, Trifluoroacetic 
Salt 40 
Starting from the downloaded Lys(Fmoc)-MBHA resin 38, automated solid phase synthesis 
with Boc-strategy was performed in order to obtain the supported homothymine PNA 
decamer 40. A control cleavage was done on a small amount of the resin, to check the 
formation of the desired product. HPLC (reverse phase): retention time 19.07 min, elution 
gradient from water (+ 0.1% TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 3077.7 [M] 
(calculated 3077.02). 
 
5.9.2.6 Synthesis of N-succinylamide-aeg[STD]-Lys(Fmoc)-MBHA Resin 42 
After neutralization of supported PNA 40 with DIPEA 5% in DCM, succinic anhydride (20 eq 
respect to the theoretical free amino groups) dissolved in 1 ml of NMP was added to the 
resin and left under vigorous shaking for 4 hours. The resin was then washed with 9xNMP 
and 5xDCM, affording the succinic modified standard sequence PNA decamer 42. A control 
cleavage was done on a small amount of the resin, to check the formation of the desired 
product. HPLC (reverse phase): retention time 19.45 min, elution gradient from water (+ 
0.1% TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 3177.3 [M] (calculated 3177.09). 
 
5.9.2.7 Synthesis of N-succinylamide-aeg[STD]-Lys(FITU)-CONH2 Decamer 
44 
Fmoc-deprotection of 42 was achieved washing the resin with 20% piperidine in DMF (3x2 
ml, 5’ shaking each time). After deprotection, the resin was washed with 5xDMF and then 
treated with a fluorescein isothiocyanate (FITC) solution in DMF (4 eq respect to the 
theoretical free lysine amino groups) and DIPEA (8 eq) and left overnight at the orbital 
shaker. The resin was so washed with 5xDMF and 5xDCM, affording the supported desired 
PNA oligomer. A control cleavage was done on a small amount of the resin, to check the 
formation of 44. Having confirmed the formation of the product, total cleavage and 
semipreparative HPLC on reverse phase were done, affording 44 as a yellow fluorescent 
solid. HPLC (reverse phase): retention time 15.40 min, elution gradient from water (+ 0.1% 
TFA)/AcN 80:20 to pure AcN in 80 min. MALDI-TOF: 3345.1 [M] (calculated 3346.22). 
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5.9.2.8 Synthesis of NP-succinylamide-aeg[STD]-Lys(FITU)-CONH2 SPION-
PNA Nanoconjugate 37 
The modified fluorescent standard sequence PNA 44 (26 mg, 0.008 mmol) was added to a 
suspension of naked SPIONs (26 mg) in dry PhCH3 (5 ml), previously sonicated at 40 °C for 
30’; the mixture was stirred, under sonication, at 40 °C for 4 h. After this time the obtained 
suspension was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The 
solid residue was first washed with fresh PhCH3 (3x5 ml), then with MeOH (2x5 ml) and at 
last with Et2O (3x5 ml) and vortex/sonication/centrifugation were cyclic repeated for each 
washing. Functionalized NPs were dried on air for a night and then in a rotating vacuum drier 
for a day, to afford 37 (36 mg) as a light brown powder. Loadings from E.A.: 26.78% (equal 
to 0.080 mmol/gNPs, ≈170 molecules/NP). FTIR (cm
-1) in trasmittance (blank KBr): 3208 (υ, 
FeO-H and N-H), 2930 (υ, aliphatic C-H), 1658 (broad υ, C=O imides, amides and 
carboxylate), 1504, 1473, 1416, 1253, 1227-1172 (υ, C-O and C-N), 1030, 633-584 (υ, Fe-O). 
UV-Vis (λmax, nm) in water: 267 (PNA), 498 (fluorescein). Tm (complementary STD sequance 
DNA) in water at 260 nm: 51 °C (heating), 50° C (cooling). 
 
5.9.2.9 Synthesis of N-cysteine-aeg[T]10-CONH2, Trifluoroacetic Salt 48 
Starting from the downloaded Boc-aegT-MBHA resin 47, manual solid phase synthesis with 
Boc-strategy was performed in order to obtain the corresponding supported homothymine 
PNA decamer. Control cleavages were done during the synthesis on a small amount of the 
resin, to check the formation of the desired 4-mer, 7-mer and finally 10-mer products. After 
Boc-deprotection of the N-terminus, N(α)-Boc-S-tbutylmercapto cysteine (5 eq respect to the 
theoretical free amino groups), was coupled whit the supported decamer in presence of 
HBTU and DIPEA in NMP solution, following the same protocol used for automated SPS of 
PNA. After capping of all the unreacted chains (negative Kaiser test), a cleavage control was 
done to check the formation of the desired product. Having confirmed the formation of 48, 
total cleavage from the resin led to the desired cysteine modified homothymine PNA 
decamer. Semipreparative HPLC on reverse phase led to pure 48 (15 mg) as a white solid. 
HPLC (reverse phase): retention time 8.78 min, elution gradient from water (+ 0.1% 
TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 2782.0 [M] (calculated 2782.71). 
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5.9.2.10 Synthesis of NP-[N-(p-phenylcarbamate)-2,5-dioxopyrrolidin-3-yl]-
cysteine-aeg[T]10-CONH2, Trifluoroacetic salt, SPION-PNA 
Nanoconjugate 45 
The modified cysteine homothymine PNA 48 (15 mg, 0.005 mmol, 1 eq) was added to a 
suspension of functionalized SPIONs 20 (15 mg, loading 31.07%, equal to 1.44 mmol/gNPs, 
0.022 mmol of organic, 4.3 eq) in dry AcN (5 ml), previously sonicated at 40 °C for 30’; the 
mixture was stirred, under sonication, at 40 °C for 4 h. After this time the obtained 
suspension was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The 
solid residue was first washed with fresh AcN (3x5 ml), then with water (2x5 ml), acetone 
(2x5 ml), at last with Et2O (3x5 ml) and vortex/sonication/centrifugation were cyclic repeated 
for each washing. Functionalized NPs were dried on air for a night and then in a rotating 
vacuum drier for a day, to afford 45 (18 mg) as a light brown powder. Loadings from E.A.: 
54.33% (equal to 0.18 mmol/gNPs, ≈610 molecules/NP). FTIR (cm
-1) in trasmittance (blank 
KBr): 3417 (broad υ, FeO-H and N-H), 3063 (partially covered υ, ArC-H), 2955 (partially 
covered υ, aliphatic C-H), 1674 (broad υ, C=O imides, amides, carbamate), 1547 (δ, N-H), 
1473, 1416, 1377 (υ, Ar-N), 1358, 1253, 1227-1101 (υ, C-O and C-N), 1032 (δ, ArC-H), 638-
565 (υ, Fe-O). UV-Vis (λmax, nm) in water: 271 (PNA), from 320 broad shouldered scattering 
of NPs. Tm (complementary standard DNA) in water at 260 nm: 70 °C (heating), 52° C 
(cooling). 
 
5.9.2.11 Synthesis of N-cysteine-aeg[STD]-CONH2, Trifluoroacetic Salt 49 
Starting from the downloaded Boc-aegT-MBHA resin 47, manual solid phase synthesis with 
Boc-strategy was performed in order to obtain the corresponding supported standard 
sequence PNA decamer. Control cleavages were done during the synthesis on a small 
amount of the resin, to check the formation of the desired 4-mer, 7-mer and finally 10-mer 
products. After Boc-deprotection of the N-terminus, N(α)-Boc-S-tbutylmercapto cysteine (5 
eq respect to the theoretical free amino groups), was coupled whit the supported decamer 
in presence of HBTU and DIPEA in NMP solution, following the same protocol used for 
automated SPS of PNA. After capping of all the unreacted chains (negative Kaiser test), a 
cleavage control was done to check the formation of the desired product. Having confirmed 
the formation of 49, total cleavage from the resin led to the desired cysteine modified 
standard sequence PNA decamer. Semipreparative HPLC on reverse phase led to pure 49 (20 
mg) as a white solid. HPLC (reverse phase): retention time 7.23 min, elution gradient from 
water (+ 0.1% TFA)/AcN 95:5 to pure AcN in 60 min. MALDI-TOF: 2831.0 [M] (calculated 
2830.76). 
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5.9.2.12 Synthesis of NP-[N-(p-phenylcarbamate)-2,5-dioxopyrrolidin-3-yl]-
cysteine-aeg[STD]-CONH2, Trifluoroacetic salt, SPION-PNA 
Nanoconjugate 46 
The modified cysteine standard sequence PNA 49 (15 mg, 0.005 mmol, 1 eq) was added to a 
suspension of functionalized SPIONs 20 (15 mg, loading 31.07%, equal to 1.44 mmol/gNPs, 
0.022 mmol of organic, 4.3 eq) in dry AcN (5 ml), previously sonicated at 40 °C for 30’; the 
mixture was stirred, under sonication, at 40 °C for 4 h. After this time the obtained 
suspension was centrifugated at 5000 r/min for 10’ and the supernatant was removed. The 
solid residue was first washed with fresh AcN (3x5 ml), then with water (2x5 ml), acetone 
(2x5 ml), at last with Et2O (3x5 ml) and vortex/sonication/centrifugation were cyclic repeated 
for each washing. Functionalized NPs were dried on air for a night and then in a rotating 
vacuum drier for a day, to afford 46 (17 mg) as a light brown powder. Loadings from E.A.: 
34.65% (equal to 0.11 mmol/gNPs, ≈270 molecules/NP). FTIR (cm
-1) in trasmittance (blank 
KBr): 3435 (broad υ, FeO-H and N-H, partially covered ArC-H), 2917 (partially covered υ, 
aliphatic C-H), 1710 (partially covered υ, C=O imides), 1644 (broad υ, C=O amides and 
carbamate), 1545 (δ, N-H), 1512 (υ, C=C), 1401 (υ, Ar-N), 1259-1033 (υ, C-O and C-N), 837 (δ, 
ArC-H), 640-580 (υ, Fe-O). UV-Vis (λmax, nm) in water: 267 (PNA), from 320 broad 
shouldered scattering of NPs. Tm (complementary standard DNA) in water at 260 nm: 54 °C 
(heating), 52° C (cooling). 
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Chapter 6: 
Final Conclusions 
 
6 Conclusions 
In this Ph.D. thesis a systematic study concerning the surface modification of 
superparamagnetic iron oxide nanoparticles, is reported. 
In particular, after a brief introduction on the classical techniques currently employed, the 
discovery of a new covalent grafting methodology based on the reactivity of isocyanate 
group towards the surface hydroxyl groups of the nanoparticles, is shown. 
In order to demonstrate this innovative anchoring system, a small library of isocyanate-base 
nanoconjugates has been synthesized (15-20). Analytical and spectroscopical 
characterizations helped us to point out the effective formation of a covalent carbamate-like 
bond between a generic isocyanate molecule and the SPIONs surface. 
From E.A., the loadings of the obtained nanoconjugates can be determined. Comparing 
these values with those obtained in classical non-covalent and siloxane-based covalent 
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interaction, we can state that the presented methodologies led to higher and easily tunable 
loading respect to the classical methodologies. 
FTIR spectroscopy has demonstrated to be the choice technique for the characterization of 
these kind of nanosystems, giving many information about the nature of the surface 
grafting. 
A first approach in the characterization of these nanoconjugates with HR-MAS NMR 
spectroscopy was also accomplished, confirming the validity and versatility of this analytical 
tool in the determination of the structure of organic molecules loaded onto magnetic 
metallic core. Preliminary DOSY experiments were also performed. 
Some of the nanoconjugates bear different additional functional groups (18-20), those have 
been demonstrated to be stable in the grafting reaction conditions, while remains still 
reactive for the binding of other organic molecules (27, 28, 34, 35). 
Thus, properly functionalized isocyanates could be used as heterobifunctional linkers for the 
supporting of biomolecules onto SPIONs, opening new strategies for the synthesis of a new 
class of bionanoconjugates. 
From several years, our research group has gained a lot of expertise in the synthesis and 
characterization of Peptide Nucleic Acids (PNAs) and a small library of SPION-PNA 
nanoconjugates has been obtained. 
In this research work, four new SPION-PNA nanoconjugates have been designed and 
synthesized (36, 37, 45, 46). 
36 and 37 are characterized by the presence of a fluorescent probe and have been loaded 
onto the nanoparticle surface by a carboxylate-base non-covalent interaction, while 45 and 
46 were obtained by a covalent C-S bond formation between the properly modified PNAs 
and the NCO-based functionalize SPIONs 20. 
All these SPIONS-PNA nanoconjugates have shown a strong affinity binding towards the 
complementary DNA strands, regardless of the presence of the magnetic nanoparticles., 
opening the possibility to use these systems in theranostic fields. 
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6.1 Future Perspectives 
In this Ph.D. research work, lots of work have been done concerning the surface 
functionalization of SPIONs, but much more work remains to be done. 
In particular, we want to expand the library of NCO-based heterobifunctional linkers 
introducing different additional functional groups, as well as, introducing properly spacers 
able to modify the chemo-physical behavior of the functionalized nanoparticles, e.g. 
increasing the water solubility or, otherwise, the hydrophobicity of the systems or tuning the 
steric hindrance on the surface. 
For biological applications, the toxicity and the possible interactions with proteins, enzymes 
or oligonucleotides have to be studied, as well as, their cellular up take and biodistribution. 
In this sense, we have recently started a profitable collaboration with Prof. Seneci’s research 
group of the Dept. of Chemistry, University of Milan, with the aim to support apoptosis 
inhibitors mimics onto SPIONs and to study their bioactivity. Biological studies will be 
performed in collaboration with the National Institute of Tumors (INT) in Milan. Only 
preliminary results were obtained and for this reason are not here reported. 
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A: Adenine 
Ac: Acetyl 
Ac2O: Acetic anhydride 
AcN: Acetonitrile 
AcOEt: Ethyl acetate 
aeg: Aminoethylglycine 
aeg[STD]-PNA: Aminoethylglycine standard sequence PNA 
aeg[T]10-PNA: Aminoethylglycine homothymine PNA 
AOT: Aerosol OT or dioctyl sodium sulfosuccinate 
APDES: 3-Aminopropyl-ethyl-diethoxysilane 
APES: 3-Aminopropyl-diethyl-ethoxysilane 
APTES: 3-Aminopropyl-triethoxysilane 
BIA: Biomolecular Interaction Analysis  
Boc: tert-Butyloxycarbonyl 
Boc-aegPNA-OH: N(Boc)-aminoethylglycine PNA monomer, carboxylic acid 
Boc-Lys(Fmoc)-OH: N(α)Boc-N(ε)Fmoc-lysine, carboxylic acid 
C: Cytosine 
Cbz: Benzyloxycarbonyl 
CDCl3: Deuterated chloroform 
COSY: Correlation spectroscopy 
CTAB: Cetyltrimethylammonium bromide 
Cys: Cysteine 
D: Diffusion coefficient 
DCM: Dichloromethane 
DMF: Dimethylformamide 
DMSO: Dimethylsulfoxide 
DMSO-d6: Deuterated dimethylsulfoxide 
DNA: Deoxyribonucleic acid 
DOSY: Diffusion ordered NMR spectroscopy 
DPPA: Diphenylphosphoryl azide 
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DSC: Differential scanning calorimetry 
E.A.: Elemental analysis 
EDTA: Ethylenediaminotetraacetic acid 
Et2O: Diethyl ether 
FAB: Fast atom bombardment 
FG: Functional group 
FITC: Fluorescein isothiocyanate 
FITU: Fluorescein isothiourea 
Fmoc: 9-Fluorenylmethoxycarbonyl 
FTIR: Fourier transform infrared spectroscopy 
G: Guanine 
HATU: O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate 
HBTU: O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate 
HPLC: High performance liquid chromatography 
HR-MAS: High resolution magic angle spinning 
HSQC: Heteronuclear single quantum correlation 
IE.P.: Isoelectric point 
IMS: Immune magnetic separation 
LED: Longitudinal eddy current delay or Longitudinal encode-
decode 
Lys: Lysine 
MALDI-TOF: Matrix assisted laser desorption ionization – Time of flight 
MBHA: 4-Methylbenzhydrylamine hydrochloride salt 
MDT: Magnetic drug targeting 
MFH: Magnetic fluid hyperthermia 
MNP: Magnetic nanoparticle 
Mp: Melting point 
MPS: Mononuclear phagocytosis system 
MRI: Magnetic resonance imaging 
mRNA: Messenger ribonucleic acid 
MS: Mass spectroscopy 
N-Ac-Cys-OH: N-Acetylcysteine, carboxylic acid 
N-Boc-Cys(StBu)-OH: N(α)-Boc-S-tbutylmercapto cysteine 
NCO: Isocyanate 
NMP: N-Methylpirrolidone 
NMR: Nuclear magnetic resonance 
NP: Nanoparticle 
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PABA: p-Aminobenzoic acid 
PCR: Polymerase chain reaction 
PFG: Pulse field gradient 
PhCH3: Toluene 
PMBA: p-Maleimidobenzoic acid 
PMB-Cl: p-Maleimidobenzoyl chloride 
PMP-AZIDE: p-Maleimidobenzoyl azide 
PMPI: p-Maleimidophenyl isocyanate 
PNA: Peptide nucleic acid 
PVP: Polyvinylpyrrolidone 
Py: Pyridine 
QCM: Quartz Crystal Microbalance  
REE: Rare earth element 
RES: Reticulendothelial system 
RNA: Ribonucleic acid 
SNP: Single nucleotide polymorphism 
SPION: Superparamagnetic iron oxide nanoparticle 
SPR: Surface Plasmon resonance 
SPS: Solid phase synthesis 
T: Thymine 
TB: Blocking temperature 
TEA: Triethylamine 
TEOS: Tetraethoxysilane 
TESPI: 3-(triethoxysylil)propyl isocyanate 
TFA: Trifluoroacetic acid 
TFMSA: Trifluoromethanesulfonic acid 
THF: Tetrahydrofuran 
Tm: Melting temperature 
TN: Néel temperature 
TOPO: Trioctylphosphine oxide 
USPIO: Ultrasmall superparamagnetic iron oxide nanoparticle 
UV-Vis: Ultraviolet-visible spectroscopy 
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